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Abstract 
The study about the validity and clinical usefulness of 
the Korean version of the Mini-Mental State 
Examination-2 
 
 Min Jae Baek 
Graduate Program of Translational Medicine 
Department of Medicine 
The Graduate School 
Seoul National University 
 
The Mini-Mental State Examination, 2
nd
 edition (MMSE-2) (Folstein et 
al., 2010) is developed to secure the disadvantages of the Mini-Mental 
State Examination (MMSE) (Folstein et al., 1975), the one of the most 
widely used cognitive screening test in clinical trials, including the story 
memory test that allows more detailed evaluation of verbal memory 
ii 
than the MMSE, and the processing speed test that can measure the 
executive function of the frontal lobe. Therefore, it is expected to be 
more sensitive than the MMSE in discriminating patients with MCI or 
early stage of dementia. The purpose of this study is to investigate the 
reliability and validity of the MMSE-2 by translating into Korean and 
also to investigate the usefulness of the MMSE-2 in Korea through five 
studies.  
In study 1, the MMSE-2 developed by Folstein et al. (2010) was 
translated into Korean and then investigated the reliability and validity 
of the MMSE-2 whether this test is reliable in distinguishing between 
healthy older adults and patients with MCI or AD. The results showed 
that the MMSE-2 can be used as a valid and reliable screening 
measure for assessing cognitive impairment in clinical settings in a 
Korean population, but its ability to distinguish patients with MCI from 
healthy older adults may not be as highly sensitive as expected.  
In study 2, based on the results of the study 1, the usefulness of the 
MMSE-2 and the K-MMSE (Korean version of the Mini-Mental State 
Examination) (Kang et al., 1997) was compared to determine which test 
iii 
is more sensitive in discriminating between healthy older adults and 
patients with MCI or AD. The results showed that the MMSE-2:SV 
(MMSE-2:Standard version) and MMSE-2:EV (MMSE-2:Expanded version) 
were more sensitive and accurate to detect early cognitive decline than 
the K-MMSE or the MMSE-2:BV (MMSE-2:Brief version), but as the 
dementia progressed, the K-MMSE or the MMSE-2:BV might be more 
useful for group discrimination than the MMSE-2:SV and the MMSE-
2:EV. Thus, the MMSE-2 appears to be more useful as a cognitive 
screening test in clinical settings than the K-MMSE.  
In study 3, by using brain MRI, the results of the K-MMSE and the 
MMSE-2 and brain atrophy in healthy older adults, patients with MCI, 
and patients with AD were compared. In particular, the relationship 
between various variables of each test and the areas with brain 
atrophy would be investigated. Moreover, the brain area associated with 
the newly added story memory test and processing speed test in the 
MMSE-2 would be examined. The results showed that the MMSE-2 was 
more related to the degree of atrophy of the general brain area than 
to the K-MMSE. In particular, the MMSE-2:EV can be more useful as a 
iv 
cognitive screening test in clinical settings because the MMSE-2:EV has 
the highest correlation with overall brain area and can measure the 
frontal lobe function which cannot be measured by the K-MMSE.  
In study 4, the reliability and validity of the MMSE-2 was 
investigated whether this test is reliable in distinguishing between 
healthy older adults and patients with VaMCI or VD. The results 
showed that as in the study 1, the MMSE-2 is also found to be 
clinically useful in distinguishing patients with vascular cognitive 
impairment (VCI) from those of healthy older adults with high validity 
and reliability.  
Finally, in study 5, based on the results of study 4, the usefulness of 
the MMSE-2 and the K-MMSE was compared to determine which test is 
more sensitive in discriminating between healthy older adults and 
patients with VaMCI or VD. The results showed that as in the study 2, 
when discriminating between healthy older adults and the group of the 
patients with VCI, the MMSE-2:SV and the MMSE-2:EV were more 
sensitive and accurate to detect early cognitive decline than the K-
MMSE or the MMSE-2:BV, but as the dementia progressed, the K-
v 
MMSE or the MMSE-2:BV might be more useful than the MMSE-2:SV 
and the MMSE-2:EV. Therefore, the MMSE-2 can be useful as a 
cognitive screening test for measuring cognitive function of patients in 
clinical settings not only for the patients with AD but also for the 
patients with VCI.  
Through this present study, we showed that the newly developed 
MMSE-2 (Folstein et al., 2010) is more sensitive and clinically useful for 
differentiating patients with MCI or early stage of dementia from 
healthy older adults than the MMSE. Therefore, if the MMSE-2 is 
widely used as a primary cognitive screening test in primary hospitals, 
public health centers, and elderly welfare centers, it is expected that it 
will be helpful for early detection of dementia. 
 
Keywords: MMSE, MMSE-2, K-MMSE, Mild cognitive impairment, 
Alzheimer’s disease, Vascular mild cognitive impairment, Vascular 
dementia 
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It is a worldwide trend that the proportion of elderly people aged 65 
and older has raised significantly since the middle of the 20th century. 
In particular, the speed of the aging population and low birth rate in 
Korea has been increased, so an extension of the average life 
expectancy has also shown that fast compared to other countries. Our 
country has entered an aging society since 2000, and the elderly 
population is expected to enter the aging society with a population of 
over 20% by 2026, and also the number of elderly people aged 65 and 
older is expected to account for more than 34% of the total population 
in 2050. This increase in the elderly population is raising awareness 
that the support of the elderly is not only the responsibility of the 
family but also the responsibility of the family and society, but the 
proportion of elderly people aged 65 and older who prepares 
themselves for their own retirement life has grown by 35% in 2007 to 
47.1% in 2011 (National Statistical Office, 2013). 
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As an aged society, the economic problems of the elderly are also 
worrisome, but the biggest concern is the health of the elderly. In 
particular, about 59% of the elderly have said that the most worrisome 
disease is dementia (Tomato News, 2013). According to the result about 
studying for senior citizens aged 60 and older, more than half have 
believed that they had severe memory loss (Zarit, et al., 1981).  
As of 2012, the prevalence of dementia in Korea over the aged of 
65 elderly was able to 9.18% which was estimated as 541 thousand 
people (156 thousand of men, 385 thousand of women). Moreover, the 
prevalence of dementia was expected to about 54 million people in 
2012, continue to raise approximately 1.27 million people in 2030, and 
expect to increase approximately 2.71 million people that will be 
doubled every 20 years. 
Among the total number of patients with dementia, they were 
account for 71.3% of Alzheimer's disease (AD), 16.9% of vascular 
dementia (VD), and 11.8% of the other types of dementia. In addition, 
the number of patients suffering from mild cognitive impairment (MCI) 
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in 2012 was estimated to exceed 27.82% of the total population aged 65 
and older (Department of health and human services, 2013). 
Dementia is defined as disability in three or more areas of cognitive 
function such as memory, language, visuospatial function, computational 
skills, conceptual or semantic knowledge, executive function, personality 
or social behavior, and emotional understanding or ability to express 
which lead to a severe disability in social and occupational functioning 
(Cummings, et al., 1992). In the following, the high prevalence kinds of 
dementia in Korea such as MCI, AD, vascular mild cognitive impairment 
(VaMCI), and VD will be investigated in more detail.  
 
Mild Cognitive Impairment (MCI) 
 
Mild Cognitive Impairment (MCI) could be a previous stage of 
dementia, which is that although the deterioration of the cognitive 
function is beyond the scope of normal range, the function of daily life 
activity or the functional activity is relatively preserved that is not 
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reasonable in diagnosing as dementia (Petersen et al., 1999). Initially, 
when making the diagnosis as MCI, a common standard is presented, 
and it is thought be as the previous stage of AD so the criteria about 
amnestic MCI is presented. However, some of patients with MCI feel 
that cognitive impairment is remained at the same level over time or 
rather improve so they think that patients with MCI have not thought 
to be as a homogeneous group. Therefore, patients with MCI have 
been classified into three different types of group in recent years 
(Petersen, 2003).  
In the first type of MCI, memory impairment is the main symptom 
which is that even though the memory impairment is shown but other 
cognitive functions are relatively preserved when compared with age on 
the neuropsychological tests and it refers to maintaining a relatively 
normal life. 
The second type is multiple domain of MCI which is that even 
though two or more cognitive disorders are shown on the 
neuropsychological tests, but a condition is not severe enough to 
diagnosis as dementia (Lopez et al., 2003).  
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The third type is non-memory domain of MCI which is that even 
though one of the cognitive functions (ex., frontal lobe function, 
language function, or visuospatial function etc.) other than memory is 
impaired on the neuropsychological tests, there is no problem in 
everyday life.  
In recent years, according to clinical findings, patients with MCI can 
be classified into various types, and it helps to predict what kinds of 
dementia will progress in the future. 
In the case of amnestic type of MCI, this is the initial state of AD 
which is one of a degenerative disease, and it is most likely to 
progress to AD (Palmer et al., 2008). Other types of MCI are 
considered to be based on vascular, metabolic, and traumatic (Kim et 
al., 2011),  
Recently, the degree of brain atrophy in patients with MCI has been 
examined via the nerve radiological studies. When the size of the 
hippocampus of patients with MCI was measured using magnetic 
resonance imaging (MRI), the size of the hippocampus of patients with 
MCI who progressed to dementia was less than patients with MCI who 
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did not progress to dementia (Kaye et al., 1997). Moreover, a 
comparison of the hippocampus and enthorinal cortex of healthy older 
adults, patients with MCI and AD showed that there was a significant 
difference between the two regions in each group (Xu et al., 2000). In 
other words, the size of the hippocampus gradually decreases as the 
disorder progresses from mild cognitive impairment to dementia, and 
this suggests that the memory capacity gradually decreases. 
 
Alzheimer’s disease (AD) 
 
Alzheimer's disease (AD) is one of the most common dementia 
diseases occurring in old age. AD is a neurodegenerative disease, which 
is caused by gradual loss of cerebral cortical cells, resulting in 
impairment of memory and general cognitive functions (language, 
executive function, visual composition, calculation ability etc.), and 
behavioral disorders and personality changes also occur which lead to 
impossible to live independently (Morris, 1999). In the early stage of AD, 
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the ability of memory and visuospatial function has been reduced, and 
then gradually the ability of praxis, calculation, and executive function 
has been deteriorated, resulting in personality changes and behavioral 
disorders. 
The most widely used diagnostic criteria for AD are DSM-V 
(Diagnostic and Statistical Manual of Mental Disorders, Fifth edition) 
(American Psychiatric Association, 2013) and NINCDS-ADRDA (National 
Institute of Neurological and Communicative Disorders and Stroke and 
the Alzheimer‟s Disease & Related Disorders Association) (McKhann et 
al., 1984). However, the preceding diagnostic criteria was less sensitive 
to early stage of AD so it was revised to “revising the NINCDS-ADRDA” 
diagnostic criteria, including biologic indices, for the early diagnosis of 
AD (Dubois et al., 2007). According to the diagnostic criteria, there is 
atrophy of the hippocampus, enthorinal cortex, and amygdala in the 
characteristic features using brain magnetic resonance imaging (MRI), 
and the characteristic features of functional neuroimaging using 
positron emission tomography (PET) are decreased glucose metabolism 
in the bilateral temporo-parietal areas. 
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Using functional magnetic resonance imaging (fMRI), as a result of 
comparing the brain functions of patients with AD and the healthy 
older adults, it was found that the functional connections between the 
hippocampus and the cortex, hippocampus and subcortical region were 
widely observed in patients with AD, and the damage of connection 
between the hippocampus and frontal lobe was also observed (Allen et 
al., 2007). This suggests that the deterioration of memory function from 
the initial symptoms of patients with AD is associated with a decrease 
in the circuit function of the hippocampus and the frontal lobe as well 
as the functional deterioration of the hippocampus. 
  
Vascular Mild Cognitive Impairment (VaMCI) 
 
Vascular cognitive impairment (VCI) refers to all cognitive 
dysfunctions caused by cerebrovascular disease (Hachinski et al., 1993). 
VCI has various forms of cognitive dysfunctions due to vascular 
dementia and cerebrovascular disease, but it also includes vascular mild 
cognitive impairment (VaMCI) which describes an abnormal condition 
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caused by vascular disease and in which a patient presents with 
cognitive deficits not sever enough to fit the criteria for dementia. 
Especially, VaMCI is characterized by a decrease in the function of the 
frontal lobe among the cognitive domains (Gorelick et al., 2011). 
According to the criteria of AHA/ASA (American Heart Association-
American Stroke Association) (Gorelick et al., 2011), VaMCI includes the 
four types of MCI such as amnestic, amnestic plus other domains, 
nonamnestic single domain, and nonamnestic multiple domain. Moreover, 
there is a clear temporal relationship between a vascular event and 
onset of cognitive deficits, and also there is a clear relationship in the 
severity and pattern of cognitive impairment and the presence of 
diffuse, subcortical cerebrovascular disease pathology.  
 
Vascular Dementia (VD) 
 
Vascular dementia (VD) is defined as the occurrence of dementia due 
to the development of cerebrovascular disease lesions in the main 
cerebral cortex involved in cognitive function including memory and 
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behavioral regulation (Romàn et al., 2002c). VD refers to dementia that 
occurs in a variety of pathologies, from aortic rupture to small vessel 
disease, rather than a single disease (Loeb et al., 1996). Thus, unlike 
AD, it is a heterogeneous group and has many subtypes. The subtypes 
of vascular disorders are divided into multi-infarct dementia, strategic 
single-infarct dementia, and small-vessel disease dementia (O’Brien et 
al., 2003). Multi-infarct dementia is mainly an ischemic stroke caused 
by stenosis or blockage of major blood vessels such as carotid artery 
or middle cerebral artery, cardioembolism or hypoperfusion. Cognitive 
dysfunction is caused by multiple damages of cerebral cortex, which 
leads to dementia. Strategic infarct dementia, unlike multi-infarct 
dementia, can present with a single localized cerebral infarction and 
can cause dementia due to different cognitive dysfunctions depending 
on the location of cerebral infarction. Subcortical vascular dementia 
may damage the prefrontal subcortical circuit or thalamo-cortical circuit 
due to multiple subcortical lacunes or white matter changes in the 
subcortical region (Romàn et al., 2002; Duering et al., 2011). In 
particular, McPherson et al. (1996) reported that dementia due to small 
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vessel disease in the subcortical region of vascular dementia is 
associated with a higher prevalence among vascular dementia. Among 
the various kinds of diagnostic criteria for vascular dementia, NINCDS-
AIREN (National Institute of Neurological Disorders and Stroke and 
Association Internationale pour la Recherche et I’enseignement en 
Neurosciences) (Romàn et al., 1993) is the most stringent and widely 




Measuring the overall cognitive function of patients with dementia by 
neuropsychological assessments is helpful in diagnosis and treatment. 
Therefore, it is important to evaluate the cognitive function of patients 
with dementia by selecting neuropsychological tests that can sensitively 
discriminate cognitive function changes in patients with dementia.  
Neuropsychological evaluation is the evaluation of human general 
cognitive functions, such as memory, language ability, visuospatial 
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function, executive function, and behavioral pattern. Through these 
tests, it is possible to know which area of the brain of patients with 
dementia is damaged according to the cognitive dysfunction, and also 
the prognosis is assessed by grasping the problems experience in daily 
life due to the deterioration of cognitive function so this information 
helps to diagnose and treat patient's illness. Moreover, it has been 
proved that the cognitive impairment of patients with dementia is 
measured sensitively through the neuropsychological tests (Petersen et 
al., 2001).  
As mentioned above, it is essential to evaluate the cognitive function 
of patients with dementia, since dementia is a disease that affects daily 
life because of various cognitive dysfunctions including memory. These 
cognitive deficits should be assessed through a cognitive state 
assessment, such as a clinical assessment scale or a neuropsychological 
test. In addition, the recently published revised NINCDS-ADRDA (Dubois 
et al., 2007), which is a diagnostic criteria for AD, also requires 
neuropsychological assessments to identify dementia. 
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In the neuropsychological assessments which measure cognitive 
function of patients with dementia, there are a comprehensive test 
battery that evaluates various cognitive domains in detail and a 
screening test that is used when it is easy to detect dementia in a 
short time. A comprehensive test battery has the advantage of 
accurately assessing the degree of disability in the cognitive function 
by evaluating various cognitive domains in detail. However, it is used in 
limited clinical settings because it is very important the cooperation of 
patients because of the long time evaluation and also expert knowledge 
is needed to interpret the results. On the other hand, a cognitive 
screening test has a limited amount of information that can be 
provided compared to a comprehensive test battery, but it can be 
applied in a short time and can be applied to patients with severe 
cognitive impairment. Moreover, it has been used in various fields such 
as public health centers and senior welfare institutions for the elderly 
as well as hospitals (Park, 2004). In the following, there is a review 
about the MMSE (Folstein et al., 1975) which has been most widely 
used as a cognitive screening test in both domestically and 
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internationally and the MMSE-2 (Folstein et al., 2010) which is recently 
developed as a cognitive screening test.  
 
1. Mini-Mental State Examination (Folstein et al., 1975) 
 
The MMSE (Folstein et al., 1975) is the most widely used cognitive 
screening test among the various cognitive screening tools in the world. 
The MMSE is a simple cognitive screening test that can evaluate the 
cognitive functions in a short time. The total score is 30 points, and six 
cognitive areas are evaluated for about 5-10 minutes. The six cognitive 
domains to be evaluated in the MMSE include time and place 
orientation, 3 words immediate recall, attention & calculation, 3 words 
delayed recall, language, and praxis. 
The several previous studies reported that the MMSE has been 
proved to be reliable and valid as a detection test for dementia, and it 
had relatively high sensitivity and specificity (Folstein et al., 1975; 
Engedal et al., 1988; O‟Connor et al., 1989; Tombaugh et al., 1992; 
Kaszniak et al., 1986). The MMSE was highly correlated with other 
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neuropsychological tests (Dick et al., 1984; Kartzman et al., 1983; Thal 
et al, 1986; Fillenbaum et al., 1987) and had a high correlation (0.73) 
with the density of synapses in the medial frontal region of the brain 
(Terry et al., 1991). The MMSE has been proved to be useful in 
detecting patients with mild to moderate stages of dementia (Kaszniak 
et al., 1986) and in measuring the cognitive abilities in patients with 
brain damage (Uhlmann et al., 1991), and also it has been reported to 
be useful in assessing diagnosis and prognosis (Tasia et al., 1979). 
Moreover, it has been reported that continuous evaluation over time 
was possible by using the MMSE (Wieslaw et al., 1993).  
In Korea, the MMSE has been developed in various types of Korean 
versions such as the Korean version of Mini-Mental State Examination 
(MMSE-K) (Kwon et al., 1989), the Korean version of the Mini-Mental 
State Examination (K-MMSE) (Kang et al., 1997), and Mini-Mental State 
Examination in the Korean version of the CERAD assessment packet 
(MMSE-KC) (Lee et al., 2002), so these tests have been widely used in 
clinical settings and in local communities including public health centers. 
Moreover, these Korean versions of the MMSE have been actively used 
16 
in domestic epidemiologic studies about the prevalence and diagnosis of 
dementia (Korean Association for Geriatric Psychiatry, 2003). In addition, 
large-scale normative data for Korean were also presented, proving the 
validity and usefulness of the Korean versions of MMSE (Kwon et al., 
1989; Lee et al., 2002; Kang et al., 2006) 
 According to the results of the standardization study and the 
sensitivity and specificity of the K-MMSE with patients with AD, VD, 
and Parkinson's disease, 67 (sensitivity = 82.7%) out of 81 patients with 
AD and 45 (sensitivity = 70.3%) out of 64 patients with VD were 
detected and the specificity was 91.3%. However, the K-MMSE is a 
useful screening tool to detect patients with moderate to severe stage 
of dementia but has not been able to detect patients with early stage 
of dementia (Kang et al., 1997). 
However, previous studies have shown some limitations of the MMSE. 
The MMSE was influenced by age, culture, and language differences, 
and there was lack of items to assess executive function of the frontal 
lobe, so that fronto-temporal dementia or vascular dementia could not 
be accurately identified. Moreover, the range of test difficulty was 
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narrow, indicating that there was a limit in distinguishing early stage of 
dementia from normal cognitive aging (Galasko et al., 1994; Tangalos et 
al., 1996; Romàn et al., 1993; Mungas et al., 2000; Kang et al., 1997). 
According to a study by Mungas et al. (2000), the tests used to assess 
overall cognitive function, such as the MMSE, had nonlinear 
characteristics that were not sensitive to changes in capability at high 
and low functional levels. Therefore, the MMSE was not sensitive to 
detecting early stage of dementia or measuring changes in severe stage 
of dementia levels due to ceiling effect and floor effect. Moreover, 
Nelson et al. (1986) reported that the MMSE was focused on verbal 
items which were not sensitive to impairment of right hemisphere, and 
also it was easy to produce false positive due to the ceiling effect of 
people with good cognitive function because of the low difficulty of the 
items. Srikanth et al. (2006) also showed that the MMSE was not 
sensitive enough to detect cognitive impairment after stroke, with a 
sensitivity of 50% and a specificity of 95%. In addition, a study by 
Scazufca et al. (2008) found that studies of community members with 
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low socioeconomic status indicated the validity of the MMSE was very 
limited.  
In summary, the MMSE is a useful tool for detecting severe stage of 
dementia, but it has limitations in distinguishing patients with mild 
cognitive impairment or early stage of dementia because of the limited 
range of difficulty, and there is a disadvantage in that there is limited 
item to measure the executive function of the frontal lobe (Galasko et 
al., 1994; Kang et al., 1997). Thus, patients with MCI or those with 
early stage of dementia may be judged to be negative during the 
primary screening tests. On the following, there is a review of the 
MMSE-2 (Folstein et al., 2010), which has been made to complement 
these shortcomings of the MMSE. 
 
2. Mini-Mental State Examination, 2
nd




The MMSE has a limited validity, does not have the ability to 
differentiate between patients with MCI or early stage of dementia, and 
does not have an item to evaluate the frontal function. Moreover, 
among the items of the MMSE, there are items that are difficult to 
translate and use in other languages, so they cannot use the same test 
globally. To overcome these shortcomings, Folstein et al. (2010) 
developed the MMSE-2 as a cognitive screening test. Unlike the MMSE, 
the MMSE-2 is composed of two alternative forms (red form & blue 
form) with the same format to reduce the learning effect that can 
occur when the same test is performed several times. In addition, 
MMSE-2 is largely divided into three parts.  
The first is the MMSE-2:Brief version (MMSE-2:BV), which is simpler 
than the MMSE. This test is a total of 16 points, which is a simpler 
test than the MMSE and is intended to be used in clinical 
epidemiological studies or in the clinical field. This test includes 
registration, orientation to time, orientation to place, and recall in 
sequence. Folstein et al. (2010) reported that among the items in the 
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MMSE, the previous four tests had reasonable validity and specificity 
for detecting dementia.  
The second is the MMSE-2:Standard version (MMSE-2:SV), which 
preserves the existing MMSE structure and scoring system. In the 
MMSE-2:SV, the order of some items in the test has been replaced 
when compared with the MMSE, and also some of items have been 
modified and developed, but the total score is 30, and the overall 
composition is the same as the MMSE.  
The third test is the MMSE-2:Expanded version (MMSE-2:EV), which 
adds two new tests such as story memory and processing speed with a 
total score of 90 points. The MMSE-2:EV is developed to be more 
clinically useful than the MMSE. It is expected that it will be more 
sensitive to discriminate patients with early stage of dementia or MCI 
by reducing the ceiling effect, increasing the range of origin points, 
and increasing the range of difficulty than the MMSE. The following is 




The MMSE-2:BV is comprised of four items: registration (3 points), 
orientation to time (5 points), orientation to place (5 points), and recall 
(3 points). In order to increase the difficulty of the test, the three 
words used in the MMSE-2 are one noun word (red form: egg, blue 
form: milk), one adjective word (red form: confident, blue form: 
sensible), and one adverb word (red form: after, blue form: before). 
These words have been syntactically diverse and have been chosen 
from familiar words in global languages (Folstein et al., 2010). 




The MMSE-2:SV is comprised of seven items: registration (3 points), 
orientation to time (5 points), orientation to place (5 points), recall (3 
points), attention and calculation (5 points), language (8 points), and 
drawing (1 points). The total possible score on the MMSE-2:SV is 30 
points which is the same as the total score on the MMSE. The overall 
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item is the same as the MMSE, but there is a modified part of the 
content. The revised tests are as follows.  
First, „Naming‟ item used in the K-MMSE has been modified. In the 
K-MMSE, „Pen‟ and „Watch‟ were used. However, there is a 
disadvantage that an examiner cannot carry these things all the time, 
so a patient is asked to ask for the body part of an examiner (red 
form: mouth, nose; blue form: eye, ear). 
Second, the „Repetition‟ item used in the MMSE has been modified. 
The sentence used in the „Repetition‟ item of the MMSE was „No ifs, 
ands, or buts‟, which was difficult to translate into other language so 
this item was modified to suit the circumstances in each country. For 
example, in the K-MMSE test, „백문이 불여일견‟ was used. One of the 
purposes of developing the MMSE-2 is to use the same test globally so 
the sentences in the MMSE-2 that can be easily translated into other 
languages are used. The sentence used in the red form is „It is a 
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lovely, cool day but too windy‟, and the sentence used in the blue 
form is „It is a lovely, sunny day but too warm.‟ 
The third revised item is „Comprehension test.‟ The „Comprehension 
test‟ used in the MMSE was „Take this piece of paper, fold it in half, 
and put it on the floor‟. In this test, patients without physical problems 
can easily act, but patients who are physically paralyzed or who do not 
move their hands may not be able to perform well, even though they 
can understand. To make up for this, in the MMSE-2, a picture with 
one triangle, one circle, and one square is shown in front of a patient, 
and then a patient is instructed to point the shapes in the order that 
an examiner spoke. In the red form, the instruction sentence is „Point 
to the triangle, then point to the square, then point to the circle.‟ In 
the blue form, the instruction sentence is „Point to the circle, then 
point to the square, then point to the triangle.‟ 
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Finally, a sentence is added in the „Reading‟ section. Since the 
MMSE-2 test has two forms (red form and blue form) unlike the MMSE, 
„Close your eyes‟ in the MMSE is used as it is in red form, „Open your 
mouth‟ is used in blue form. The remaining items (writing and drawing) 




The MMSE-2:EV includes two new tests such as story memory (25 
points) and processing speed (35 points) with the MMSE-2:SV and the 
total score is 90 points. Folstein et al. (2010) added the story memory 
test as a test to assess verbal memory which is useful in discriminating 
patients with MCI or early stage of dementia from healthy older adults. 
The previous studies have suggested that the story memory test is an 
important tool for measuring the verbal memory of patients with AD 
(Butters et al., 1987; Storandt et al., 1984). In addition, it includes the 
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processing speed test which can evaluate the psychomotor speed of the 
frontal lobe function. 
There are two stories (red and blue forms) used in the story memory 
test, each consisting of four sentences, and the level of difficulty of 
sentences is the sixth grade of elementary school. The number of 
words in the story memory test used in red form is 62, and the 
number of words in the story memory test used in blue form is 66. 
Both stories are written in the past tense, using active voice, and 
possibly made without repeating phrases or words. Folstein et al. (2010) 
included the story memory test as a verbal memory test because it was 
important to assess verbal memory in detail to distinguish between 
healthy older adults and patients with MCI or early stage of dementia. 
In the previous studies, the verbal memory tasks were the most useful 
tests in discriminating cognitive functions in patients with early stage 
dementia and healthy older adults (Eslinger et al., 1994; Jones et al., 
1992). Moreover, the story memory test was the most useful test to 
distinguish between those who develop dementia and those who do not 
(Christensen et al., 1997), and the first deterioration of the 
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performance of patients with early stage of dementia was detected in 
the story memory test among the various types of verbal memory tests 
(Morris et al., 1991). Therefore, it can be predicted that the story 
memory test is sensitive to evaluate verbal memory, so that it can 
discriminate between healthy older adults and patients with MCI or 
early stage of AD more accurately.  
The processing speed test is a test which measures the psychomotor 
speed and visual searching and attention ability related to the executive 
function of the frontal lobe (Folstein et al., 2010). Processing speed test 
is similar to the symbol digit modality test (SDMT: Smith, 1982). In the 
fMRI study, 18 normal subjects were examined for their relationship to 
the brain area associated with SDMT, the fronto-parieto-occipital 
network, caudate nucleus, and cerebellum were activated (Forn et al., 
2009).  
In recent years, the MMSE-2 (Folstein et al., 2010) is developed to 
secure the disadvantages of the MMSE, including the story memory test 
that allows more detailed evaluation of verbal memory than the MMSE 
and the processing speed test that can measure executive function of 
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the frontal lobe, so it is expected to be more sensitive than the MMSE 
in discriminating patients with MCI or early stage of dementia. 
Therefore, the purpose of this study is to investigate the reliability 
and validity of the MMSE-2 by translating into Korean and also to 
measure the usefulness of the MMSE-2 in Korea through five studies.  
In study 1, the MMSE-2 developed by Folstein et al. (2010) is 
translated into Korean, and then it is investigated the reliability and 
validity of the MMSE-2 whether this test is reliable in distinguishing 
between healthy older adults and patients with MCI or AD.  
In study 2, based on the results of study 1, the purpose of this study 
is to compare the usefulness of the MMSE-2 and the K-MMSE to 
determine which test is more sensitive in discriminating between 
healthy normal adults and patients with MCI or AD.  
In study 3, by using brain MRI, the results of K-MMSE and MMSE-2 
and brain atrophy in healthy older adults, patients with MCI, and 
patients with AD are compared. In particular, the relationship between 
various variables of each test and the areas with brain atrophy will be 
investigated. Moreover, the brain area associated with the newly added 
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story memory test and processing speed test in the MMSE-2 will be 
evaluated.  
In study 4, the processing speed test which measures executive 
function of the frontal lobe, and the story memory test which measures 
verbal memory in detail are added in the MMSE-2. Therefore, patients 
with early stage of VD who are difficult to distinguish from the MMSE 
will be able to discriminate more sensitively. Thus, the purpose of this 
study is to evaluate the reliability and validity of the MMSE-2 whether 
this test is reliable in distinguishing between healthy older adults and 
patients with VaMCI or VD.  
Finally, in study 5, based on the results of study 4, the purpose of 
this study is to compare the usefulness of the MMSE-2 and the K-
MMSE to determine which test is more sensitive in discriminating 





The Validity and Reliability of the Mini-Mental 
State Examination-2 for Detecting Mild Cognitive 
Impairment and Alzheimer’s Disease  
in a Korean Population 
 
Introduction 
The dementia prevalence rate among elderly people is rapidly 
increasing as the general population of most countries age. Early 
detection is the best way to treat dementia and to plan healthcare. 
Although the Diagnostic and Statistical Manual of Mental Disorder 
(DSM-5) criteria (American Psychiatric Association, 2013) are used for 
the diagnosis of dementia, screening tests can identify patients at risk. 
The Mini-Mental State Examination (MMSE) is the one of the most 
widely used screening tests in clinical trials and in general practice to 
detect cognitive impairment in older adults (Folstein et al., 1975; Lezak 
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et al., 2004). The MMSE is a quick and easy measure that assesses 
seven areas of cognitive functioning, and it was shown to have both 
good test-retest reliability (0.80-0.95)
 
(Folstein et al., 1975; Lezak et al., 
2004; O‟Connor et al., 1989; Tombaugh et al., 1992) and acceptable 
sensitivity and specificity to detect mild to moderate stages of dementia 
(Folstein et al., 1975; Lezak et al., 2004; O‟Connor et al., 1989; 
Tombaugh et al., 1992; Bondi et al., 1996; Engedal et al., 1998). 
However, the MMSE is less sensitive in detecting patients with MCI and 
those in the early stages of dementia, and it is also insensitive to 
impairments in executive functioning, abstract reasoning, and visual 
perception/construction (Galasko et al., 1994; Kang et al., 1997; Nys et 
al., 2005). Moreover, false-positive errors might be more common 
among patients with less education and of lower socioeconomic status, 
and a ceiling effect might be more common among patients with a 
high level of education and patients with MCI because of the low level 
of item difficulty (Nelson et al., 1986). Furthermore, some items in the 
MMSE were difficult to translate into another language, so they have 
been adjusted to accommodate the culture of each country. 
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(Folstein et al., 2010) as a reliable 
cognitive screening measure to provide finer discrimination. First, there 
are equivalent, alternative forms of each MMSE-2 version (red and 
blue forms) to decrease the possibility of practice effects that can 
occur over serial examinations. The equivalency of the alternative 
MMSE-2 forms was 0.96 (Folstein et al., 2010). Moreover, unlike the 
MMSE, there are three different versions of the MMSE-2: the MMSE-2: 
Brief Version (MMSE-2:BV), which is a shortened version of the MMSE; 
the MMSE-2: Standard Version (MMSE-2:SV), which is equivalent to the 
MMSE; and the MMSE-2: Expanded version (MMSE-2:EV), which is 
slightly longer than the MMSE, is more sensitive to changes with aging 
and has a ceiling effect.  
The total score of the MMSE-2: BV is 16 points. This test is simpler 
than the MMSE, and it is used to conduct a rapid clinical assessment 
and to screen larger populations. The MMSE-2:BV is comprised of four 
items: registration, orientation to time, orientation to place, and recall. 
According to Folstein et al. (2010),
 
these four items have adequate 
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sensitivity and specificity to detect the cognitive decline of patients 
with dementia.  
The total possible score on the MMSE-2:SV, is 30 points, which is the 
same as the total score on the MMSE. The structure of the MMSE was 
maintained, but some items from the MMSE were changed. Among 
them, some items that were hard to translate into other languages 
were changed, and some items were replaced to increase the degree of 
difficulty of the MMSE-2.  
Finally, the total score of the MMSE-2:EV is 90 points because two 
more items (story memory and processing speed) were added to 
increase the clinical utility of the MMSE by extending a ceiling effect 
and to increase the sensitivity and specificity of this version to detect 
cognitive impairment not only in patients with Alzheimer’s disease (AD) 
but also in patients with subcortical dementia. The story memory item 
evaluates verbal explicit learning and verbal free recall, and the 
processing speed test (symbol-digit-coding test) measures psychomotor 
ability and incidental learning primarily associated with the executive 
function of the frontal lobe (Folstein et al., 2010).  
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According to the result of the study on the MMSE-2 (Folstein et al., 
2010), the sensitivities of the MMSE-2:SV and the MMSE-2:EV were 
both 84% for discriminating patients with AD from healthy older adults. 
Moreover, the sensitivities of the MMSE-2:SV and the MMSE-2:EV were 
72% and 75% for discriminating patients with subcortical dementia from 
normal cognitive aging. That is, the MMSE-2 is a more useful screening 
measure for dementia and cognitive impairment than the MMSE. 
Therefore, the purpose of this study is to evaluate the validity and 
reliability of the MMSE-2 for assessing patients with MCI and AD in a 
Korean population. Specifically, we would like to focus on the 
usefulness of the MMSE-2 as a sensitive screening measure for 







Materials and Methods 
1. Participants 
1.1. Patients 
Between June 2012 and April 2013, 323 outpatients and inpatients at 
the Clinical Neuroscience Center at the Seoul National University 
Bundang Hospital who complained of memory disturbance or a decline 
in cognitive functioning underwent a medical examination via an 
interview, a neurological examination, blood tests, brain imaging with 
CT or MRI, and neuropsychological assessments to obtain a diagnosis. 
Among them, 226 patients (90 male, 136 female) were diagnosed with 
MCI, and 97 patients (36 male, 61 female) were diagnosed with AD. All 
patients were over 50 years old.  
The patients with MCI were diagnosed according to Petersen’s 
criteria (Petersen et al., 2001), and the patients with AD were 
diagnosed with ‘probable AD’ based on the criteria of the National 
Institute of Neurological and Communicative Disorders and Stroke and 
the Alzheimer’s disease and Related Disorders Associations (NINCDS-
35 
ADRDA) (McKhann et al., 1984). Moreover, based on the Clinical 
Dementia Rating (CDR) (Morris, 1993) and the Clinical Dementia Rating 
Scale Sum of Boxes (CDR-SOB) (O‟Bryant et al., 2008; O‟Bryant et al., 
2010) scores, patients were classified as having MCI (CDR 0.5, CDR-
SOB 0.5-2.5), early stage of AD (CDR 0.5, CDR-SOB 3.0-4.0), mild stage 
of AD (CDR 1, CDR-SOB 4.5-9.0), or moderate stage of AD (CDR 2, 
CDR-SOB 9.5-15.5).  
 
1.2. Control participants 
Between June 2012 and April 2013, 91 healthy adults who were all 
over 50 years of old age participated in this study. They were either 
the caregivers for one of the patients undergoing treatment at Seoul 
National University Bundang Hospital, or they were recruited from a 
health care center. They did not have subjective memory complaints, 
any of 29 exclusionary diseases, or a history suggestive of a decrease 
in cognitive function (Christensen et al., 1997).
 
They also had scores 
that were higher than or at most one standard deviation below the 
mean scores of the respective age- and education-matched population 
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on the Mini-Mental State Examination in Korea (Kang et al., 1997) and 
had an average score of 0.42 or lower on the Korean Instrumental 
Activities of Daily Living (K-IADL) (Kang et al., 2002). This score has 
been found to discriminate dementia from normal cognitive aging. The 
K-IADL is an 11-item questionnaire that includes IADLs of shopping, 
mode of transportation, ability to handle finances, housekeeping, food 
preparation, ability to use a telephone, taking medication, recent 
memory, hobbies, watching television, and fixing. All participants were 
determined to be free of cognitive deficits, and they all consented to 
participate in this study. Moreover, all participants were free from 
neurological or psychiatric illnesses, underwent the same 
neuropsychological assessments as the cognitively impaired subjects and 




The Psychological Association Research (PAR) holds the copyright to 
the MMSE-2, and they allowed us to translate the MMSE-2 into Korean 
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before the start of this study. Because one of the purposes of 
developing the MMSE-2 was to conduct the same test across the world, 
which the MMSE cannot do, the items of the MMSE-2 should not be 
modified to adjust to cultural background. Therefore, two neurologists 
and two neuropsychologists with over ten years of clinical experience 
translated the MMSE-2 into Korean and then, after performing many 
stages of modification, sent the back-translated MMSE-2 to PAR for 
certification. The final version of the MMSE-2 in Korean was modified 
by experts at PAR, and then the Korean version of the MMSE-2 was 
finalized in April 2012. 
The MMSE-2 is composed of alternative forms, such as the red form 
and the blue form, to reduce the learning effect that may take place 
upon repeated use. Moreover, as mentioned earlier, the MMSE-2 has 
three versions, the MMSE-2:BV, the MMSE-2:SV, and the MMSE-2:EV, 
and nine subtests of the MMSE-2 are as follows.  
The MMSE-2:BV is composed of four subtests in the following order: 
registration, orientation to time, orientation to place, and recall. The 
MMSE-2:SV is composed of seven subtests in the following order: 
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attention and calculation, language, drawing, and the four subtests of 
the MMSE-2:BV. The MMSE-2:EV is composed of nine subtests in the 
following order: story memory, processing speed, and the seven subtests 
of the MMSE-2:SV. The detailed explanation of story memory and 
processing speed, which are included in the MMSE-2, is as follows. 
 
2.2. Story memory test 
The story memory test measures verbal explicit learning and verbal 
immediate free recall. The story memory test is composed of four 
sentences, and the sentences are on a sixth grade reading level. The 
red form and the blue form of the MMSE-2 each contain a different 
story. The story on the red form was 62 words long, and the story on 
the blue form was 66 words long. Each story was written in the past 
tense using the active voice, and contained no repetitive words or 
phrases (Folstein et al., 2010). 
 
2.3. Processing speed test (Symbol-Digit-Coding test) 
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The processing speed measure is tapping into frontal lobe areas. This 
test measures psychomotor ability primarily associated with executive 
function of the frontal lobe: this is one of the components of the 
symbol-digit-coding test. Participants are asked to pair symbols with 
digits within a 30 seconds time limit. Although the stimuli of the red 
and blue forms are the same, the template that the participants draw 
is different on each form of the test (Folstein et al., 2010). 
 
2.4. Other neuropsychological assessments 
To measure the correlation of the MMSE-2 with other 
neuropsychological assessments, a variety of cognitive functions, such 
as attention, verbal memory, visuospatial function ability, executive 
function, and language function, were measured. Attention was assessed 
using forward and backward digit span tests (Kang et al., 2002). Verbal 
memory was assessed using the Seoul Verbal Learning Test (SVLT) 
(Kang et al., 2003), and a copy of the Rey Complex Figure Test (RCFT) 
(Meyers et al., 1995) was used to assess visuospatial function. 
Neuropsychological assessments primarily associated with executive 
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function, including the Stroop Color-Word Test (Lee et al., 2000), the 
Semantic Word Fluency Test (SWF) and the Phonemic Word Fluency 
Test (PWF) (Kang et al., 2000), were used. Naming ability was assessed 
using the Korean version of the Boston Naming Test (K-BNT) (Kim et 
al., 1997). Global measurements, including the MMSE in Korean (Kang 
et al., 1997), CDR (Morris, 1993), and CDR-SOB (O‟Bryant et al., 2008; 
O‟Bryant et al., 2010) were also conducted.  
 
3. Procedure 
First, to measure the equivalency of the alternative forms of the 
MMSE-2 tests, 138 patients completed both the red and blue forms of 
the MMSE-2. To eliminate the order effect, half of the 138 patients 
completed the red form of the MMSE-2 first and the other half 
completed the blue form of the MMSE-2 first. According to the result 
of Pearson’s correlation analysis, the correlation coefficient was high 
between the red and blue forms of the MMSE-2:BV (r=0.90, p<0.001), 
the MMSE-2:SV (r=0.97, p<0.001), and the MMSE-2:EV (r=0.97, p<0.001).  
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Therefore, half of the patients who participated in this study 
completed the red form of the MMSE-2, and the other half of 
completed the blue form of the MMSE-2. Also, the order in which the 
neuropsychological assessments were administered is shown in Table 1.  
 
4. Statistical analysis 
An analysis of variance (ANOVA) was used to compare age and 
education levels, and a chi-square test was used to compare gender 
across all three groups. The results of the neuropsychological tests 
including the MMSE, among the three groups were analyzed using an 
analysis of covariance (ANCOVA) after controlling for demographic 
variables (age and education). Moreover, the MMSE-2 scores of all 
three groups were analyzed with an ANCOVA followed by Tukey’s 
test for post-hoc analysis.  
Reliability was assessed through measurements of internal consistency, 
test-retest reliability, and interrater reliability. The internal consistency 
of the MMSE-2 was measured using Cronbach’s α coefficient. To 
assess test-retest reliability, the MMSE-2 was re-administered one to 
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two months (34.48±3.48 days) after the initial test to 16 patients with 
MCI, 4 patients with AD, and 7 healthy older adults, and the data were 
analyzed using Pearson’s correlation coefficients. Moreover, to assess 
the equivalency of the blue and red forms of the MMSE-2, 138 
participants were given both the blue and red forms in a 
counterbalanced design, with the second administration immediately 
following the first, and the data were analyzed using Pearson 
correlation coefficients. Interrater reliability was calculated between two 
neuropsychologists (n=160) using the intraclass correlation coefficient 
(ICC).  
Finally, the validity of the MMSE-2 was analyzed as follows. To 
evaluate the construct validity, a Varimax rotated factor analysis was 
used to explore the factor structure of the 13 items. Moreover, to 
assess the concurrent validity of the MMSE-2, Pearson’s correlation 
coefficient was used to compare the MMSE-2 with the MMSE, the CDR, 
the CDR-SOB, SVLT, the copy test of RCFT, the SWF, the PWF, the 
Stroop Color-Word test, the K-BNT, and the digit span test (forward & 
backward). To verify the discriminant validity based on the severity of 
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dementia, all participants were classified into four groups according to 
CDR and CDR-SOB, and the average scores of the MMSE-2 were 
compared among these four groups using ANCOVA. To evaluate the 
diagnostic utility of the MMSE-2, the sensitivity and specificity of the 
MMSE-2 was examined using a receiver operating characteristics (ROC) 
curve and area under the curve (AUC) measurements. Data were 
analyzed using SPSS 18.0. (SPSS Inc., Chicago, IL, USA), and p < 0.05 










1. The participants’ demographic data  
The demographic data are presented in Table 2. A total of 414 
elderly participants (155 men and 259 women) were enrolled in this 
study. The mean age of the patients with MCI was 71.05±7.73 years 
(range: 70-72 years), and the mean age of the patients with AD was 
75.38±7.60 (range: 73-77 years). The mean age of the healthy older 
adults was 67.05±7.55 years (range: 65-69 years). The mean number of 
years of education was 11.45±4.80 years (range: 10-12 years) in the 
patients with MCI, 9.63±5.15 years (range: 8-11 years) in the patients 
with AD, and 10.98±5.21 years (range: 9-12 years) in the healthy older 
adults.  
There was no significant difference in the participants’ gender, χ
2 
(1,414) = 1.76, p = 0.42, but there were significant differences in age, 
F(2, 411) = 27.82, p < 0.001, and education, F(2, 411) = 4.38, p < 0.013, 
between the three groups. According to Tukey’s post hoc analysis, the 
mean age of the patients with AD was significantly higher than the 
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mean age of the patients with MCI and of the healthy older adults, and 
the mean age for the patients with MCI was significantly higher than 
that of the healthy older adults. Moreover, the mean number of years 
of education for the patients with MCI was higher than for the patients 
with AD, and there was no significant difference in the mean number 
of years of education between the patients with AD and the healthy 
older adults or between the patients with MCI and the healthy older 
adults. 
 
2. The results of participants’neuropsychological 
assessments  
The results of the neuropsychological assessments of the three 
groups (MCI, AD, and healthy older adults) were compared. With 
respect to each of the cognitive domain scores, the three groups 
differed significantly in each of the domain assessed: attention, verbal 
memory, visuospatial function, language function, and frontal/executive 
function (all p < 0.05). Tukey’s post hoc analysis of the cognitive 
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domain revealed that the scores of the healthy older adults were 
significantly higher than the scores of the patients with MCI and AD 
and that the scores of the patients with MCI were significantly higher 
than the scores of the patients with AD in the MMSE, the SVLT, the 
copy of the RCFT, the SWF, the PWF, the Stroop Color-Word test 
(color naming), the K-BNT, and the digit span test (forward & 
backward). However, in the Stroop Color-Word test (word reading), 
although there was no significant difference between the healthy older 
adults and the patients with MCI, the scores of the two groups (healthy 
older adults and MCI) were significantly higher than those of the 
patients with AD. The mean scores of the subtests for each group and 
the results of Tukey’s post-hoc analysis are presented in Table 3.  
 
3. MMSE-2  
3.1. The equivalency of the blue and red forms of the MMSE-2 
The MMSE-2 blue and red forms equating sample consisted of 138 
participants with an average age of 72.22±7.46 years and an average 
educational level of 10.58±5.10 years. The average scores of the 
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MMSE-2:BV (red and blue forms), MMSE-2:SV (red and blue forms), and 
MMSE-2:EV (red and blue forms) are presented in Table 4. The 
reliability was high for all three alternative forms: the MMSE-2:BV (r = 
0.90, p < 0.01), the MMSE-2:SV (r = 0.97, p < 0.01), and MMSE-2:EV (r 
= 0.97, p < 0.01).  
 
3.2. The results of the MMSE-2 in the groups of normal, MCI, 
and AD 
The MMSE-2:BV scores of the participants in the three groups are 
shown in Table 5. An ANCOVA that controlled for age and education 
revealed significant differences between the three groups on the 
MMSE-2:BV. According to Tukey’s post hoc analyses, the total score 
of the MMSE-2:BV was significantly higher for the healthy older adults 
than for the patients with MCI and the patients with AD, and it was 
significantly higher for the patients with MCI than for the patients with 
AD. Especially, among all items of the MMSE-2, the score of recall was 
significantly higher for the healthy older adults than for the patients 
with MCI and the patients with AD, and it was significantly higher for 
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the patients with MCI than for the patients with AD. However, there 
were no significant differences in the items registration, orientation to 
time, and orientation to place between the healthy older adults and the 
patients with MCI, but the scores of the three items in the MMSE-2:BV 
were significantly higher for the healthy older adults and the patients 
with MCI than for the patients with AD.  
The MMSE-2:SV scores of the participants in the three groups are 
shown in Table 6. An ANCOVA that controlled for age and education 
revealed significant differences between the three groups on the 
MMSE-2:SV. Tukey’s post hoc analyses showed that the total score of 
the MMSE-2:SV was significantly higher for the healthy older adults 
than for the patients with MCI and the patients with AD, and it was 
also significantly higher for the patients with MCI than for the patients 
with AD. Particularly, among all MMSE-2 items, the score of recall was 
significantly higher for the healthy older adults than for the patients 
with MCI and the patients with AD, and it was also significantly higher 
for the patients with MCI than for the patients with AD. However, 
there were no significant differences in the items registration, 
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orientation to time, orientation to place, attention and calculation, 
language, or drawing between the healthy older adults and the patients 
with MCI, but the scores of six items on the MMSE-2:SV were 
significantly higher for the healthy older adults and the patients with 
MCI than for the patients with AD.  
The MMSE-2:EV scores of the participants in the three groups are 
shown in Table 7. An ANCOVA that controlled for age and education 
revealed significant differences between the three groups on the 
MMSE-2:EV. Tukey’s post hoc analyses showed that the total score of 
the MMSE-2:EV was significantly higher for the healthy older adults 
than for the patients with MCI and the patients with AD, and it was 
also significantly higher for the patients with MCI than for the patients 
with AD. Particularly, among the MMSE-2:EV items, the scores of recall, 
story memory, and processing speed were significantly higher for the 
healthy older adults than for the patients with MCI and the patients 
with AD, and the scores of three items were also significantly higher 
for the patients with MCI than for the patients with AD. However, 
there were no significant differences in the items registration, 
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orientation to time, orientation to place, attention and calculation, 
language, or drawing between the healthy older adults and the patients 
with MCI, but the scores of six items on the MMSE-2:EV were 
significantly higher for the healthy older adults and the patients with 
MCI than for the patients with AD.  
 
4. Reliability analyses 
4.1. Internal Consistency 
The internal reliability (Cronbach‟s α) of three versions of the 
MMSE-2 (red and blue forms) among the three groups are presented in 
Table 8. The interrater reliability was high because alphas ranged from 
0.62 to 0.79. 
 
4.2. Test-retest reliability 
  Sixteen patients with MCI, 4 patients with AD, and 7 healthy older 
adults were tested twice, at an interval that averaged 34.48±3.48 days, 
to examine the test-retest reliability. The mean age of the participants 
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was 68.37±11.17 years and the mean number of years of education 
was 11.17±3.95 years. The test-retest reliability of three versions of 
the MMSE-2 was high, ranging from 0.76 to 0.90 (Table 9).  
 
4.3. Interrater reliability 
Two trained neuropsychologists were present during the 
administration of the MMSE-2 to 160 participants. One-way, single-
measure intraclass correlation coefficients (ICCs) were calculated for 
each item of the MMSE-2 (Table 10). The ICCs ranged from 0.94 to 
0.99. There was 100% agreement for registration, orientation to time, 
orientation to place, attention and calculation, naming, repetition, 
comprehension, reading, writing, drawing, and the psychomotor speed 
task. 
 
5. Validity analyses 
5.1. Construct validity 
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Construct validity was examined via principal component analysis with 
Varimax rotation to determine the factor structure of the MMSE-2 in 
each group. The results of the factor analyses in each group are as 
follows.  
The factor analysis of the healthy older adults identified two factors 
in the MMSE-2 that explained approximately 48.4% of the total 
variance, as shown in Table 11. Factor 1 included six subtests (recall, 
orientation to place, story memory, processing speed, attention and 
calculation, and orientation to time) that explained 36.0% of the 
variance. We named this factor as‚tests that are sensitive to decline 
in cognitive functions”. Factor 2 included three subtests (registration, 
language, and drawing) that explained 12.4% of the variance. We 
named this factor as “tests that are not sensitive to decline in 
cognitive functions”. 
The factor analysis of the patients with MCI identified three factors 
in the MMSE-2 that explained approximately 52.2% of the total 
variance (Table 12). Factor 1 included three subtests (attention and 
calculation, drawing, and processing speed) that explained 27.5% of the 
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variance. We named this factor as‚tests related with frontal lobe 
function”. Factor 2 included two subtests (recall and story memory) that 
explained 13.3% of the variance. We named this factor as “tests related 
with verbal memory”. Factor 3 included three subtests (orientation to 
place, orientation to time, and registration) that explained 11.3% of the 
variance. We named this factor as “tests related with orientation and 
immediate recall”. 
The factor analysis of the patients with AD identified two factors in 
the MMSE-2 that explained approximately 45.3% of the total variance 
(Table 13). Factor 1 included five subtests (language, processing speed, 
drawing, attention and calculation, and registration) that explained 30.2% 
of the variance. We named this factor as “tests for cognitive domains 
except for episodic memory”. Factor 2 included four subtests 
(orientation to time, recall, story memory, and orientation to place) that 
explained 15.1% of the variance. We named this factor as “tests for 
episodic memory”. 
 
5.2. Concurrent validity  
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The concurrent validity of the MMSE-2 was examined through 
correlation with the values of the MMSE, the CDR, the CDR-SOB, the 
SVLT, the copy of RCFT, the SWF, the PWF, the Stroop Color-Word 
test, the K-BNT, and the digit span test (forward & backward). The 
results showed that the three versions of the MMSE-2 were 
significantly correlated with the cognitive function tests (Table 14). 
Particularly, the correlation coefficients were high between the MMSE-
2:BV and the MMSE (r = 0.84, p < 0.01), the MMSE-2:SV and the 
MMSE (r = 0.92, p < 0.01), and the MMSE-2:EV and the MMSE (r = 
0.83, p < 0.01).  
 
6. Discriminant validity by CDR stage analysis 
To examine the utility of the MMSE-2 to detect dementia severity, 
the participants were reclassified into five groups according to their 
CDR and CDR-SOB scores. Specifically, the healthy older adults were 
assigned a CDR score of 0 (CDR-SOB 0), the patients with MCI were 
assigned a CDR score of 0.5 (CDR-SOB 0.5-2.5), the patients with early 
stage of AD were assigned a CDR score of 0.5 (CDR-SOB 3.0-4.0), the 
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patients with mild stage of AD were assigned a CDR score of 1 (CDR-
SOB 4.5-9.0), and the patients with moderate stage of AD were 
assigned a CDR score of 2 (CDR-SOB 9.5-15.5). The average age, 
educational level, and gender of the participants are presented in Table 
15. Although there was no significant difference in gender, χ
2
(1,414) = 
3.03, p = 0.93, between the five groups, there were significant 
differences in age, F(4,409) = 14.703, p < 0.001, and education, F(4,409) 
= 2.598, p = 0.036. 
The scores of all three versions of the MMSE-2 for the participants 
in the five groups are presented in Table 16. An ANCOVA that 
controlled for age and education revealed significant differences 
between the five groups in all three versions of the MMSE-2. 
According to Tukey’s post hoc analyses, the five groups differed 
significantly with respect to the scores of the MMSE-2:BV and the 
MMSE-2:SV. However, on the MMSE-2:EV, the three groups (MCI, early 
stage of AD, and healthy older adults) differed significantly, but there 
was no significant difference between the patients with mild stage of 
AD and the patients with moderate stage of AD.  
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7. Diagnostic utility 
To measure the diagnostic utility of the three versions of the MMSE-
2, the ROC curve analysis and the area under the curve (AUC) was 
calculated. The results of each version of the MMSE-2 were as follows.  
 
7.1. MMSE-2:BV 
First, for discriminating the healthy older adults from the patients 
with MCI, the AUC of the MMSE-2:BV was 0.71 (95% confidence 
interval, CI, 0.64-0.77, p < 0.001). The sensitivity of the MMSE-2:BV 
was 60% and the specificity was 75% when using a cut-off score of ≤ 
14 of 16 to predict MCI. Second, for discriminating the patients with 
MCI from the patients with AD, the AUC of the MMSE-2:BV was 0.93 
(95% CI, 0.90-0.96, p < 0.001). The sensitivity of the MMSE-2:BV was 
88% and the specificity was 87% when using a cut-off score of ≤ 10 
of 16 to predict AD. Finally, for discriminating the healthy older adults 
from the patients with AD, the AUC of the MMSE-2:BV was 0.97 (95% 
CI, 0.96-0.99, p < 0.001). The sensitivity of the MMSE-2:BV was 98% 
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and the specificity was 70% when using a cut-off score of ≤ 10 of 16 
to predict AD (Figure 1). 
 
7.2. MMSE-2:SV 
 First, for discriminating the healthy older adults from the patients 
with MCI, the AUC of the MMSE-2: SV was 0.72 (95% CI, 0.66-0.79, p 
< 0.001). The sensitivity of the MMSE-2:SV was 74% and the specificity 
was 59% when using a cut-off score of ≤ 26 of 30 to predict MCI. 
Second, for discriminating the patients with MCI from the patients with 
AD, the AUC of the MMSE-2:SV was 0.93 (95% CI, 0.89-0.96, p < 
0.001). The sensitivity of the MMSE-2:SV was 84% and the specificity 
was 87% when using a cut-off score of ≤23 of 30 to predict AD. 
Finally, for discriminating the healthy older adults from the patients 
with AD, the AUC of the MMSE-2:SV was 0.95 (95% CI, 0.92-0.98, p < 
0.001). The sensitivity of the MMSE-2:SV was 92% and the specificity 





First, for discriminating the healthy older adults from the patients 
with MCI, the AUC of the MMSE-2:EV was 0.73 (95% CI, 0.66-0.80, p < 
0.001). The sensitivity of the MMSE-2:EV was 71% and the specificity 
was 69% when using a cut-off score of ≤ 46 of 90 to predict MCI. 
Second, for discriminating the patients with MCI from the patients with 
AD, the AUC of the MMSE-2:EV was 0.92 (95% CI, 0.89-0.95, p < 
0.001). The sensitivity of the MMSE-2:EV was 82% and the specificity 
was 85% when using a cut-off score of ≤ 36 of 90 to predict AD. 
Finally, for discriminating the healthy older adults from the patients 
with AD, the AUC of the MMSE-2:EV was 0.94 (95% CI, 0.91-0.98, p < 
0.001). The sensitivity of the MMSE-2:EV was 92% and the specificity 










This study verified the newly developed MMSE-2 as a reliable and 
valid cognitive screening measure for MCI and AD in a Korean 
population. The results demonstrated several key points. 
First, the results of the MMSE-2 and other neuropsychological 
assessments that measure attention, verbal memory, visuospatial 
function, language function, and frontal/executive function significantly 
differed between the three groups (healthy older adults, MCI, AD).  
Second, the MMSE-2 was shown to have good internal consistency, 
high test-retest reliability, and high inter-rater reliability. 
Third, to demonstrate the construct validity of the MMSE-2, a factor 
analysis was performed on each of the three groups. For the patients 
with MCI, the MMSE-2 was divided into three factors. The first factor 
included the tests related to working memory and frontal lobe 
functioning, such as attention and calculation, drawing, and psychomotor 
speed task. The drawing test was correlated with temporal elements of 
working memory, and it had indirect effects on attention and 
calculation (Shigemori et al., 2010). The second factor included the tests 
60 
related to verbal memory, such as recall and story memory tests. The 
third factor included the tests related to orientation and immediate 
recall, such as orientation to place, orientation to time, and registration 
tests. Tests of working memory and verbal memory were sensitive for 
detecting early decline in cognitive function (Greene et al., 1996; 
Johnson et al., 1994; Salthouse et al., 1988). Moreover, working memory 
was related to a decline in episodic memory, and tests of verbal 
memory measured episodic memory. Thus, the tests related to episodic 
memory may be sensitive in assessing cognitive functioning of the 
patients with MCI.  
For the patients with AD, the MMSE-2 was divided into two factors. 
The first factor included language, processing speed, drawing, attention 
and calculation, and registration, which can measure overall cognitive 
functioning other than memory. The second factor included the tests 
related to episodic memory, such as orientation to time, recall, story 
memory, and orientation to place.  
We compared the factor analysis of the patients with AD and that of 
the patients with MCI. For the patients with MCI, the tests of 
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orientation to time and orientation to place were not sensitive to 
changes in cognitive functions, but for the patients with AD, tests of 
recall and story memory and tests of orientation to time and orientation 
to place were sensitive to changes in cognitive functions. Therefore, as 
mild cognitive impairment progresses to AD, tests related to episodic 
memory seems to become sensitive to changes in cognitive function.  
In the healthy older control group, the MMSE-2 was divided into two 
factors: tests that are sensitive to decline in cognitive functions, such 
as recall, orientation to place, story memory, processing speed, 
attention and calculation, and orientation to time orientation; and tests 
that are not sensitive to decline in cognitive functions, such as 
registration, language and drawing. Therefore, this demonstrated that 
the factor analyses differed between the groups based on the degree 
of cognitive impairment and confirmed that all MMSE-2 items were 
clearly divided between the groups. 
The present study also showed that the MMSE-2 was highly 
correlated with various neuropsychological assessments with verified 
validity. Particularly, the MMSE-2 had a very high correlation with the 
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MMSE, and it also demonstrated a high correlation with verbal memory 
frontal lobe function tests. Even though there is executive function test 
in the MMSE such as attention and calculation, the MMSE is insensitive 
to impairments in executive functioning, abstract reasoning, and visual 
perception/concentration (Nys et al., 2005). However, the MMSE-2, as 
Folstein et al. (2010) suggested, has shown its ability to measure 
executive function in more detail, and thus, it can measure a greater 
variety of cognitive functions than the MMSE.  
Fourth, the scores of the MMSE-2 could also discriminate between 
each of the CDR and CDR-SOB stages. Thus, the scores of the MMSE-
2 declined significantly as CDR and CDR-SOB scores increased, which 
confirms that the MMSE-2 is able to discriminate between the stages of 
CDR and CDR-SOB. This showed that the MMSE-2 is a useful 
instrument as a screening measure for detecting the progress of 
cognitive impairment. However, with the MMSE-2:EV, there was no 
significant difference between the patients with mild stage of AD and 
the patients with moderate stage of AD. One of many possible reasons 
for this finding is that the difficulty levels of story memory and 
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processing speed tests might seem too challenging for the patients 
beyond mild stage of AD, and so a floor effect is highly probable. Thus, 
the MMSE-2:BV and MMSE-2:SV can be more effective than the 
MMSE-2:EV in assessing cognitive functions of the patients with mild 
stage of AD and the patients with moderate stage of AD. 
Finally, the sensitivity and specificity of the three versions of the 
MMSE-2 in discriminating between the healthy older adults and the 
patients with MCI were tested: for the MMSE-2:BV, the sensitivity was 
60% and the specificity was 75% at the cut-off score of 14/15; for the 
MMSE-2:SV, the sensitivity was 74% and the specificity was 59% at the 
cut-off score of 26/27; and for the MMSE-2:EV, the sensitivity was 71% 
and the specificity was 69% at the cut-off score of 46/47. All three 
versions of the MMSE-2 could similarly discriminate between the two 
groups.  
Moreover, the sensitivity and specificity of the three versions of the 
MMSE-2 in discriminating between the patients with MCI and the 
patients with AD were tested: for the MMSE-2:BV, the sensitivity was 
88% and the specificity was 87% at the cut-off score of 11/12; for the 
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MMSE-2:SV, the sensitivity was 84%, and the specificity was 87% at the 
cut-off score of 23/24; and for the MMSE-2:EV, the sensitivity was 82% 
and the specificity was 85% at the cut-off score of 36/37. All three 
versions of the MMSE-2 could similarly discriminate between the two 
groups. 
The sensitivity and specificity of three versions of the MMSE-2 in 
discriminating between the healthy older adults and the patients with 
AD were tested: for the MMSE-2:BV, the sensitivity was 98% and the 
specificity was 70% at the cut-off score of 10/11; for the MMSE-2:SV, 
the sensitivity was 93%, and the specificity was 80% at the cut-off 
score of 22/23; and for the MMSE-2:EV, the sensitivity was 92% and 
the specificity was 71% at the cut-off score of 34/35. All three 
versions of the MMSE-2 could similarly discriminate between the two 
groups. 
Overall, the MMSE-2 is useful for discriminating between the patients 
with MCI vs. the patients with AD and between healthy older adults vs. 
the patients with AD, but its ability to discriminate between the healthy 
older adults vs. the patients with MCI is less than satisfactory. 
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Nevertheless, the MMSE-2 is slightly more sensitive in this area than 
the MMSE, which has sensitivity of 82.7% at the cut-off score of 23/24 
[9]. 
In summary, according to these results, as Folstein et al. (2010) 
suggested, the MMSE-2 can be used as a valid and reliable screening 
measure for assessing cognitive impairment in clinical settings in a 
Korean population, but its ability to distinguish the patients with MCI 












Table 1. Order of neuropsychological assessments 
Order List of neuropsychological assessments 
1 MMSE-2 (red form or blue form) 
2 SVLT-immediate recall 
3 RCFT-copy 
4 Digit span-forward 
5 Digit span-backward 
6 Stroop Color-Word test (word reading) 
7 Stroop Color-Word test (color naming) 
8 SVLT-delayed recall 
9 SVLT-recognition 
10 SWF-animal 




Abbreviations: MMSE-2, Mini-Mental State Examination-2; SVLT, Seoul Verbal 
Learning Test; RCFT, Rey Complex Figure Test; SWF, Semantic Word Fluency; 
PWF, Phonemic Word Fluency; K-BNT, Korean version of Boston Naming Test; 














Table 2. Characteristics of participants (M±SD) 
 All participants (n=414) 
Normal (n=91) MCI (n=226) AD (n=97) 
Age (years) 67.05±7.55 71.05±7.73* 75.38±7.60
“
 
Education (years) 10.98±5.21 11.45±4.80 9.63±5.15
”
 
Male/Female 29/62 90/136 36/61 
Abbreviations: M, Mean; SD, Standard deviation; MCI, Mild Cognitive impairment; 
AD, Alzheimer’s disease. 
Note. 
*p < 0.001 for MCI vs. Normal. 
“
p < 0.001 for AD vs. MCI and Normal. 
”










Table 3. The results of neuropsychological assessments in the groups of normal, MCI, and AD (M±SD) 
Neuropsychological 
assessments 
N(1) MCI(2) AD(3) F df Post-hoc 
MMSE 27.29±2.31 25.68±2.68 19.33±3.82 201.32* 2, 409 1>2>3 
SVLT-immediate recall 21.47±4.06 17.15±4.39 10.91±3.71 111.87* 2, 409 1>2>3 
SVLT-delayed recall 7.26±2.00 3.49±2.92 0.29±0.92 152.14* 2, 409 1>2>3 
SVLT-recognition 9.46±1.68 7.42±2.42 3.70±2.87 104.73* 2,409 1>2>3 
RCFT-copy 32.41±3.87 28.87±5.32 22.50±7.63 66.91* 2, 403 1>2>3 
SWF-animal 17.40±4.14 12.86±3.75 8.84±4.31 80.74* 2, 409 1>2>3 
SWF-supermarket items 18.97±5.32 14.46±5.84 8.33±4.57 61.57* 2, 404 1>2>3 
PWF-ㄱ, ㅇ, ㅅ 26.35±11.01 20.41±9.78 13.83±8.95 27.51* 2, 358 1>2>3 
Stroop Color-Word test 
(word reading) 
110.89±5.98 111.13±4.03 105.31±13.68 13.49* 2, 374 1=2>3 
Stroop Color-Word test 
(color naming) 
88.30±17.91 70.41±23.45 40.73±24.30 63.86* 2, 354 1>2>3 
K-BNT 48.15±8.09 40.48±9.97 28.70±11.22 63.33* 2, 409 1>2>3 
Digit span-forward 6.07±1.51 5.63±1.40 4.91±1.45 6.44* 2, 409 1>2>3 
Digit span-backward 4.10±1.15 3.56±0.97 2.92±0.95 25.23* 2, 409 1>2>3 
Abbreviations: M, Mean; SD, Standard deviation; N, Normal; MCI, Mild Cognitive Impairment; AD, Alzheimer's 
Disease; MMSE, Korean version of the Mini-Mental State Examination; SVLT, Seoul Verbal Learning Test; 
RCFT, Rey Complex Figure Test; SWF, Semantic Word Fluency; PWF, Phonemic Word Fluency; K-BNT, 
Korean version of Boston Naming Test; 1, Normal; 2, Mild Cognitive Impairment; 3, Alzheimer‟s Disease. 
Note.  




Table 4. The results of red and blue forms of the three versions of the MMSE-2 (M±SD) 




Red 12.10 2.896 r=0.90 
(p < 0.01) Blue 11.88 2.891 
Standard Version 
Red 23.91 4.175 r=0.97  
(p < 0.01) Blue 23.82 4.026 
Expanded Version 
Red 39.99 11.136 r=0.97  
(p < 0.01) Blue 41.12 11.488 












Table 5. The results of the MMSE-2:BV in the groups of normal, MCI, and AD (M±SD) 
MMSE-2:BV N(1) MCI(2) AD(3) F df η
2
 Post-hoc 
Registration 2.91±0.44 2.91±0.35 2.60±0.59 12.38* 2, 409 0.18 1=2>3 
Orientation to time 4.80±0.43 4.54±0.77 2.40±1.52 175.53* 2, 409 0.39 1=2>3 
Orientation to place 4.86±0.38 4.73±0.53 3.62±1.06 91.73* 2, 409 0.38 1=2>3 
Recall 1.87±0.85 1.20±0.84 0.26±0.51 77.30* 2, 409 0.27 1>2>3 
Total score 14.43±1.32 13.37±1.58 8.91±2.54 230.62* 2, 409 0.55 1>2>3 
Abbreviations: M, Mean; SD, Standard deviation; N, Normal; MCI, Mild Cognitive Impairment; AD, Alzheimer's Disease; 
MMSE-2:BV, Mini-Mental State Examination-2:Brief Version; 1, Normal; 2, Mild Cognitive Impairment; 3, Alzheimer‟s 
Disease. 
Note. 














Table 6. The results of the MMSE-2:SV in the groups of normal, MCI, and AD (M±SD) 
MMSE-2:SV N(1) MCI(2) AD(3) F df η
2
 Post-hoc 
Registration 2.91±0.44 2.91±0.35 2.60±0.59 12.38* 2, 409 0.18 1=2>3 
Orientation to time 4.80±0.43 4.54±0.77 2.40±1.52 175.53* 2, 409 0.39 1=2>3 
Orientation to place 4.86±0.38 4.73±0.53 3.62±1.06 91.73* 2, 409 0.38 1=2>3 
Recall 1.87±0.85 1.20±0.84 0.26±0.51 77.30* 2, 409 0.27 1>2>3 
Attention and 
Calculation 
4.09±1.17 3.77±1.24 2.61±1.56 28.29* 2, 409 0.38 1=2>3 
Language 7.69±0.92 7.67±0.57 7.19±1.00 7.94* 2, 409 0.26 1=2>3 
Drawing 0.95±0.23 0.90±0.30 0.69±0.47 13.54* 2, 409 0.18 1=2>3 
Total Score 27.26±2.66 25.71±2.35 19.39±3.94 205.00* 2, 409 0.69 1>2>3 
Abbreviations: M, Mean; SD, Standard deviation; N, Normal; MCI, Mild Cognitive Impairment; AD, Alzheimer's Disease; 
MMSE-2:SV, Mini-Mental State Examination-2:Standard Version; 1, Normal; 2, Mild Cognitive Impairment; 3, 
Alzheimer‟s Disease. 
Note. 











Table 7. The results of the MMSE-2:EV in the groups of normal, MCI, and AD (M±SD) 
MMSE-2:EV N(1) MCI(2) AD(3) F df η
2
 Post-hoc 
Registration 2.91±0.44 2.91±0.35 2.60±0.59 12.38* 2, 409 0.18 1=2>3 
Orientation to time 4.80±0.43 4.54±0.77 2.40±1.52 175.53* 2, 409 0.39 1=2>3 
Orientation to place 4.86±0.38 4.73±0.53 3.62±1.06 91.73* 2, 409 0.38 1=2>3 
Recall 1.87±0.85 1.20±0.84 0.26±0.51 77.30* 2, 409 0.27 1>2>3 
Attention and 
calculation 
4.09±1.17 3.77±1.24 2.61±1.56 28.29* 2, 409 0.38 1=2>3 
Language 7.69±0.92 7.67±0.57 7.19±1.00 7.94* 2, 409 0.26 1=2>3 
Drawing 0.95±0.23 0.90±0.30 0.69±0.47 13.54* 2, 409 0.18 1=2>3 
Story memory 10.46±3.50 7.15±3.21 3.34±1.80 109.96* 2, 409 0.46 1>2>3 
Processing speed  12.24±4.31 10.47±4.03 6.35±3.40 38.78* 2, 409 0.40 1>2>3 
Total Score 49.84±9.59 43.48±7.81 29.06±7.17 168.37* 2, 409 0.69 1>2>3 
Abbreviations: M, Mean; SD, Standard deviation; N, Normal; MCI, Mild Cognitive Impairment; AD, Alzheimer's Disease; 
MMSE-2:EV, Mini-Mental State Examination-2:Expanded Version; 1, Normal; 2, Mild Cognitive Impairment; 3, 
Alzheimer‟s Disease. 
Note.  





Table 8. Internal Consistency: MMSE-2:BV, MMSE-2:SV, and MMSE-2:EV (red 
and blue forms)  
MMSE-2 
Red form Blue form 
N(r) MCI(r) AD(r) N(r) MCI(r) AD(r) 
BV 0.728 0.730 0.715 0.697 0.718 0.746 
SV 0.741 0.665 0.726 0.686 0.676 0.709 
EV 0.686 0.698 0.726 0.621 0.668 0.705 
Total 0.783 0.747 0.729 0.793 0.751 0.728 
Abbreviations: N, Normal; MCI, Mild Cognitive Impairment; AD, Alzheimer's 
Disease; MMSE-2, Mini-Mental State Examination-2; BV, Brief version; SV, 

























r M SD M SD 
BV 0.76* 13.48 1.45 13.52 1.55 
SV 0.82* 26.04 2.05 26.07 2.15 
EV 0.90* 45.67 6.39 44.37 5.87 
Abbreviations: M, Mean; SD, Standard deviation; MMSE-2, Mini-Mental State 
Examination-2; BV, Brief version; SV, Standard version; EV, Expanded version; 
r, Pearson‟s correlation coefficient. 
Note.  

















Table 10. Interrater reliability of the MMSE-2 
MMSE-2 ICC % agreement 
Registration - 100% 
Orientation to time - 100% 
Orientation to place - 100% 
Recall 0.99  
Attention and calculation - 100% 
Naming - 100% 
Repetition - 100% 
Comprehension - 100% 
Reading - 100% 
Writing - 100% 
Drawing - 100% 
Story memory 0.94  
Processing speed - 100% 




















Recall 0.736 -0.021 
Orientation to place 0.633 0.076 
Story memory 0.628 0.432 
Processing speed  0.597 0.496 
Attention and calculation 0.574 0.505 
Orientation to time 0.560 0.029 
Registration 0.105 0.793 
Language 0.045 0.657 
Drawing 0.060 0.498 
Abbreviations: 1, “Tests that are sensitive to decline in cognitive functions”; 2, 



















1 2 3 
Attention and 
Calculation 
0.766 0.174 -0.228 
Drawing 0.643 -0.129 0.306 
Processing speed 0.593 0.271 0.325 
Language 0.303 0.291 0.131 
Recall -0.018 0.839 0.048 
Story memory 0.415 0.669 0.124 
Orientation to place 0.099 0.149 0.640 
Orientation to time -0.168 0.404 0.638 
Registration 0.242 -0.101 0.574 
Abbreviations: 1, “Tests related with frontal lobe function”; 2, “Tests related 





















Language 0.749 0.129 
Processing speed 0.718 0.330 
Drawing 0.674 -0.219 
Attention and Calculation 0.606 0.305 
Registration 0.551 -0.036 
Orientation to time 0.233 0.780 
Recall -0.175 0.612 
Story memory 0.020 0.546 
Orientation to place 0.324 0.477 
Abbreviations: 1, “Tests for cognitive domains except for verbal memory”; 2, 












Table 14. Correlation between the MMSE-2 and cognitive measures 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
1. MMSE-2:BV 1               
2. MMSE-2:SV 0.901* 1              
3. MMSE-2:EV 0.791* 0.875* 1             
4. MMSE 0.838* 0.920* 0.827* 1            
5. Digit-span- forward 0.345* 0.492* 0.529* 0.480* 1           
6. Digit-span- backward 0.37* 0.497* 0.561* 0.521* 0.488* 1          
7. SVLT-immediate 
recall 
0.617* 0.655* 0.718* 0.642* 0.340* 0.410* 1         
8. SVLT-delayed recall 0.620* 0.598* 0.686* 0.586* 0.219* 0.362* 0.780* 1        
9. SVLT-recognition 0.645* 0.594
*
 0.618* 0.572* 0.276* 0.297* 0.652* 0.703* 1       
10. RCFT-copy 0.492* 0.607
*
 0.602* 0.602* 0.350* 0.438* 0.463* 0.398* 0.315* 1      
11. SWF-animal 0.496* 0.550* 0.600* 0.549* 0.347* 0.374* 0.602* 0.565* 0.470* 0.453* 1     
12. SWF-supermarket 
items 
0.537* 0.545* 0.624* 0.535* 0.255* 0.373* 0.610* 0.584* 0.495* 0.391* 0.655* 1    
13. PWF 0.373* 0.486* 0.575* 0.500* 0.471* 0.493* 0.452* 0.383* 0.370* 0.459* 0.579* 0.512* 1   
14. Stroop Color-Word 
(word reading) 
0.377* 0.471* 0.423* 0.487* 0.284* 0.272* 0.243* 0.216* 0.224* 0.433* 0.311* 0.286* 0.336* 1  
15. Stroop Color-Word 
(color naming) 
0.562* 0.610* 0.675* 0.625* 0.357* 0.444* 0.638* 0.594* 0.491* 0.452* 0.581* 0.591* 0.493* 0.282* 1 
16. K-BNT 0.543* 0.617* 0.666* 0.643* 0.424* 0.416* 0.580* 0.531* 0.553* 0.515* 0.567* 0.478* 0.453* 0.346* 0.519* 
Abbreviations: MMSE-2, Mini-Mental State Examination; BV, Brief version; SV, Standard version; EV, Expanded 
version; MMSE, Korean version of Mini-Mental State Examination; SVLT, Seoul Verbal Learning Test; RCFT, Rey 
Complex Figure Test; SWF, Semantic Word Fluency; PWF, Phonemic Word Fluency; K-BNT, Korean version of 




Table 15. Participants‟ average age, education, and gender classified by CDR 
& CDR-SOB stages (M±SD) 
 N(91) 
























Education 10.98±5.21 11.45±4.98 9.97±5.03 9.16±5.19
”
 11.57±5.65 
Male/Female 29/62 90/135 14/21 20/35 2/5 
Abbreviations: CDR, Clinical Dementia Rating; CDR-SOB, Clinical Dementia 
Rating-Sum of Boxes; M, Mean; SD, Standard deviation; N, Normal; MCI, Mild 
Cognitive Impairment; EAD, Early stage of Alzheimer’s Disease; MiAD, Mild 
stage of Alzheimer’s Disease; MoAD, Moderate stage of Alzheimer’s Disease. 
Note. 
*p < 0.001 for Normal vs. MCI, Normal vs. EAD, Normal vs. MiAD. 
“
p < 0.01 for MCI vs. EAD, MCI vs. MiAD. 
”














Table 16. The results of the three versions of the MMSE-2 according to CDR & CDR-SOB (M±SD) 
MMSE-2 
N(1) 



















F df Post-hoc 
BV 14.43±1.33 13.37±1.58 10.71±1.86 8.13±2.28 6.00±1.53 161.69* 4, 407 1>2>3>4>5 
SV 27.26±2.66 25.71±2.35 22.03±2.85 18.35±3.5 14.43±3.60 151.66* 4, 407 1>2>3>4>5 
EV 49.84±9.59 43.48±7.81 33.14±5.78 27.71±6.45 19.29±5.68 105.77* 4, 407 1>2>3>4=5 
Abbreviations: M, Mean; SD, Standard deviation; MMSE-2; Mini-Mental State Examination; BV, Brief Version; SV, 
Standard Version; EV, Expanded Version; N, Normal; MCI, Mild Cognitive Impairment; EAD, Early stage of 
Alzheimer’s Disease; MiAD, Mild stage of Alzheimer’s Disease; MoAD, Moderate stage of Alzheimer’s Disease; 1, 
Normal; 2, Mild Cognitive Impairment; 3, Early stage of Alzheimer‟s Disease; 4, Mild stage of Alzheimer‟s Disease; 5, 
Moderate stage of Alzheimer‟s Disease.  
Note.  








Figure 1. Mini-Mental State Examination-2:Brief Version (MMSE-2:BV). Receiver 
operator characteristic (ROC) curve analysis of the MMSE-2:BV in the groups of 
normal, mild cognitive impairment (MCI), and Alzheimer’s Disease (AD). (A) 
Normal vs. MCI, Area Under the Curve (AUC) = 0.71. (B) MCI vs. AD, Area 
Under the Curve (AUC) = 0.93. (C) Normal vs. AD, Area Under the Curve 













Figure 2. Mini-Mental State Examination-2:Standard Version (MMSE-2SV). 
Receiver operator characteristic (ROC) curve analysis of the MMSE-2:SV in the 
groups of normal, mild cognitive impairment (MCI), and Alzheimer’s Disease (AD). 
(A) Normal vs. MCI, Area Under the Curve (AUC) = 0.72. (B) MCI vs. AD, 
Area Under the Curve (AUC) = 0.93. (C) Normal vs. AD, Area Under the 












Figure 3. Mini-Mental State Examination-2:Expanded Version (MMSE-2:EV). 
Receiver operator characteristic (ROC) curve analysis of the MMSE-2:EV in the 
groups of normal, mild cognitive impairment (MCI), and Alzheimer’s Disease (AD). 
(A) Normal vs. MCI, Area Under the Curve (AUC) = 0.73. (B) MCI vs. AD, 
Area Under the Curve (AUC) = 0.92. (C) Normal vs. AD, Area Under the 












Comparison between the Mini-Mental State 
Examination and the Mini-Mental State 
Examinaiton-2 in Korean patients with Mild 
Cognitive Impairment and Alzheimer’s Disease 
 
Introduction 
In study 1, the reliability and validity of the MMSE-2 in the patients 
with MCI, the patients with AD, and the healthy older adults were 
assessed in order to determine whether the MMSE-2 can be used 
clinically useful in Korea. The results were summarized as follows. 
There were significant differences in the MMSE-2 (BV, SV, and EV) 
across the patients with MCI, the patients with AD, and the healthy 
older adults. Moreover, the results of factor analysis showed that the 
MMSE-2 was varied according to the severity of cognitive impairment 
in each group, and it was confirmed that the items of the MMSE-2 
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were clearly divided for each group. The MMSE-2 and various 
neuropsychological assessments were highly correlated. Especially, the 
MMSE-2 was highly correlated with the K-MMSE, verbal memory test, 
and the frontal lobe function tests.  
Moreover, the sensitivity and specificity of the three versions of the 
MMSE-2 (BV, SV, and EV) were relatively high in discriminating 
participants with normal cognitive aging from the patients with MCI and 
AD, so the MMSE-2 is a valid and reliable cognitive screening 
instrument for assessing cognitive impairment in Korean population, but 
its ability to distinguish the patients with MCI from those with normal 
cognitive aging may not be as highly sensitive as expected.  
Therefore, in study 2, the purpose of this study is to compare the 
usefulness of the MMSE-2 (Folstein et al., 2010) and the K-MMSE 
(Kang et al., 1997) to determine which test is more sensitive in 
discriminating between normal cognitive aging and the patients with 




Materials and Methods 
1. Participants 
The groups of the patients (MCI and AD) and control participants 




The description of the MMSE-2 was the same as that of study 1. 
 
2.2. K-MMSE 
The K-MMSE is a Korean version of the MMSE developed by Kang 
et al. (1997), and it is made in the same format as the original, and 
the total score of the K-MMSE is 30 points. In the K-MMSE, the items 
in the original MMSE (Folstein et al., 1975) are used as much as 
possible, but the orientation is separated by time and place. The 
overlapping pentagram for a „Copy‟ test is included as an item of 
language test in the MMSE, but it is separated in the K-MMSE as a 
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„Visual construction.‟ In addition, although there are two items such as 
serial 7s and spelling the word “WORLD” backwards to evaluate 
„Attention and calculation‟ in the MMSE, but serial 7s is only included 
in the K-MMSE. Therefore, the K-MMSE is composed of seven subtests 
in the following order: orientation to time (5 points), orientation to 
place (5 points), registration (3 points), attention and calculation (5 
points), recall (3 points), language (8 points), and visual construction (1 
point).  
 
2.3. Other neuropsychological Assessments 
The MMSE-2 and the K-MMSE were performed with a time interval 
of at least 1 hour in order to compensate for the learning effect that 
could be occurred when using the MMSE-2 and the K-MMSE at the 
same time, and the detailed neuropsychological assessments were 
performed in the meantime. In the detailed neuropsychological 
assessments, there were Seoul Verbal Learning Test (SVLT) (Kang et al., 
2003) for assessing verbal memory, a copy of the Rey Complex Figure 
89 
Test for assessing visuospatial function (Meyers et al., 1995), the 
Semantic Word Fluency Test (SWT) and the Phonemic Word Fluency 
Test (PWF) (Kang et al., 2000) and the Korean-Color Word Stroop Test 
(K-CWST) (Lee at al., 2000) for assessing executive function of the 
frontal lobe, the Korean version of the Boston Naming Test (K-BNT) 
(Kim et al., 1997) for assessing naming ability, and forward and 
backward digit span test for assessing attention. Moreover, global 
measurements, including CDR (Morris, 1993) & CDR-SOB (O‟Bryant et 
al., 2008, 2010), were also conducted.  
 
3. Procedure 
There were overlapping subtests in the MMSE-2 and the K-MMSE 
(eg: orientation to time, orientation to place, attention and calculation, 
writing, and drawing). The overlapping subtests were not repeated and 
scored equally. However, in the case of the attention and calculation 
test, it was repeated because the three words should be learned and 
recalled between this test, but the score was given to the same as the 
score of the test which was conducted at first. Even if the items were 
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the same, if the content of the test was different from one test to 
another, questions were taken and scored separately. The order of the 
detailed neuropsychological assessments including the MMSE-2 and the 
K-MMSE was the same as in study 1.  
 
4. Statistical analysis 
First, an analysis of variance (ANOVA) was used to compare age and 
education levels, and a chi square test was used to compare gender 
across the three groups (226 patients with MCI, 97 patients with AD, 
and 91 healthy older adults).  
Second, the results of the MMSE-2 (BV, SV, and EV) in the three 
groups were analyzed using an analysis of covariance (ANCOVA) after 
controlling for demographic variables (age and education).  
Third, the results of the K-MMSE in the three groups were analyzed 
using an ANCOVA after controlling for demographic variables (age and 
education).  
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Fourth, the discriminant analysis was performed to examine the 
classification accuracy and discrimination of the patients with MCI and 
AD in the MMSE-2 and the K-MMSE.  
Finally, to evaluate the sensitivity and specificity of the MMSE-2 and 
the K-MMSE for differentiating among the three groups were examined 
using a receiver operating characteristic (ROC) curve and area under 
the curve (AUC) measurements.  
Data were analyzed using SPSS 18.0 (SPSS Inc., Chicago, IL, USA), 
and p < 0.05 was considered to be significant for all analyses.   
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Results 
1. The participants’ demographic data 
The demographic characteristics of the patients with MCI, the 
patients with AD, and the healthy older adults were the same as those 
of study 1.  
 
2. The results of participants’ neuropsychological 
assessments  
The results of the neuropsychological assessments in the three groups 
were the same as those of study 1.  
 
3. The results of the MMSE-2 in the groups of normal, 
MCI, and AD 
3.1. MMSE-2:BV, SV, EV 
The results of the MMSE-2 (BV, SV, and EV) in the three groups 
were the same as those of study 1.  
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4. The results of the K-MMSE in the groups of normal, 
MCI, and AD 
The results of the K-MMSE scores in the three groups are presented 
in Table 1. An ANCOVA that controlled for age and education revealed 
significant differences among the three groups on the K-MMSE. 
According to Tukey‟s post hoc analyses, the scores of recall and total 
in the K-MMSE were significantly higher for the healthy older adults 
than for the group of patients (MCI and AD), and they were 
significantly higher for the patients with MCI than for the patients with 
AD. However, there were no significant differences in the subtests 
such as registration, orientation to time, orientation to place, attention 
and calculation, language, and drawing between the healthy older adults 
and the patients with MCI, but the scores of six subtests in the K-
MMSE were significantly higher for the healthy older adults and the 
patients with MCI than for the patients with AD.  
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5. Comparison of the discriminant analysis between the 
MMSE-2 and the K-MMSE 
5.1. MMSE-2 
5.1.1. The discriminant analysis of the MMSE-2 in the groups of 
normal, MCI, and AD 
The discriminant analysis by simultaneous input method was 
performed by using the nine subtests of the MMSE-2 as independent 
variables and the three groups (healthy older adults, MCI, and AD) as 
dependent variables. Two significant discriminant functions were 
calculated through analysis, and the results are shown in Table 2. The 
results showed that the first function distinguished between the healthy 
older adults vs. the group of patients (MCI and AD), and the second 
function distinguished between the patient with MCI vs. the patients 
with AD. The first function was statistically significant, explained 92.1% 
of the total variance in the model (Wilk‟s Lambda = 0.342, χ
2
 = 436.80, 
p < 0.001), and the second function was also statistically significant, 
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explained 7.9% of the total variance in the model (Wilk‟s Lambda = 
0.881, χ
2
 = 51.51, p < 0.001).  
According to the results of the standardized canonical discriminant 
function coefficients in the discriminant function, orientation to time 
was the most discriminating subtest in the first function (Normal vs. 
MCI and AD), and story memory was the most discriminating subtest in 
the second function (MCI vs. AD) (Table 3). The structure matrix 
canonical loadings of the predictor variables and the two discriminant 
functions indicated that the first function was strongly correlated with 
orientation to time (canonical loading = 0.78), orientation to place 
(canonical loading = 0.58), recall (canonical loading = 0.55), processing 
speed (canonical loading = 0.42), and attention and calculation (canonical 
loading = 0.33). The second function was strongly correlated with story 
memory (canonical loading = -0.66) (Table 4). These results indicated 
that the best discriminating subtest between the healthy older adults 
and the group of patients (MCI and AD) was orientation to time, and 
the best discriminating subtest between the patients with MCI and the 
patients with AD was story memory. 
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The results of classifying the samples by the two functions are 
presented in Table 5. According to the classification results, in the 
MMSE-2:BV, 55.3% of the patients with MCI, 78.4% of the patients with 
AD, and 72.5% of the healthy older adults were correctly classified, and 
thus the overall classification accuracy was 64.5%. In the MMSE-2:SV, 
58.0% of the patients with MCI, 79.4% of the patients with AD, and 
72.5% of the healthy older adults were correctly classified, and thus the 
overall classification accuracy was 66.2%. In the MMSE-2:EV, 68.6% of 
the patients with MCI, 78.4% of the patients with AD, and 72.5% of the 
healthy older adults were correctly classified, and thus the overall 
classification accuracy was 71.7%. 
 
5.1.2. The discriminant analysis of the MMSE-2 in the healthy 
older adults vs. the patients with MCI 
The discriminant analysis by simultaneous input method was 
performed by using the nine subtests of the MMSE-2 as independent 
variables and the two groups (healthy older adults and MCI) as 
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dependent variables. One significant discriminant function was 
calculated through analysis, and the results are shown in Table 6. 
There was significant difference between the two groups over nine 
independent variables (Wilk‟s Lambda = 0.790, χ
2
 = 73.35, p < 0.001).  
According to the results of the standardized canonical discriminant 
function coefficients in the discriminant function, story memory was the 
most discriminating subtest (Table 7). Moreover, the structure matrix 
canonical loadings of the predictor variables and the discriminant 
function indicated that the function was strongly correlated with story 
memory (canonical loading = 0.88), recall (canonical loading = 0.70), 
processing speed (canonical loading = 0.38), and orientation to time 
(canonical loading = 0.34), but the function was not significantly 
correlated with attention and calculation, orientation to place, drawing, 
language, and registration (Table 8). These results indicated that the 
best discriminating subtest between the healthy older adults and the 
patients with MCI was story memory.  
The results of classifying the samples by the function are presented 
in Table 9. According to the classification results, in the MMSE-2:BV, 
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73.6% of the healthy older adults and 64.2% of the patients with MCI 
were correctly classified, and thus the overall classification accuracy 
was 66.9%. In the MMSE-2:SV, 71.4% of the healthy older adults and 
65.0% of the patients with MCI were correctly classified, and thus the 
overall classification accuracy was 66.9%. In the MMSE-2:EV, 73.6% of 
the healthy older adults and 74.8% of the patients with MCI were 
correctly classified, and thus the overall classification accuracy was 
74.4%. 
 
5.1.3. The discriminant analysis of the MMSE-2 in the patients 
with MCI vs. the patients with AD  
The discriminant analysis by simultaneous input method was 
performed by using the nine subtests of the MMSE-2 as independent 
variables and the two groups (MCI and AD) as dependent variables. 
One significant discriminant function was calculated through analysis, 
and the results are shown in Table 10. There was significant difference 
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between the two groups over nine independent variables (Wilk‟s 
Lambda = 0.129, χ
2
 = 268.22, p < 0.001).  
According to the results of the standardized canonical discriminant 
function coefficients in the discriminant function, orientation to time 
was the most discriminating subtest (Table 11). In addition, the 
structure matrix canonical loadings of the predictor variables and the 
discriminant function indicated that the function was strongly correlated 
with orientation to time (canonical loading = 0.81), orientation to place 
(canonical loading = 0.61), story memory (canonical loading = 0.53), 
recall (canonical loading = 0.49), processing speed (canonical loading = 
0.43), and attention and calculation (canonical loading = 0.35), but the 
function was not significantly correlated with registration, language, and 
drawing (Table 12). These results indicated that the best discriminating 
subtest between the patients with MCI and the patients with AD was 
orientation to time. 
The results of classifying the samples by the function are presented 
in Table 13. According to the classification results, in the MMSE-2:BV, 
89.4% of the patients with MCI and 81.4% of the patients with AD 
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were correctly classified, and thus the overall classification accuracy 
was 87.0%. In the MMSE-2:SV, 92.5% of the patients with MCI and 82.5% 
of the patients with AD were correctly classified, and thus the overall 
classification accuracy was 89.5%. In the MMSE-2:EV, 92.0% of the 
patients with MCI and 82.5% of the patients with AD were correctly 
classified, and thus the overall classification accuracy was 89.2%. 
 
5.1.4. The discriminant analysis of the MMSE-2 in the healthy 
older adults vs. the patients with AD  
The discriminant analysis by simultaneous input method was 
performed by using the nine subtests of the MMSE-2 as independent 
variables and the two groups (healthy older adults and AD) as 
dependent variables. One significant discriminant function was 
calculated through analysis, and the results are shown in Table 14. 
There was significant difference between the two groups over nine 
independent variables (Wilk‟s Lambda = 0.247, χ
2
 = 253.62, p < 0.001).  
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According to the results of the standardized canonical discriminant 
function coefficients in the discriminant function, story memory was the 
most discriminating subtest (Table 15). Moreover, the structure matrix 
canonical loadings of the predictor variables and the discriminant 
function indicated that the function was strongly correlated with story 
memory (canonical loading = 0.75), recall (canonical loading = 0.67), 
orientation to time (canonical loading = 0.61), orientation to place 
(canonical loading = 0.44), processing speed (canonical loading = 0.44), 
and attention and calculation (canonical loading = 0.31), but the 
function was not significantly correlated with drawing, registration, and 
language (Table 16). These results indicated that the best discriminating 
subtest between the healthy older adults and the patients with AD was 
story memory. 
The results of classifying the samples by the function are presented 
in Table 17. According to the classification results, in the MMSE-2:BV, 
91.2% of the healthy older adults and 88.7% of the patients with AD 
were correctly classified, and thus the overall classification accuracy 
was 89.9%. In the MMSE-2:SV, 91.2% of the healthy older adults and 
102 
89.7% of the patients with AD were correctly classified, and thus the 
overall classification accuracy was 90.4%. In the MMSE-2:EV, 93.4% of 
the healthy older adults and 97.9% of the patients with AD were 




5.2.1. The discriminant analysis of the K-MMSE in the groups of 
normal, MCI, and AD 
The discriminant analysis by simultaneous input method was 
performed by using the seven subtests of the K-MMSE as independent 
variables and the three groups (healthy older adults, MCI, and AD) as 
dependent variables. Two significant discriminant functions were 
calculated through analysis, and the results are shown in Table 18. The 
results showed that the first function distinguished between the healthy 
older adults and the group of patients (MCI and AD), and the second 
function distinguished between the patients with MCI and the patients 
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with AD. The first function was statistically significant, explained 97.4% 
of the total variance in the model (Wilk‟s Lambda = 0.395, χ
2
 = 397.15, 
p < 0.001), and the second function was also statistically significant, 
explained 2.6% of the total variance in the model (Wilk‟s Lambda = 
0.963, χ
2
 = 15.28, p < 0.05).  
According to the results of the standardized canonical discriminant 
function coefficients in the discriminant function, orientation to time 
was the most discriminating subtest in the first function, and recall was 
the most discriminating subtest in the second function (Table 19). 
The structure matrix canonical loadings of the predictor variables and 
the two discriminant functions indicated that the first function was  
strongly correlated with orientation to time (canonical loading = 0.83), 
orientation to place (canonical loading = 0.61), language (canonical 
loading = 0.42), and attention and calculation (canonical loading = 0.35). 
The second function was very strongly correlated with recall (canonical 
loading = 0.84) (Table 20). These results indicated that the best 
discriminating subtest between the healthy older adults and the group 
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of patients was orientation to time, and the best discriminating subtest 
between the patients with MCI and the patients with AD was recall. 
The results of classifying the samples by the two functions are 
presented in Table 21. According to the classification results, 83.6% of 
the patients with MCI, 68.0% of the patients with AD, and 28.6% of the 
healthy older adults were correctly classified, and thus the overall 
classification accuracy was 67.9%. 
 
5.2.2. The discriminant analysis of the K-MMSE in the healthy 
older adults vs. the patients with MCI 
The discriminant analysis by simultaneous input method was 
performed by using the seven subtests of the K-MMSE as independent 
variables and the two groups (healthy older adults and MCI) as 
dependent variables. One significant discriminant function was 
calculated through analysis, and the results are shown in Table 22. 
There was significant difference between the two groups over seven 
independent variables (Wilk‟s Lambda = 0.905, χ
2
 = 30.96, p < 0.001).  
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According to the results of the standardized canonical discriminant 
function coefficients in the discriminant function, recall was the most 
discriminating subtest (Table 23). Moreover, the structure matrix 
canonical loadings of the predictor variables and the discriminant 
function indicated that the function was strongly correlated with recall 
(canonical loading = 0.81), orientation to time (canonical loading = 0.55), 
language (canonical loading = 0.43), attention and calculation (canonical 
loading = 0.37), and orientation to place (canonical loading = 0.36), but 
the function was not significantly correlated with registration and 
drawing (Table 24). These results indicated that the best discriminating 
subtest between the healthy older adults and the patients with MCI was 
recall. 
The results of classifying the samples by the function are presented 
in Table 25. According to the classification results, 69.2% of the healthy 
older adults and 61.1% of the patients with MCI were correctly 
classified, and thus the overall classification accuracy was 63.4%. 
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5.2.3. The discriminant analysis of the K-MMSE in the patients 
with MCI vs. the patients with AD  
The discriminant analysis by simultaneous input method was 
performed by using the seven subtests of the K-MMSE as independent 
variables and the two groups (MCI and AD) as dependent variables. 
One significant discriminant function was calculated through analysis, 
and the results are shown in Table 26. There was significant difference 
between the two groups over seven independent variables (Wilk‟s 
Lambda = 0.443, χ
2
 = 258.82, p < 0.001).  
According to the results of the standardized canonical discriminant 
function coefficients in the discriminant function, orientation to time 
was the most discriminating subtest (Table 27). Moreover, the structure 
matrix canonical loadings of the predictor variables and the discriminant 
function indicated that the function was strongly correlated with 
orientation to time (canonical loading = 0.83), orientation to place 
(canonical loading = 0.63), recall (canonical loading = 0.43), language 
(canonical loading = 0.40), and attention and calculation (canonical 
loading = 0.36), but the function was not significantly correlated with 
107 
drawing and registration (Table 28). These results indicated that the 
best discriminating subtest between the patients with MCI and the 
patients with AD was orientation to time. 
The results of classifying the samples by the function are presented 
in Table 29. According to the classification results, 92.0% of the 
patients with MCI and 81.4% of the patients with AD were correctly 
classified, and thus the overall classification accuracy was 88.9%. 
 
5.2.4. The discriminant analysis of the K-MMSE in the healthy 
older adults vs. the patients with AD  
The discriminant analysis by simultaneous input method was 
performed by using the seven subtests of the K-MMSE as independent 
variables and the two groups (healthy older adults and AD) as 
dependent variables. One significant discriminant function was 
calculated through analysis, and the results are shown in Table 30. 
There was significant difference between the two groups over seven 
independent variables (Wilk‟s Lambda = 0.294, χ
2
 = 223.55, p < 0.001).  
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According to the results of the standardized canonical discriminant 
function coefficients in the discriminant function, recall was the most 
discriminating subtest (Table 31). Moreover, the structure matrix 
canonical loadings of the predictor variables and the discriminant 
function indicated that the function was strongly correlated with 
orientation to time (canonical loading = 0.69), recall (canonical loading = 
0.65), orientation to place (canonical loading = 0.50), language (canonical 
loading = 0.36), and attention and calculation (canonical loading = 0.35), 
but the function was not significantly correlated with drawing and 
registration (Table 32). These results indicated that the best 
discriminating subtest between the healthy older adults and the patients 
with AD was orientation to time.  
The results of classifying the samples by the function are presented 
in Table 33. According to the classification results, 95.6% of the healthy 
older adults and 94.8% of the patients with AD were correctly classified, 
and thus the overall classification accuracy was 95.2%. 
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6. Diagnostic utility of the MMSE-2 and the K-MMSE 
6.1. MMSE-2 
The results of each version of the MMSE-2 (BV, SV, and EV) were 
the same as in study 1.  
 
6.2. K-MMSE 
The ROC curve analysis and the area under the curve (AUC) was 
performed to verify the diagnostic utility of the K-MMSE in the three 
groups (MCI, AD, and healthy older adults). 
First, for discriminating the healthy older adults from the patients 
with MCI, the AUC of the K-MMSE was 0.70 (95% confidence interval, 
CI, 0.64-0.77, p < 0.001). The sensitivity of the K-MMSE was 70% and 
the specificity was 59% when using a cut-off score of ≤ 26 of 30 to 
predict MCI. Second, for discriminating the patients with MCI from the 
patients with AD, the AUC of the K-MMSE was 0.94 (95% CI, 0.91-0.96, 
p < 0.001). The sensitivity of the K-MMSE was 84% and the specificity 
was 88% when using a cut-off score ≤ 23 of 30 to predict AD. Finally, 
for discriminating the healthy older adults from the patients with AD, 
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the AUC of the K-MMSE was 0.97 (95% CI, 0.95-0.99, p < 0.001). The 
sensitivity of the K-MMSE was 95% and the specificity was 78% when 
using a cut-off score ≤ 22 of 30 to predict AD (Figure 1). 
 
7. Comparison between the MMSE-2 and the K-MMSE 
7.1. Comparison between the healthy older adults and the 
patients with MCI  
7.1.1. The MMSE-2:BV vs. the K-MMSE 
The MMSE-2:BV and the K-MMSE were compared with the ROC 
curve analysis to determine which test was more sensitive in 
discriminating between the healthy older adults vs. the patients with 
MCI. The AUC of the MMSE-2:BV was 0.708, and the AUC of the K-
MMSE was 0.703, but there was no significant difference between the 
two tests (Table 34). 
 
7.1.2. The MMSE-2:SV vs. the K-MMSE 
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The MMSE-2:SV and the K-MMSE were compared with the ROC 
curve analysis to determine which test was more sensitive in 
discriminating between the healthy older adults vs. the patients with 
MCI. The AUC of the MMSE-2:SV was 0.720, and the AUC of the K-
MMSE was 0.703, but there was no significant difference between the 
two tests (Table 34). 
 
7.1.3. The MMSE-2:EV vs. the K-MMSE 
   The MMSE-2:EV and the K-MMSE were compared with the ROC 
curve analysis to determine which test was more sensitive in 
discriminating between the healthy older adults vs. the patients with 
MCI. The AUC of the MMSE-2:EV was 0.728, and the AUC of the K-
MMSE was 0.703, but there was no significant difference between the 
two tests (Table 34). 
 
7.2. Comparison between the patients with MCI and the patients 
with AD 
7.2.1. The MMSE-2:BV vs. the K-MMSE 
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The MMSE-2:BV and the K-MMSE were compared with the ROC 
curve analysis to determine which test was more sensitive in 
discriminating between the patients with MCI vs. the patients with AD. 
The AUC of the MMSE-2:BV was 0.903, and the AUC of the K-MMSE 
was 0.936, but there was no significant difference between the two 
tests (Table 35). 
 
7.2.2. The MMSE-2:SV vs. the K-MMSE 
The MMSE-2:SV and the K-MMSE were compared with the ROC 
curve analysis to determine which test was more sensitive in 
discriminating between the patients with MCI vs. the patients with AD. 
The AUC of the MMSE-2:SV was 0.925, and the AUC of the K-MMSE 
was 0.936, but there was no significant difference between the two 
tests (Table 35). 
 
7.2.3. The MMSE-2:EV vs. the K-MMSE 
The MMSE-2:EV and the K-MMSE were compared with the ROC 
curve analysis to determine which test was more sensitive in 
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discriminating between the patients with MCI vs. the patients with AD. 
The AUC of the MMSE-2:EV was 0.921, and the AUC of the K-MMSE 
was 0.936, but there was no significant difference between the two 
tests (Table 35). 
 
7.3. Comparison between the healthy older adults and the 
patients with AD 
7.3.1. The MMSE-2:BV vs. the K-MMSE 
The MMSE-2:BV and the K-MMSE were compared with the ROC 
curve analysis to determine which test was more sensitive in 
discriminating between the healthy older adults vs. the patients with 
AD. The AUC of the MMSE-2:BV was 0.973, and the AUC of the K-
MMSE was 0.971, but there was no significant difference between the 
two tests (Table 36). 
 
7.3.2. The MMSE-2:SV vs. the K-MMSE 
The MMSE-2:SV and the K-MMSE were compared with the ROC 
curve analysis to determine which test was more sensitive in 
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discriminating between the healthy older adults vs. the patients with 
AD. The AUC of the MMSE-2:SV was 0.952, and the AUC of the K-
MMSE was 0.971, but there was no significant difference between the 
two tests (Table 36). 
 
7.3.3. The MMSE-2:EV vs. the K-MMSE 
The MMSE-2:EV and the K-MMSE were compared with the ROC 
curve analysis to determine which test was more sensitive in 
discriminating between the healthy older adults vs. the patients with 
AD. The AUC of the MMSE-2:EV was 0.943, and the AUC of the K-
MMSE was 0.971, but there was no significant difference between the 









In study 2, the cognitive screening tests, the MMSE-2 and the K-
MMSE, were compared to determine which test was more sensitive in 
discriminating across the three groups (healthy older adults, MCI, and 
AD). The results demonstrated several key points.  
First, the results of the MMSE-2 (BV, SV, and EV) and the K-MMSE 
were significantly differed across the three groups (healthy older adults, 
MCI, and AD). In all three versions of the MMSE-2, the subtests in the 
MMSE-2 such as recall, story memory, and processing speed of the 
healthy older adults were significantly higher than those of the patients 
with MCI and AD, and also the items in the MMSE-2 of the patients 
with MCI were significantly higher than those of the patients with AD. 
Therefore, deficits in verbal memory were most pronounced.  
In addition, in the K-MMSE, the subtest in the K-MMSE such as 
recall of the healthy older adults were significantly higher than those 
of the patients with MCI and AD, and also the item in the K-MMSE for 
the patients with MCI was significantly higher than those of the 
patients with AD. 
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 When comparing the magnitude of the recall test in the MMSE-2 
(η
2
 = 0.27) and the K-MMSE (η
2
 = 0.19), the recall test in the MMSE-
2 could be seen to discriminate each group slightly more sensitively 
than the K-MMSE. Moreover, among the verbal memory tests, when 
comparing the magnitude of the story memory test in the MMSE-2 (η
2
 
= 0.35) with the recall tests in the MMSE-2 (η
2
 = 0.27) and the K-
MMSE (η
2
 = 0.19), the story memory was the most sensitive among 
verbal memory tests to distinguish in each group. Thus, verbal memory 
tests (recall and story memory) included in the MMSE-2 might be more 
sensitive to differentiate across the three groups (healthy older adults, 
MCI and AD).  
Second, the results of the discriminant analysis of the MMSE-2 were 
as follows. In the MMSE-2, the subtests that discriminated significantly 
between the healthy older adults and the groups of patients (MCI and 
AD) were orientation to time, orientation to place, recall, processing 
speed, and attention and calculation. Moreover, the subtest which 
discriminated significantly between the patients with MCI and the 
patients with AD was story memory. The subtests such as orientation 
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to time, orientation to place, recall, and story memory in the MMSE-2 
are all tests which measure episodic memory, and the subtests such as 
processing speed and attention and calculation are the tests that 
measure psychomotor ability and working memory of the frontal lobe. 
As shown in many previous studies, these results suggested that 
measuring episodic memory is an important variable in group 
discrimination because episodic memory is one of the first deteriorating 
functions in patients with MCI or AD (Backman et al., 2005; Bennett et 
al., 2002; Chen et al., 2000; Grober et al., 2008).  
In addition, in the MMSE-2, the subtests that discriminated 
significantly between the healthy older adults and the patients with MCI 
were story memory, recall, processing speed, and orientation to time. 
These results also showed that the tests related with episodic memory 
are the most sensitive tests for group discrimination, which is a result 
of supporting previous studies (Backman et al., 2005; Bennett et al., 
2002; Chen et al., 2000; Grober et al., 2008). The subtests that 
discriminated significantly between the patients with MCI and the 
patients with AD in the MMSE-2 were orientation to time, orientation 
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to place, story memory, recall, processing speed, and attention and 
calculation, and these results showed that as the dementia processes, 
not only episodic memory but also the frontal lobe function has been 
decreased.  
Third, the results of the discriminant analysis of the K-MMSE were 
as follows. In the K-MMSE, the subtests that discriminated significantly 
across the three groups (healthy older adults, MCI, and AD) were 
orientation to time, orientation to place, language, and attention and 
calculation. Moreover, the subtest in the K-MMSE that discriminated 
significantly between the patients with MCI and the patients with AD 
was recall. In the K-MMSE, as in the MMSE-2, these results also 
showed that measuring episodic memory is most sensitive for group 
discrimination.  
In addition, in the K-MMSE, the subtests that discriminated 
significantly between the healthy older adults and the patients with MCI 
were recall, orientation to time, language, and attention and calculation. 
These tests are the most sensitive measures for episodic memory and 
working memory. The subtests that distinguished significantly between 
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the patients with MCI and the patients with AD were orientation to 
time, orientation to place, recall, language, and attention and calculation, 
and these results also showed that as the dementia processes, not only 
episodic memory but also frontal lobe function has been decreased. In 
conclusion, the tests related with episodic memory are the most 
sensitive tests for group discrimination in both the MMSE-2 and the K-
MMSE. 
Comparing the results of the discriminant analysis of the MMSE-2 
and the K-MMSE comprehensively, the classification accuracy of the 
MMSE-2 in the three groups was 71.7%, and the classification accuracy 
of the K-MMSE in the three groups was 67.9%, suggesting that the 
MMSE-2 was more accurate than the K-MMSE. In more detail, the 
accuracy rate of classifying the healthy older adults and the patients 
with MCI was 74.4% for the MMSE-2 and 63.4% for the K-MMSE, 
suggesting that the MMSE-2 was more sensitive and accurate than the 
K-MMSE. Moreover, the accuracy of classification of the patients with 
MCI and the patients with AD was 89.2% for the MMSE-2 and 88.9% 
for the K-MMSE, suggesting that the accuracy of classification of both 
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tests was similar. Finally, the accuracy of classification of the healthy 
older adults and the patients with AD was 95.7% for the MMSE-2 and 
95.2% for the K-MMSE, suggesting that these two tests were similar.  
In summary, the MMSE-2 was a more sensitive test than the K-
MMSE when discriminating across the three groups. Especially, the 
MMSE-2 is about 10% more accurate than the K-MMSE when 
discriminating between the healthy older adults and the patients with 
MCI. However, there was no significant difference between the two 
tests when discriminating between the healthy older adults and the 
patients with AD or between the patients with MCI and the patients 
with AD.  
Finally, when the AUC of the MMSE-2 and the K-MMSE were 
compared, there was no significant difference between the two tests in 
all tests. However, the MMSE-2:SV and the MMSE-2:EV might be 
slightly more sensitive than the K-MMSE in distinguishing between the 
healthy older and the patients with MCI, and rather the MMSE-2:BV 
and the K-MMSE might be seem to discriminate slightly more sensitive 
when discriminating the patients with AD from the healthy older adults 
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and the patients with MCI. In other words, when discriminating between 
the healthy older adults and the patients with MCI, the more difficult 
test was better for group discrimination, and when discriminating the 
patients with AD from the healthy older adults and the patients with 
MCI, it was shown that the test with easy difficulty was better for 
group discrimination.  
The overall results showed that as for the development purpose of 
the MMSE-2, when discriminating between the healthy older adults and 
the group of patients (MCI and AD), the MMSE-2:SV and MMSE-2:EV 
are more sensitive and accurate to detect early cognitive decline than 
the K-MMSE or the MMSE-2:BV, but as the dementia progresses, the 
K-MMSE or the MMSE-2:BV may be more useful for group 
discrimination than the MMSE-2:SV and the MMSE-2:EV. Thus, the 
MMSE-2 appears to be more useful as a cognitive screening test in 







Table 1. The results of the K-MMSE in the groups of normal, MCI, and AD 
(M±SD) 







4.80±0.43 4.54±0.77 2.40±1.52 175.53* 2, 409 0.46 1=2>3 
Orientation to 
place 
4.86±0.38 4.73±0.53 3.62±1.06 91.73* 2, 409 0.31 1=2>3 
Registration 3.00±0.00 2.98±0.13 2.94±0.24 3.13
”
 2, 409 0.02 1=2>3 
Attention and 
Calculation 
4.09±1.17 3.77±1.24 2.61±1.56 28.29* 2, 409 0.12 1=2>3 
Recall 1.74±1.07 1.12±1.07 0.15±0.36 48.01* 2, 409 0.19 1>2>3 
Language 7.88±0.36 7.71±0.61 6.90±1.18 40.06* 2, 409 0.16 1=2>3 
Drawing 0.95±0.23 0.90±0.30 0.69±0.47 13.54* 2, 409 0.06 1=2>3 
Total 27.31±2.30 25.75±2.46 19.31±3.80 229.27
“
 2, 409 0.53 1>2>3 
Abbreviations: M, Mean; SD, Standard deviation; N, Normal; MCI, Mild Cognitive 
Impairment; AD, Alzheimer's Disease; K-MMSE, Korean version of the Mini-
Mental State Examination; 1, Normal; 2, Mild Cognitive Impairment; 3, 
Alzheimer‟s Disease. 
Note. 
*p < 0.001. 
“
p < 0.01. 
”












Table 2. The results by the discriminant functions analysis in the groups of 













1 1.577 92.1 92.1 0.782 0.342 436.801 18 0.000 
2 0.135 7.9 100.0 0.345 0.881 51.510 8 0.000 
Abbreviation: MMSE-2, Mini-Mental State Examination-2; MCI, Mild Cognitive 







Table 3. The standardized canonical discriminant function coefficients in the 




Registration 0.014 0.189 
Orientation to time 0.573 0.469 
Orientation to place 0.292 0.253 
Recall 0.265 -0.298 
Attention and calculation 0.072 0.161 
Language -0.047 0.178 
Drawing 0.100 0.032 
Story memory 0.346 -0.754 
Processing speed -0.033 -0.085 
Abbreviation: MMSE-2, Mini-Mental State Examination-2; MCI, Mild Cognitive 









Table 4. The results of the structure matrix in the groups of normal, MCI, and 
AD (MMSE-2) 
Discriminatory factors 
Correlation with the discriminant functions 
Function 1 Function 2 
Orientation to time 0.784* 0.422 
Orientation to place 0.578* 0.330 
Recall 0.547* -0.449 
Processing speed 0.420* -0.107 
Attention and calculation 0.334* 0.041 
Registration 0.234* 0.207 
Language 0.231* 0.074 
Drawing 0.210* 0.162 
Story memory 0.608 -0.661* 
Abbreviation: MMSE-2, Mini-Mental State Examination-2; MCI, Mild Cognitive 






















Table 5. Classification rates (%) by discriminant analysis in the groups of 
normal, MCI, and AD (MMSE-2) 
MMSE-2 
  Predictive groups 
 Groups Normal MCI AD Total 
BV 
Frequency 
Normal 66 24 1 91 
MCI 82 125 19 226 
AD 0 21 76 97 
% 
Normal 72.5 26.4 1.1 100.0 
MCI 36.3 55.3 8.4 100.0 
AD 0.0 21.6 78.4 100.0 
MMSE-2:BV Classification accuracy 64.5% 
SV 
Frequency 
Normal 66 23 2 91 
MCI 79 131 16 226 
AD 0 20 77 97 
% 
Normal 72.5 25.3 2.2 100.0 
MCI 35.0 58.0 7.1 100.0 
AD 0.0 20.6 79.4 100.0 
               MMSE-2:SV Classification accuracy 66.2% 
EV 
Frequency 
Normal 66 23 2 91 
MCI 54 155 17 226 
AD 0 21 76 97 
% 
Normal 72.5 25.3 2.2 100.0 
MCI 23.9 68.6 7.5 100.0 
AD 0.0 21.6 78.4 100.0 
                MMSE-2:EV Classification accuracy 71.7% 
Abbreviations: MMSE-2, Mini-Mental State Examination-2; BV, Brief Version; SV, 











Table 6. The result by the discriminant function analysis in the healthy older 













1 0.266 100.0 100.0 0.459 0.790 73.352 9 0.000 
Abbreviations: MMSE-2, Mini-Mental State Examination-2; MCI, Mild Cognitive 








Table 7. The standardized canonical discriminant function coefficients in the 





Orientation to time 0.117 
Orientation to place 0.008 
Recall 0.366 
Attention and calculation -0.080 
Language -0.199 
Drawing 0.016 
Story memory 0.813 
Processing speed 0.026 
Abbreviations: MMSE-2, Mini-Mental State Examination-2; MCI, Mild Cognitive 








Table 8. The results of the structure matrix in the healthy older adults and 
the patients with MCI (MMSE-2) 
Discriminatory factors 
Correlation with the discriminant functions 
Function 1 
Story memory 0.883 
Recall 0.697 
Processing speed 0.378 
Orientation to time 0.341 
Attention and calculation 0.230 




Abbreviations: MMSE-2, Mini-Mental State Examination-2; MCI, Mild Cognitive 






















Table 9. Classification rates (%) by discriminant analysis in the healthy older 
adults and the patients with MCI (MMSE-2) 
MMSE-2 
  Predictive groups 
 Groups Normal MCI Total 
BV 
Frequency 
Normal 67 24 91 
MCI 81 145 226 
% 
Normal 73.6 26.4 100.0 
MCI 35.8 64.2 100.0 
MMSE-2:BV Classification accuracy 66.9% 
SV 
  Predictive groups 
 Groups Normal MCI Total 
Frequency 
Normal 65 26 91 
MCI 79 147 226 
% 
Normal 71.4 28.6 100.0 
MCI 35.0 65.0 100.0 
MMSE-2:SV Classification accuracy 66.9% 
EV 
  Predictive groups 
 Groups Normal MCI Total 
Frequency 
Normal 67 24 91 
MCI 57 169 226 
% 
Normal 73.6 26.4 100.0 
MCI 25.2 74.8 100.0 
MMSE-2:EV Classification accuracy 74.4% 
Abbreviations: MMSE-2, Mini-Mental State Examination-2; BV, Brief Version; SV; 













Table 10. The result by the discriminant function analysis in the patients with 













1 1.334 100.0 100.0 0.756 0.129 268.222 9 0.000 
Abbreviations: MMSE-2, Mini-Mental State Examination-2; MCI, Mild Cognitive 








Table 11. The standardized canonical discriminant function coefficients in the 





Orientation to time 0.585 
Orientation to place 0.311 
Recall 0.238 
Attention and calculation 0.139 
Language -0.024 
Drawing 0.093 
Story memory 0.257 
Processing speed -0.011 
Abbreviations: MMSE-2, Mini-Mental State Examination-2; MCI, Mild Cognitive 









Table 12. The results of the structure matrix in the patients with MCI and the 
patients with AD (MMSE-2) 
Discriminatory factors 
Correlation with the discriminant functions 
Function 1 
Orientation to time 0.809 
Orientation to place 0.609 
Story memory 0.530 
Recall 0.494 
Processing speed 0.426 




Abbreviations: MMSE-2, Mini-Mental State Examination-2; MCI, Mild Cognitive 





















Table 13. Classification rates (%) by discriminant analysis in the patients with 
MCI and the patients with AD (MMSE-2) 
MMSE-2 
  Predictive groups 
 Groups MCI AD Total 
BV 
Frequency 
MCI 202 24 226 
AD 18 79 97 
% 
MCI 89.4 10.6 100.0 
AD 18.6 81.4 100.0 
MMSE-2:BV Classification accuracy 87.0% 
SV 
  Predictive groups 
 Groups MCI AD Total 
Frequency 
MCI 209 17 226 
AD 17 80 97 
% 
MCI 92.5 7.5 100.0 
AD 17.5 82.5 100.0 
MMSE-2:SV Classification accuracy 89.5% 
EV 
  Predictive groups 
 Groups MCI AD Total 
Frequency 
MCI 208 18 226 
AD 17 80 97 
% 
MCI 92.0 8.0 100.0 
AD 17.5 82.5 100.0 
MMSE-2:EV Classification accuracy 89.2% 
Abbreviations: MMSE-2, Mini-Mental State Examination-2; BV, Brief Version; SV, 













Table 14. The result by the discriminant function analysis in the healthy older 













1 3.044 100.0 100.0 0.868 0.247 253.615 9 0.000 
Abbreviations: MMSE-2, Mini-Mental State Examination-2; AD, Alzheimer‟s 









Table 15. The standardized canonical discriminant function coefficients in the 





Orientation to time 0.423 
Orientation to place 0.224 
Recall 0.389 
Attention and calculation -0.074 
Language -0.078 
Drawing 0.170 
Story memory 0.553 
Processing speed -0.045 
Abbreviations: MMSE-2, Mini-Mental State Examination-2; AD, Alzheimer‟s 








Table 16. The results of the structure matrix in the healthy older adults and 
the patients with AD (MMSE-2) 
Discriminatory factors 
Correlation with the discriminant functions 
Function 1 
Story memory 0.745 
Recall 0.670 
Orientation to time 0.611 
Orientation to place 0.444 
Processing speed 0.438 




Abbreviations: MMSE-2, Mini-Mental State Examination-2; AD, Alzheimer‟s 





















Table 17. Classification rates (%) by discriminant analysis in the healthy older 
adults and the patients with AD (MMSE-2) 
MMSE-2 
  Predictive groups 
 Groups Normal AD Total 
BV 
Frequency 
Normal 83 8 91 
AD 11 86 97 
% 
Normal 91.2 8.8 100.0 
AD 11.3 88.7 100.0 
MMSE-2:BV Classification accuracy 89.9% 
SV 
  Predictive groups 
 Groups Normal AD Total 
Frequency 
Normal 83 8 91 
AD 10 87 97 
% 
Normal 91.2 8.8 100.0 
AD 10.3 89.7 100.0 
MMSE-2:SV Classification accuracy 90.4% 
EV 
  Predictive groups 
 Groups Normal AD Total 
Frequency 
Normal 85 6 91 
AD 2 95 97 
% 
Normal 93.4 6.6 100.0 
AD 2.1 97.9 100.0 
MMSE-2:EV Classification accuracy 95.7% 
Abbreviations: MMSE-2, Mini-Mental State Examination-2; BV, Brief Version; SV, 













Table 18. The result by the discriminant functions analysis in the groups of 












1 1.440 97.4 97.4 0.768 0.395 379.151 14 0.000 
2 0.038 2.6 100.0 0.192 0.963 15.281 6 0.018 
Abbreviation: K-MMSE, Korean version of the Mini-Mental State Examination; 
Mild Cognitive Impairment; AD, Alzheimer‟s Disease; 1, Normal vs. MCI & AD; 








Table 19. The standardized canonical discriminant function coefficients in the 




Orientation to time 0.651 -0.357 
Orientation to place 0.285 -0.323 
Registration -0.033 0.182 
Attention and calculation 0.131 0.129 
Recall 0.331 0.905 
Language 0.183 0.060 
Drawing 0.075 -0.043 
Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 
MCI, Mild Cognitive Impairment; AD, Alzheimer‟s Disease; 1, Normal vs. MCI & 








Table 20. The results of the structure matrix in the groups of normal, MCI, 
and AD (K-MMSE) 
Discriminatory factors 
Correlation with the discriminant functions 
Function 1 Function 2 
Orientation to time 0.829* -0.328 
Orientation to place 0.612* -0.277 
Language 0.415* 0.018 
Attention and calculation 0.349* 0.121 
Drawing 0.243* -0.002 
Registration 0.119* 0.109 
Recall 0.455 0.837* 
Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 
MCI, Mild Cognitive Impairment; AD, Alzheimer‟s Disease; 1, Normal vs. MCI & 





Table 21. Classification rates (%) by discriminant analysis in the groups of 
normal, MCI, and AD (K-MMSE) 
  Predictive groups 
 Groups Normal MCI AD Total 
Frequency 
Normal 26 64 1 91 
MCI 25 189 12 226 
AD 0 31 66 97 
% 
Normal 28.6 70.3 1.1 100.0 
MCI 11.1 83.6 5.3 100.0 
AD 0.0 32.0 68.0 100.0 
Classification accuracy 67.9% 
Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 







Table 22. The result by the discriminant function analysis in the healthy older 












1 0.105 100 100 0.308 0.905 30.961 7 0.000 
Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 
MCI, Mild Cognitive Impairment; 1, Normal vs. MCI. 
 
 
Table 23. The standardized canonical discriminant function coefficients in the 




Orientation to time 0.343 
Orientation to place 0.064 
Registration 0.121 




Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 
MCI, Mild Cognitive Impairment; 1, Normal vs. MCI. 
 
 
Table 24. The results of the structure matrix in the healthy older adults and 
the patients with MCI (K-MMSE) 
Discriminatory factors 
Correlation with the discriminant functions 
Function 1 
Recall 0.808 
Orientation to time 0.545 
Language 0.434 
Attention and calculation 0.367 
Orientation to place 0.364 
Registration 0.222 
Drawing 0.213 
Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 
MCI, Mild Cognitive Impairment; 1, Normal vs. MCI. 
 
138 
Table 25. Classification rates (%) by discriminant analysis in the healthy older 
adults and the patients with MCI (K-MMSE) 
  Predictive groups 
 Groups Normal MCI Total 
Frequency 
Normal 63 28 91 
MCI 88 138 226 
% 
Normal 69.2 30.8 100.0 
MCI 38.9 61.1 100.0 
Classification accuracy 63.4% 
Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 

























Table 26. The result by the discriminant function analysis in the patients with 












1 1.260 100.0 100.0 0.747 0.443 258.822 7 0.000 
Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 
MCI, Mild Cognitive Impairment; AD, Alzheimer‟s Disease; 1, MCI vs. AD. 
 
 
Table 27. The standardized canonical discriminant function coefficients in the 




Orientation to time 0.650 
Orientation to place 0.303 
Registration -0.057 




Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 
MCI, Mild Cognitive Impairment; AD, Alzheimer‟s Disease; 1, MCI vs. AD. 
 
 
Table 28. The results of the structure matrix in the patients with MCI and the 
patients with AD (K-MMSE) 
Discriminatory factors 
Correlation with the discriminant functions 
Function 1 
Orientation to time 0.833 
Orientation to place 0.627 
Recall 0.431 
Language 0.404 
Attention and calculation 0.355 
Drawing 0.244 
Registration 0.105 
Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 
MCI, Mild Cognitive Impairment; AD, Alzheimer‟s Disease; 1, MCI vs. AD. 
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Table 29. Classification rates (%) by discriminant analysis in the patients with 
MCI and the patients with AD (K-MMSE) 
  Predictive groups 
 Groups MCI AD Total 
Frequency 
MCI 208 18 226 
AD 18 79 97 
% 
MCI 92.0 8.0 100.0 
AD 18.6 81.4 100.0 
Classification accuracy 88.9% 
Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 

























Table 30. The result by the discriminant function analysis in the healthy older 












1 2.404 100.0 100.0 0.840 0.294 223.545 7 0.000 
Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 
AD, Alzheimer‟s Disease; 1, Normal vs. AD. 
 
 
Table 31. The standardized canonical discriminant function coefficients in the 




Orientation to time 0.583 
Orientation to place 0.175 
Registration 0.044 




Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 
AD, Alzheimer‟s Disease; 1, Normal vs. AD. 
 
 
Table 32. The results of the structure matrix in the healthy older adults and 
the patients with MCI (K-MMSE) 
Discriminatory factors 
Correlation with the discriminant functions 
Function 1 
Orientation to time 0.688 
Recall 0.648 
Orientation to place 0.500 
Language 0.361 
Attention and calculation 0.346 
Drawing 0.223 
Registration 0.115 
Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 
AD, Alzheimer‟s Disease; 1, Normal vs. AD. 
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Table 33. Classification rates (%) by discriminant analysis in healthy older 
adults and the patients with AD (K-MMSE) 
  Predictive groups 
 Groups Normal AD Total 
Frequency 
Normal 87 4 91 
AD 5 92 97 
% 
Normal 95.6 4.4 100.0 
AD 5.2 94.8 100.0 
Classification accuracy 95.2% 
Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 

























Table 34. The AUC of the MMSE-2:BV, the MMSE-2:SV, the MMSE-2:EV, and 
the K-MMSE for the healthy older adults compared with the patients with MCI 




















 70%  59% 
Abbreviations: AUC, Area Under the Curve; MMSE-2:BV, Mini-Mental State 
Examinaion-2:Brief Version; MMSE-2:SV, MMSE-2:Standard Version; MMSE-2:EV, 
MMSE-2:Expanded Version; K-MMSE, Korean version of the Mini-Mental State 
Examination; MCI, Mild Cognitive Impairment. 
Note. 
*p = 0.866 for MMSE-2:BV vs. K-MMSE. 
“
p = 0.458 for MMSE-2:SV vs. K-MMSE. 
”



















Table 35. The AUC of the MMSE-2:BV, the MMSE-2:SV, the MMSE-2:EV, and 
the K-MMSE for the patients with MCI compared with the patients with AD 





















Abbreviations: AUC, Area Under the Curve; MMSE-2:BV, Mini-Mental State 
Examinaion-2:Brief Version; MMSE-2:SV, MMSE-2:Standard Version; MMSE-
2:EV, MMSE-2:Expanded Version; K-MMSE, Korean version of the Mini-
Mental State Examination; MCI, Mild Cognitive Impairment; AD, Alzheimer’s 
Disease. 
Note. 
*p = 0.705 for MMSE-2:BV vs. K-MMSE. 
“
p = 0.273 for MMSE-2:SV vs. K-MMSE. 
”


















Table 36. The AUC of the MMSE-2:BV, the MMSE-2:SV, the MMSE-2:EV, and 
the K-MMSE for the healthy older adults compared with the patients with AD 

















Abbreviations: AUC, Area Under the Curve; MMSE-2:BV, Mini-Mental State 
Examinaion-2:Brief Version; MMSE-2:SV, MMSE-2:Standard Version; MMSE-
2:EV, MMSE-2:Expanded Version; K-MMSE, Korean version of the Mini-
Mental State Examination; AD, Alzheimer’s Disease. 
Note. 
*p = 0.861 for MMSE-2:BV vs. K-MMSE. 
“
p = 0.084 for MMSE-2:SV vs. K-MMSE. 
”








Figure 1. Korean version of the Mini-Mental State Examination (K-MMSE). 
Receiver operator characteristic (ROC) curve analysis of the K-MMSE in the 
groups of normal, mild cognitive impairment (MCI), and Alzheimer’s Disease (AD). 
(A) Normal vs. MCI, Area Under the Curve (AUC) = 0.70. (B) MCI vs. AD, 
Area Under the Curve (AUC) = 0.94. (C) Normal vs. AD, Area Under the 










Comparison between the Anatomic 
Correlation of the Mini-Mental State 
Examination and the Mini-Mental State 
Examination-2: A Voxel-Based Morphometric 
Study in the Patients with Mild Cognitive 




In studies 1 and 2, the reliability and validity of the newly developed 
MMSE-2 were analyzed in the patients with MCI and AD, and the 
sensitivity and specificity of the MMSE-2 were high so it has been 
shown that it can be used clinically as a cognitive screening test in 
Korea. In addition, as a result of analyzing the difference between the 
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K-MMSE and the MMSE-2, the MMSE-2:SV and the MMSE-2:EV were 
more sensitive to discriminate between the healthy older adults and the 
patients with MCI than the K-MMSE, and the K-MMSE and the MMSE-
2:BV could be used more usefully as dementia progressed. Therefore, 
the MMSE-2 is found to be more useful in the clinical setting 
depending on the group of the patients as a cognitive screening test.  
In study 3, the purpose of this study is to examine the correlations 
between the total scores of the MMSE-2 and the K-MMSE with global 
volume changes in cortical gray matter measured by structural 
magnetic resonance imaging (MRI) using voxel-based morphometry 
(VBM).  
As mentioned earlier, as AD progresses, the cognitive function of 
patients has been declined, volume loss in cerebral cortex has been 
appeared, and the neurotic plaques and neurofibrillary tangles has been 
accumulated in the brain tissue (Braak et al., 1991; Golde et al., 2000).  
In recent years, there have been a number of studies that have 
analyzed the relationship between the total score of the MMSE and the 
cortical gray matter volume changes in patients with cognitive decline. 
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Since the role of the hippocampus, especially in the temporal lobe, is 
related with episodic memory (Scoville et al., 1957), many studies have 
examined the relationship between changes of cognitive function of the 
patients with amnestic MCI and the size of the hippocampus. The 
previous studies showed that when the relationship between the total 
score of the MMSE and size of hippocampus in patients with MCI and 
AD was compared, as the hippocampal atrophy progressed, the total 
score of the MMSE has been decreased, suggesting that the MMSE 
would be proved to be a sensitive test for hippocampal atrophy (Yavuz 
et al., 2007; Laakso et al., 1995; Babiloni et al., 2009).  
Jack et al. (1999) reported that the hippocampus of patients with 
amnestic MCI and AD were atrophied and shrinking and also reported 
that the size of the hippocampus was important in predicting AD. 
However, the important features of patients with AD were not only 
atrophy of hippocampus, but also atrophy of the areas related to the 
anatomical temporo-parietal network associated with episodic memory. 
The temporo-parietal network includes the hippocampus including the 
parahippocampal gyrus, the entorhinal cortex, the retrosplenial area, the 
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posterior cingulate gyrus, and the precuneus (Buckner, 2004; Walhovd, 
et al., 2008; Singh et al., 2006).  
In a study by Apostolova et al. (2006), the relationship between the 
total score of the MMSE and structural neuroimaging in 29 patients 
with AD and 5 patients with amnestic MCI was analyzed. As a result, it 
was found that the total score of the MMSE and the gray matter 
integrity in the inner cortex, parahippocampal, precuneus, superior 
parietal lobule, subgenual cingulate gyrus, and orbitofrontal cortices 
were strongly correlated. In other words, as the score of MMSE has 
been decreased, the degree of brain atrophy has been changed 
severely. Moreover, there was a significant correlation between the 
total score of the MMSE and the size of gray matter in bilaterally 
temporal lobe, middle frontal gyrus, left angular gyrus, and 
supramarginal gyrus. The MMSE was found to be related to the overall 
size of gray matter of both cerebral hemispheres, particularly in the 
left hemisphere (Ridha et al., 2007; Sluimer et al., 2008; Hua et al., 
2008).  
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Fjell et al. (2009) also examined the relationship between cerebral 
cortical thickness measured by brain MRI and the total scores of the 
MMSE in 96 patients with severe AD and 93 healthy older adults. The 
results showed that the total score of the MMSE and the size of 
overall brain, cerebral cortex, accumbens, cerebral white matter, 
inferior lateral ventricles, and hippocampus were highly correlated. The 
brain size of the patients with AD was reduced by 58% compared with 
the healthy older adults.  
In addition, there were also a number of the previous studies 
reporting the relationship between the total score of the MMSE and 
regional cerebral blood flow (rCBF) (Eberling et al., 1993; DeKosky et 
al., 1990; Wolfe et al., 1995; Ushijima et al., 2002). In the study of 
Ushijima et al. (2002), the relationship between the total score of the 
MMSE and rCBF in 59 patients with AD and 12 healthy older adults 
was analyzed. CBF was measured using SPECT with N-isopropyl-p-
[
123
I]iodoamphetamine autoradiography (Iida et al., 1994). As a result, the 
total score of the MMSE was significantly correlated with the frontal 
lobe, medial temporal lobe, and parietal lobe. The results of examining 
152 
the relationship between CBF and subtests of the MMSE were as 
follows. Orientation was related to the parietal lobe and hippocampus, 
registration was related to the anterior temporal cortex, attention and 
calculation was related to the frontal lobe, recall was related to the 
medial temporal lobe, and language was related to the posterior 
temporal lobe.  
Although there have been many studies on the correlation of the 
MMSE with various brain imaging techniques, there is no study to 
examine the relationship between the MMSE-2 and global volume 
changes in cortical gray matter. Therefore, in study 3, the purpose of 
this study is to examine the correlations between the total scores of 
the MMSE-2 and the K-MMSE with global volume changes in cortical 
gray matter measured by structural magnetic resonance imaging (MRI) 
using voxel-based morphometry (VBM) and to measure how they 
change with progression of dementia. Moreover, the area of brain that 
correlates with the newly added story memory test and processing 
speed test in the MMSE-2 will be investigated.  
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Materials and Methods 
1. Participants 
1.1. Patients 
Among the patients who participated in study 1, the data of 22 
patients with MCI (8 males and 14 females) and 11 patient with AD (5 
males, 6 females) who underwent brain MRI within approximately 6 
months after examining the MMSE-2 and the K-MMSE were used in 
this study. They were diagnosed as MCI (CDR 0.5, CDR-SOB 0.5-2.0), 
early stage of AD (CDR 0.5, CDR-SOB 2.5-4.0), mild stage of AD (CDR 
1, CDR-SOB 4.5-9.0), and moderate stage of AD (CDR 2, CDR-SOB 9.5-
15.5).  
 
1.2. Control participants 
Among the healthy older adults who participated in study 1, the data 
of 10 healthy older adults (5 males and 5 females) who underwent 
brain MRI within approximately 6 months after examining the MMSE-2 
and the K-MMSE were used in this study.  
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2. Instruments 
2.1. MMSE-2  
The description of the MMSE-2 was the same as that of study 1 
and 2.  
 
2.2. K-MMSE 
The description of the K-MMSE was the same as that of study 1 
and 2.  
 
2.3. Data acquisition and analysis 
MRI was acquired using T1-weighted three dimensional (3D) 
volumetric spoiled gradient echo (SPGR) sequences on GE Signa Philips 
Intera Achieva 3.0T (Philips, Amsterdam, Netherlands). T1-weighted 3D 
volumetric SPGR sequences were parallel to the midline of the brain 
and 170-180 consecutive sagittal sections of 1 mm thickness were 
obtained. The conditions of the image were as follows. We analyzed 
only the images taken within 6 months after examining the MMSE-2 
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and the MMSE-2, with TR 8.1 msec, TE 4.6 msec, no interslice gap, 
FOV 240x240 mm and NEX =1. Images were analyzed by MATLAB 7.6.0 
(Mathworks, Natick, MA, USA) and Statistical Parametric Mapping (SPM5, 
Wellcome Department of Imaging Neuroscience, London, UK). In order 
to keep each brain size and each anatomical position constant, each 
brain surface was planted in a standard three-dimensional circular 
pattern. First, the original images were segmented. Segmentation is a 
method of classifying the anatomical parts such as gray matter, white 
matter, and cerebrospinal fluid according to the purpose of the 
research. Gray matter, white matter, and cerebrospinal fluid were all 
subdivided, and this was put into „gray.nii‟, a basic template in SPM 5, 
so that gray matter of the brain was placed at a certain position. 
Differences between the MRIs of each patient were corrected according 
to the International Consortium for Brain Mapping template for East 
Asian Brains during normalization, and the bias full width at half 
maximum (FWHM) was 70 mm. Smoothing was performed (12mm FWHM 
isotropic Gaussian kernel) to minimize gray matter variation. Thus, a 
cortical image of a certain size was obtained in accordance with the 
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purpose of the study. Multiple regression analysis was used to compare 
the gray matter of brain with the patients with MCI, the patients with 
AD, and the healthy older adults after correcting age and educational 
level as covariates. The estimated threshold value for each region was 
set to be p = 0.005, and the voxel extent threshold was 100. After 
comparing the data among the patients with MCI, the patients with AD, 
and the healthy older adults (uncorrected, p < 0.005), and the area of 
brain atrophy was identified using Talairach Client 2.4.2 




The procedure was the same as study 2, and the brain MRI images 
taken only within 6 months from the date after examining the MMSE-2 
and the K-MMSE were selected and analyzed.  
 
4. Statistical analysis  
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First, an ANOVA was used to compare age and education levels, and 
a chi square test was used to compare gender across the three groups 
(22 patients with MCI, 11 patients with AD, and 10 healthy older adults).  
Second, the results of the MMSE-2 (BV, SV, and EV) among the 
three groups were analyzed using an ANCOVA after controlling for age 
as a covariate.  
Third, the results of the K-MMSE among the three groups were 
analyzed using an ANCOVA after controlling for age as a covariate. 
Finally, multiple regression analysis was used to analyze the 
correlation between the total scores of the MMSE-2 (BV, SV, and EV) 
and the total score of the K-MMSE and the size of gray matter volume 
through VBM analysis. 
Data were analyzed using SPSS 18.0 (SPSS Inc., Chicago, IL, USA), 
and p < 0.05 was considered to be significant for all analyses, and 




1. The demographic data in the groups of normal, MCI, 
and AD 
The demographic characteristics of the patients with MCI, the 
patients with AD, and the healthy older adults are presented in Table 1. 
The mean age of the patients with MCI was 70.95±7.93 years (range: 
56-85 years), and the mean age of the patients with AD was 
74.09±6.32 (range: 65-88 years). The mean age of the healthy older 
adults was 65.60±7.63 years (range: 55-77 years). The mean number of 
years of education was 11.68±4.36 years (range: 6-18 years) in the 
patients with MCI, 11.18±4.62 years (range: 6-16 years) in the patients 
with AD, and 12.50±4.20 years (range: 6-18 years) in the healthy older 
adults.  
There were no significant differences in the participants’ gender, 
χ
2
(1, 43) = 0.604, p = 0.74, education, F(2, 40) = 0.241, p = 0.79, but 
there was significant difference in age, F(2, 40) = 3.447, p < 0.05, 
among the three groups. According to Tukey’s post hoc analysis, the 
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mean age of the patients with AD was significantly higher than the 
mean age of the healthy older adults, but there was no significant 
difference in the mean age between the patients with AD and the 
patients with MCI or between the patients with MCI and the healthy 
older adults. 
 
2. The results of the MMSE-2 in the groups of normal, 
MCI, and AD 
2.1. MMSE-2:BV 
The MMSE-2:BV scores of the participants in the three groups are 
shown in Table 2. An ANCOVA that controlled for age revealed 
significant differences among the three groups on the MMSE-2:BV. 
According to Tukey‟s post hoc analysis, the scores of orientation to 
time, orientation to place, and total score of the MMSE-2:BV were 
significantly higher for the patients with MCI and the healthy older 
adults than for the patients with AD, but there was no significant 
difference between the patients with MCI and the healthy older adults. 
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However, there were no significant differences in the items such as 
registration and recall in the three groups.  
 
2.2. MMSE-2:SV 
The MMSE-2:SV scores of the participants in the three groups are 
shown in Table 3. An ANCOVA that controlled for age revealed 
significant differences among the three groups on the MMSE-2:SV. 
According to Tukey‟s post hoc analysis, the score of attention and 
calculation was significantly higher for the healthy older adults than for 
the patients with MCI and AD, and it was significantly higher for the 
patients with MCI than for the patient with AD. Moreover, the scores 
of orientation to time, orientation to place, and total score of the 
MMSE-2:SV were significantly higher for the patients with MCI and the 
healthy older adults than for the patients with AD, but there were no 
significant differences between the patients with MCI and the healthy 
older adults. However, there were no significant differences in the 




Finally, The MMSE-2:EV scores of the participants in the three 
groups are shown in Table 4. An ANCOVA that controlled for age 
revealed significant differences among the three groups on the MMSE-
2:EV. According to Tukey‟s post hoc analysis, the scores of attention 
and calculation, story memory, and total score of the MMSE-2:EV were 
significantly higher for the healthy older adults than for the patients 
with MCI and AD, and they were significantly higher for the patients 
with MCI than for the patient with AD. Moreover, the scores of 
orientation to time, orientation to place, and processing speed were 
significantly higher for the patients with MCI and the healthy older 
adults than for the patients with AD, but there were no significant 
differences between the patients with MCI and the healthy older adults. 
However, there were no significant differences in the items such as 
registration, recall, language, and drawing in the three groups.  
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3. The results of the K-MMSE in the groups of normal, 
MCI, and AD 
The K-MMSE score of the participants in the three groups are 
presented in Table 5. An ANCOVA that controlled for age revealed 
significant differences among the three groups on the K-MMSE. 
According to Tukey‟s post hoc analysis, the score of attention and 
calculation was significantly higher for the healthy older adults than for 
the patients with MCI and AD, and it was significantly higher for the 
patients with MCI than for the patient with AD. Moreover, the scores 
of orientation to time, orientation to place, and total score of the K-
MMSE were significantly higher for the patients with MCI and the 
healthy older adults than for the patients with AD, but there were no 
significant differences between the patients with MCI and the healthy 
older adults. However, there were no significant differences in the 




4. Voxel-based morphometry of gray matter 
4.1. MMSE-2 
4.1.1. MMSE-2:BV (Table 6; Figure 1) 
 The gray matter volume reduction and the total score of the MMSE-
2:BV in the patients with MCI, the patients with AD, and the healthy 
older adults were compared. The results showed that the gray matter 
volume in the left fusiform gyrus and left inferior temporal gyrus of 
the patients with MCI and AD was significantly reduced than the 
healthy older adults (uncorrected, p < 0.005).  
 
4.1.2. MMSE-2:SV (Table 7; Figure 2) 
The gray matter volume reduction and the total score of the MMSE-
2:SV in the patients with MCI, the patients with AD, and the healthy 
older adults were compared. The results showed that the gray matter 
volume in the right inferior temporal gyrus, left fusiform gyrus, left 
inferior temporal gyrus, left hippocampus, and right fusiform gyrus of 
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the patients with MCI and AD was significantly reduced than the 
healthy older adults (uncorrected, p < 0.005).  
 
4.1.3. MMSE-2:EV (Table 8; Figure 3) 
The gray matter volume reduction and the total score of the MMSE-
2:EV in the patients with MCI, the patients with AD, and the healthy 
older adults were compared. The results showed that the gray matter 
volume in the right cuneus, left cuneus, right inferior temporal gyrus, 
right inferior occipital gyrus, right inferior temporal gyrus, left inferior 
frontal operculum, left precentral gyrus, left superior temporal pole, 
right angular gyrus, right medial temporal gyrus, and right fusiform 
gyrus of the patients with MCI and AD was significantly reduced than 
the healthy older adults (uncorrected, p < 0.005).  
 
4.1.4. MMSE-2:EV- story memory (Table 9; Figure 4) 
Among the subtests in the MMSE-2, only the story memory test was 
analyzed. The gray matter volume reduction and the score of story 
memory test of the MMSE-2 in the patients with MCI, the patients with 
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AD, and the healthy older adults were compared. The results showed 
that the gray matter volume in the right inferior occipital gyrus, left 
cuneus, left fusiform gyrus, left medial frontal gyrus, right angular 
gyrus, right medial superior frontal gyrus, right anterior cingulate gyrus, 
left supramarginal gyrus, left superior temporal gyrus, left inferior 
frontal operculum, left medial temporal gyrus, and right inferior frontal 
operculum of the patients with MCI and AD was significantly reduced 
than the healthy older adults (uncorrected, p < 0.005).  
 
4.1.5. MMSE-2:EV- processing speed (Table 10; Figure 5) 
Among the subtests in the MMSE-2, only the processing speed test 
was analyzed. The gray matter volume reduction and the score of 
processing speed test of the MMSE-2 in the patients with MCI, the 
patients with AD, and the healthy older adults were compared. The 
results showed that the gray matter volume in the left cerebellum of 
the patients with MCI and AD was significantly reduced than the 
healthy older adults (uncorrected, p < 0.005).  
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4.2. K-MMSE (Table 11; Figure 6) 
The gray matter volume reduction and the total score of the K-
MMSE in the patients with MCI, the patients with AD, and the healthy 
older adults were compared. The results showed that the gray matter 
volume in the left fusiform gyrus, left inferior temporal gyrus, left 
hippocampus, left cuneus, right inferior temporal gyrus, right fusiform 
gyrus, left inferior temporal gyrus, left superior occipital gyrus, and left 
calcarine fissure of the patients with MCI and AD was significantly 











In study 3, the gray matter volume reduction of the brain was 
compared with the two tests (MMSE-2 and K-MMSE) using VBM 
analysis to determine whether the MMSE-2 and the K-MMSE scores 
correlated with focal brain volume reduction in the patients with MCI 
and AD.  
The results of study 3 were as follows. First, the results of the 
MMSE-2 (BV, SV, and EV) and the K-MMSE were significantly differed 
among the three groups (healthy older adults, MCI, and AD). Although 
there were no significant differences in both the MMSE-2:BV and the 
MMSE-2:SV between the healthy older adults and the patients with MCI, 
the scores of the MMSE-2:BV and the MMSE-2:SV for the healthy older 
adults and the patients with MCI were significantly higher than for the 
patients with AD. Especially, there were significant differences in the 
items of the MMSE-2:SV such as orientation to time, orientation to 
place, and attention and calculation, but there were no significant 
differences on the items such as registration and recall. Moreover, the 
scores of the healthy older adults were significantly higher than the 
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patients of MCI and AD, and the scores of the patients with MCI were 
significantly higher than the patients with AD in the subtests of the 
MMSE-2:EV such attention and calculation, and story memory test. 
These results are consistent with the results of study 1 and 2, and the 
most discriminating tests are verbal and working memory tests related 
to episodic memory. Finally, in the K-MMSE, there was no significant 
difference between the healthy older adults and the patients with MCI, 
but there was a significant difference between the two groups (healthy 
older adults and MCI) and the patients with AD. This data is in 
agreement with the previous study (Kang et al., 1997). Therefore, as 
shown in studies 1 and 2, the previous results showed that the most 
sensitive tests that can distinguish the patients with MCI and AD from 
the healthy older adults are the tests related to episodic memory such 
as story memory, orientation to time, and orientation to place. 
The correlation between the MMSE-2 and gray matter volume 
reduction of the brain using the VBM analysis was as follows. First of 
all, the MMSE-2:BV scores correlated positively with gray matter 
volume in the left fusiform gyrus and left inferior temporal gyrus. 
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Moreover, the MMSE-2:SV scores correlated positively with gray matter 
volume in the right inferior temporal gyrus, left fusiform gyrus, left 
inferior temporal gyrus, left hippocampus, and right fusiform gyrus. 
Finally, the MMSE-2:EV scores correlated positively with gray matter 
volume in the right cuneus, left cuneus, right inferior temporal gyrus, 
right inferior occipital gyrus, right inferior temporal gyrus, left inferior 
frontal operculum, left precentral gyrus, left superior temporal pole, 
right angular gyrus, right medial temporal gyrus, and right fusiform 
gyrus. 
 According to the results of the previous studies about gray matter 
atrophy in the patients with MCI and AD, the gray matter atrophy of 
the patients with MCI was found in the hippocampus, parahippocampal 
gyrus, anterior cingulate gyrus, middle frontal gyrus, inferior parietal 
lobule, paracentral gyrus, pars opercularis, posterior cingulate gyrus, 
superior frontal gyrus, and temporal pole (Chuanming et al., 2011). As 
the Alzheimer's disease progresses, the area of gray matter atrophy of 
brain becomes wider. The gray matter atrophy of the patients with AD 
was found in global area of the temporal and parietal lobes including 
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the hippocampus, parahippocampal gyrus, entorhinal, retrosplenial area, 
posterior cingulate gyrus, precuneus cortices, superior parietal lobule, 
supramarginal gyrus, inferior parietal lobule, and fusiform gyrus 
(Buckner, 2004; Walhovd et al., 2008; Singh et al., 2006). Furthermore, 
the gray matter atrophy of the patients with AD was also found in 
global area of the frontal lobe and the lateral occipital lobe including 
the superior frontal gyrus, middle frontal gyrus, pars opercularis, frontal 
pole, precentral gyrus, and lateral orbitofrontal lobe (Fjell et al., 2009).  
When we look at the atrophic areas of gray matter associated with 
the MMSE-2:BV and the MMSE-2:SV, there were many parts that 
correspond to areas where gray matter volume reduction in the 
patients with MCI and AD, especially in bilateral temporal lobes. 
However, the above two tests did not correlate with cerebral gray 
matter atrophy of the parietal lobe and frontal lobe which were shown 
in patients with MCI and AD. However, when we look at the atrophic 
areas of gray matter associated with the MMSE-2:EV, there were a 
high correlation with the broader area of bilateral temporal lobes, 
parietal lobe, and frontal lobe.  
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In addition, the K-MMSE scores correlated positively with gray matter 
volume in the left fusiform gyrus, left inferior temporal gyrus, left 
hippocampus, left cuneus, right inferior temporal gyrus, right fusiform 
gyrus, left inferior temporal gyrus, left superior occipital gyrus, and left 
calcarine fissure. This data is consistent with the previous studies 
(Yavuz et al., 2007; Laakso et al., 1995; Babiloni et al., 2009; Jack et 
al., 1999; Buckner, 2004; Walhovd et al, 2008; Singh et al., 2006, 
Apostolova et al., 2006; Fjell et al., 2009). However, the K-MMSE was 
also highly correlated with both parietal and temporal lobes, but not 
with the frontal lobe.  
Thus, it was shown that the MMSE-2:EV evaluated more global brain 
regions than the MMSE-2:BV, the MMSE-2:SV and the K-MMSE. One of 
the shortcomings of the MMSE is that it is insensitive to impairment in 
executive functioning of the frontal lobe (Galasko et al., 1994; Kang et 
al., 1997), but the MMSE-2:EV can evaluate executive function of the 
frontal lobe, unlike the MMSE, so it can be thought that the MMSE-
2:EV can evaluate more accurately about the overall cognitive 
functioning of the patients.  
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In the following, among the subtests of the MMSE-2:EV, the 
correlation between the story memory test, which is the most sensitive 
test to discriminate the patients with MCI and AD from the healthy 
older adults, and the atrophy of cortical gray matter was analyzed 
separately. The results showed that scores of the story memory test in 
the MMSE-2:EV correlated positively with the right inferior occipital 
lobe, left cuneus, left fusiform gyrus, left medial frontal gyrus, right 
angular gyrus, right medial superior frontal gyrus, right anterior 
cingulate gyrus, left supramarginal gyrus, left superior temporal gyrus, 
left inferior frontal operculum, left medial temporal gyrus, and right 
inferior frontal operculum. In other words, the story memory test was 
found to be associated with bilateral temporal, frontal, and parietal 
lobes as a whole.  
Nolde et al. (1998) examined the relationship between the story 
memory test and the prefrontal cortex through functional magnetic 
resonance imaging (fMRI). The results showed that both prefrontal 
functions were activated when recalling the story. In more detail, when 
recalling the story in detail, only the left prefrontal lobe was activated, 
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and when the story was recalled by simplification or integration, the 
right prefrontal lobe was activated.  
The existing researches on information processing of story recall 
were as follows. According to Hudon et al. (2006), when we looked at 
information processing when we recalled a story, the important and big 
proposition of the story was stored at first and then the detailed or 
less important part of the story was stored. Moreover, when people 
remembered the story, they seemed to remember more topics than the 
details of the story (Meyer, 1975). In other words, rather than 
remembering each word in the story, people usually tend to memorize 
the whole theme of the story. In addition, a comparison of storytelling 
tests between young adults and older adults with normal cognitive 
functioning revealed that young adults were more likely to remember 
more information than elderly people, but there was no difference in 
remembering the subject of the story (Hultsch et al., 1984). According 
to O'Donnell, et al. (1988), remembering the story was required the 
ability to manage stories in terms of time flow and logical evolution 
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and to integrate and organize thinking, so it is said that the overall 
cognitive function was measured.  
Therefore, when memorizing a story, it is necessary to memorize the 
whole meaning of the words composing the story rather than to 
memorize each one of them, and to remember the common sense and 
the stories related to it so it may be related to the whole brain area 
rather than the hippocampus, and it is presumed to be related not only 
to the left temporal lobe but also the right temporal lobe and the 
frontal lobe. In other words, it is believed that the story memory test 
is related to the whole brain function as it is known.  
In addition, the processing speed test has been found to be 
associated with the left cerebellum. The symbol-digit coding test is a 
tool to measure psychomotor ability, visual searching, and attention 
ability associated with executive function of the frontal lobe (Folstein et 
al., 2010). The processing speed test is similar to the symbol digit 
modality test (SDMT) (Smith, 1982). In the fMRI study, 18 normal 
subjects were examined for their relationship to the brain area 
associated with SDMT, and the fronto-parieto-occipital network, caudate 
175 
nucleus, and cerebellum were activated (Forn et al., 2009). The 
cerebellum is mainly related to the information processing related to 
the cognitive function as well as the control of motor capacity related 
to the sensorimotor function (Habas et al., 2009; Krienen et al., 2009; 
O’Reilly et al., 2010). Therefore, it can be thought that there might 
be a connection between cerebellum and the processing speed test 
which evaluates psychomotor ability.  
Therefore, the overall results of this study suggested that the MMSE-
2 was more related to the degree of atrophy of the general brain area 
than to the K-MMSE. In particular, the MMSE-2:EV can be more useful 
as a cognitive screening test in clinical settings because the MMSE-
2:EV has the highest correlation with overall brain area and can 







Table 1. Characteristics of participants (M±SD) 
 All participants (n=43) 
Normal (n=10) MCI (n=22) AD (n=11) 
Age (years) 65.60±7.63 70.95±7.93 74.09±6.32* 
Education (years) 12.50±4.20 11.68±4.36 11.18±4.62 
Male/Female 5/5 8/14 5/6 
Abbreviations: M, Mean; SD, Standard deviation; MCI, Mild Cognitive impairment; 
AD, Alzheimer’s disease. 
Note. 


















Table 2. The results of the MMSE-2:BV in the groups of normal, MCI, and AD (M±SD) 





Registration 3.00±0.00 2.95±0.21 2.73±0.47 2.276 2, 39 0.105 1=2=3 
Orientation to time 4.70±0.48 4.59±0.59 2.64±1.21 23.000* 2, 39 0.541 1=2>3 
Orientation to place 5.00±0.00 4.59±0.59 3.36±1.12 13.546* 2, 39 0.410 1=2>3 
Recall 1.40±1.08 1.14±0.89 0.64±0.92 1.109 2, 39 0.054 1=2=3 
Total score 14.10±1.37 13.27±1.39 9.27±2.72 18.96* 2, 39 0.493 1=2>3 
Abbreviations: M, Mean; SD, Standard deviation; N, Normal; MCI, Mild Cognitive Impairment;  
AD, Alzheimer's Disease; MMSE-2:BV, Mini-Mental State Examination-2:Brief Version; 1, Normal; 2,  
Mild Cognitive Impairment; 3, Alzheimer‟s Disease. 
Note.  









Table 3. The results of the MMSE-2:SV in the groups of normal, MCI, and AD (M±SD) 





Registration 3.00±0.00 2.95±0.21 2.73±0.47 2.276 2, 39 0.105 1=2=3 
Orientation to time 4.70±0.48 4.59±0.59 2.64±1.21 23.000* 2, 39 0.541 1=2>3 
Orientation to place 5.00±0.00 4.59±0.59 3.36±1.12 13.546* 2, 39 0.410 1=2>3 
Recall 1.40±1.08 1.14±0.89 0.64±0.92 1.109 2, 39 0.054 1=2=3 
Attention and Calculation 4.70±0.68 3.45±1.37 2.27±1.49 5.719
“
 2, 39 0.227 1>2>3 
Language 7.90±0.32 7.68±0.57 7.36±1.21 0.566 2, 39 0.028 1=2=3 
Drawing 1.00±0.00 0.77±0.43 0.64±0.51 0.726 2, 39 0.036 1=2=3 
Total Score 27.70±1.83 25.23±2.72 19.55±4.57 14.553* 2, 39 0.427 1=2>3 
Abbreviations: M, Mean; SD, Standard deviation; N, Normal; MCI, Mild Cognitive Impairment; AD,  
Alzheimer's Disease; MMSE-2:SV, Mini-Mental State Examination-2:Standard Version; 1, Normal;  
2, Mild Cognitive Impairment; 3, Alzheimer‟s Disease.  
Note.  
*p < 0.001. 
“








Table 4. The results of the MMSE-2:EV in the groups of normal, MCI, and AD (M±SD) 





Registration 3.00±0.00 2.95±0.21 2.73±0.47 2.276 2, 39 0.105 1=2=3 
Orientation to time 4.70±0.48 4.59±0.59 2.64±1.21 23.000* 2, 39 0.541 1=2>3 
Orientation to place 5.00±0.00 4.59±0.59 3.36±1.12 13.546* 2, 39 0.410 1=2>3 
Recall 1.40±1.08 1.14±0.89 0.64±0.92 1.109 2, 39 0.054 1=2=3 
Attention and Calculation 4.70±0.68 3.45±1.37 2.27±1.49 5.719
“
 2, 39 0.227 1>2>3 
Language 7.90±0.32 7.68±0.57 7.36±1.21 0.566 2, 39 0.028 1=2=3 
Drawing 1.00±0.00 0.77±0.43 0.64±0.51 0.726 2, 39 0.036 1=2=3 
Story memory 11.30±2.95 6.59±3.14 3.27±1.49 16.061* 2, 39 0.452 1>2>3 
Processing speed  13.30±4.14 10.27±4.29 6.18±3.46 4.477* 2, 39 0.187 1=2>3 
Total Score 52.30±8.21 42.14±8.40 29.00±6.99 16.736* 2, 39 0.462 1>2>3 
Abbreviations: M, Mean; SD, Standard deviation; N, Normal; MCI, Mild Cognitive Impairment; AD,  
Alzheimer's Disease; MMSE-2:EV, Mini-Mental State Examination-2:Expanded Version; 1, Normal;  
2, Mild Cognitive Impairment; 3, Alzheimer‟s Disease. 
Note.  
*p < 0.001. 
“






Table 5. The results of the K-MMSE in the groups of normal, MCI, and AD (M±SD) 





Orientation to time 4.70±0.48 4.59±0.59 2.64±1.21 23.000* 2, 39 0.541 1=2>3 
Orientation to place 5.00±0.00 4.59±0.59 3.36±1.12 13.546* 2, 39 0.410 1=2>3 
Registration 3.00±0.00 3.00±0.00 3.00±0.00     
Attention and Calculation 4.70±0.68 3.45±1.37 2.27±1.49 5.719* 2, 39 0.227 1>2>3 
Recall 1.50±0.85 1.09±1.19 0.18±0.41 2.947 2, 39 0.131 1=2=3 
Language 8.00±0.00 7.59±0.80 7.27±1.19 0.804 2, 39 0.040 1=2=3 
Drawing 1.00±0.00 0.77±0.43 0.64±0.51 0.726 2, 39 0.036 1=2=3 
Total Score 27.90±1.29 25.09±3.32 19.36±4.32 14.050* 2, 39 0.419 1=2>3 
Abbreviations: M, Mean; SD, Standard deviation; N, Normal; MCI, Mild Cognitive Impairment; AD,  
Alzheimer's Disease; K-MMSE, Korean version of the Mini-Mental State Examination; 1, Normal;  
2, Mild Cognitive Impairment; 3, Alzheimer‟s Disease. 
Note. 






Table 6. The correlation of the MMSE-2:BV and area of gray matter volume 
reduction in the groups of normal, MCI, and AD 
 Coordinates x, y, z Area of gray matter volume reduction z-score 
-28 -12 -32 Left fusiform gyrus 3.30 
-36 -2 -34 Left inferior temporal gyrus 3.25 
Abbreviations: MMSE-2:BV, Mini-Mental State Examination-2:Brief version; MCI, 




Figure 1. The area of gray matter volume reduction correlated with the MMSE-
2:BV in the groups of normal, MCI, and AD  
 
Abbreviations: MMSE-2:BV, Mini-Mental State Examinaiton-2:Brief Version; MCI, 
Mild Cognitive Impairment; AD, Alzheimer‟s Disease. 
Note. 







Table 7. The correlation of the MMSE-2:SV and area of gray matter volume 
reduction in the groups of normal, MCI, and AD 
 Coordinates x, y, z Area of gray matter volume reduction z-score 
54 -66 -12 Right inferior temporal gyrus 3.83 
-28 -14 -34 Left fusiform gyrus 3.64 
-38 -4 -34 Left inferior temporal gyrus 3.51 
-28 -8 -18 Left hippocampus 3.25 
38 -54 -18 Right fusiform gyrus 3.23 
38 -66 -16 Right fusiform gyrus 3.16 
Abbreviations: MMSE-2:SV, Mini-Mental State Examination-2:Standard version; 
MCI, Mild Cognitive Impairment; AD, Alzheimer‟s Disease. 
 
 
Figure 2. The area of gray matter volume reduction correlated with the MMSE-
2:SV in the groups of normal, MCI, and AD 
 
Abbreviations: MMSE-2:SV, Mini-Mental State Examination-2:Standard version; 
MCI, Mild Cognitive Impairment; AD, Alzheimer‟s Disease. 
Note. 




Table 8. The correlation of the MMSE-2:EV and area of gray matter volume 
reduction in the groups of normal, MCI, and AD 
 Coordinates x, y, z Area of gray matter volume reduction z-score 
16 -80 36 Right cuneus 4.38 
2 -82 28 Left cuneus 4.32 
54 -64 -12 Right inferior temporal gyrus 4.11 
38 -86 -12 Right inferior occipital gyrus 4.03 
50 -54 -20 Right inferior temporal gyrus 3.66 
-58 10 14 Left inferior frontal operculum 4.02 
-44 6 42 Left precentral gyrus 3.90 
-56 6 0 Left superior temporal pole 3.69 
48 -70 40 Right angular gyrus 3.91 
52 -74 22 Right medial temporal gyrus 3.05 
24 -36 -18 Right fusiform gyrus 2.75 
Abbreviation: MMSE-2:EV, Mini-Mental State Examination-2:Expanded version; 
MCI, Mild Cognitive Impairment; AD, Alzheimer‟s Disease. 
 
Figure 3. The area of gray matter volume reduction correlated with the MMSE-
2:EV in the groups of normal, MCI, and AD 
 
Abbreviations: MMSE-2:EV, Mini-Mental State Examination-2:Expanded version; 
MCI, Mild Cognitive Impairment; AD, Alzheimer‟s Disease. 
Note. 
Uncorrected p < 0.005. 
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Table 9. The correlation of the story memory test in the MMSE-2 and area of 
gray matter volume reduction in the groups of normal, MCI, and AD 
 Coordinates x, y, z Area of gray matter volume reduction z-score 
40 -84 -12 Right inferior occipital lobe 4.96 
2 -82 30 Left cuneus 4.59 
-28 -12 -36 Left fusiform gyrus 4.56 
-26 38 46 Left medial frontal gyrus 4.29 
36 -56 42 Right angular gyrus 4.19 
4 44 36 Right medial superior frontal gyrus 4.14 
6 50 26 Right anterior cingulate gyrus 3.95 
-62 -26 34 Left supramarginal gyrus 4.08 
-60 4 -8 Left superior temporal gyrus 4.07 
-60 10 14 Left inferior frontal operculum 4.03 
-52 -20 -14 Left medial temporal gyrus 3.95 
50 16 34 Right inferior frontal operculum 3.88 
Abbreviation: MMSE-2, Mini-Mental State Examination-2; MCI, Mild Cognitive 
Impairment; AD, Alzheimer‟s Disease 
 
Figure 4. The area of gray matter volume reduction correlated with the story 
memory test in the MMSE-2 in the groups of normal, MCI, and AD 
 
Abbreviations: MMSE-2, Mini-Mental State Examination-2; MCI, Mild Cognitive 
Impairment; AD, Alzheimer‟s Disease. 
Note. 
Uncorrected p < 0.005. 
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Table 10. The correlation of the processing speed test in the MMSE-2 and 
area of gray matter volume reduction in the groups of normal, MCI, and AD 
 Coordinates x, y, z Area of gray matter volume reduction z-score 
-14 -88 -38 Left cerebellum 3.89 
Abbreviation: MMSE-2, Mini-Mental State Examination-2; MCI, Mild Cognitive 





Figure 5. The area of gray matter volume reduction correlated with the 
processing speed test in the MMSE-2 in the groups of normal, MCI, and AD 
 
Abbreviations: MMSE-2, Mini-Mental State Examination-2; MCI, Mild Cognitive 
Impairment; AD, Alzheimer‟s Disease. 
Note. 





Table 11. The correlation of the K-MMSE and area of gray matter volume 
reduction in the groups of normal, MCI, and AD 
 Coordinates x, y, z Area of gray matter volume reduction z-score 
-26 14 -34 Left fusiform gyrus 3.71 
-40 -6 -34 Left inferior temporal gyrus 3.39 
-26 -8 -18 Left hippocampus 3.30 
2 -82 28 Left cuneus 3.61 
54 -62 -14 Right inferior temporal gyrus 3.55 
36 -72 -16 Right fusiform gyrus 3.52 
-60 -48 -20 Left inferior temporal gyrus 2.95 
-18 -70 30 Left superior occipital gyrus 3.11 
-18 -64 10 Left calcarine fissure 2.87 
Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 
MCI, Mild Cognitive Impairment; AD, Alzheimer‟s Disease. 
 
Figure 6. The area of gray matter volume reduction correlated with the K-
MMSE in the groups of normal, MCI, and AD 
 
Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 
MCI, Mild Cognitive Impairment; AD, Alzheimer‟s Disease. 
Note. 




The Validity and Reliability of the Mini-Mental 
State Examination-2 for Detecting Vascular Mild 
Cognitive Impairment and Vascular Dementia  
in a Korean Population 
 
Introduction 
In study 1, the validity and reliability of the MMSE-2 were verified 
and shown to be useful clinically as a cognitive screening test in Korea.  
In study 2, the K-MMSE which has been widely used in Korea as a 
cognitive screening test and the MMSE-2 were compared to verify 
which test was more sensitive to discriminate the patients with 
dementia from the healthy older adults. The results showed that the 
MMSE-2:SV and MMSE-2:EV were more sensitive to discriminate the 
healthy older adults from the patients with MCI than the K-MMSE, and 
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as the dementia progressed, the K-MMSE or the MMSE-2:BV could be 
used more usefully in the clinical settings. Therefore, the MMSE-2 can 
be used more effectively than the K-MMSE as a cognitive screening 
test in clinical settings.  
In study 3, the gray matter volume reduction of the brain was 
compared with the two tests (MMSE-2 and K-MMSE) using VBM 
analysis to determine whether the MMSE-2 and the K-MMSE scores 
correlated with focal brain volume reduction in the patients with MCI 
and AD. The MMSE-2 was more related to the degree of atrophy of 
the overall brain area than to the K-MMSE. In particular, the MMSE-
2:EV had the highest correlation with the general brain area, and also 
it could measure the frontal lobe function that could not be measured 
by the K-MMSE. 
As mentioned earlier, one of the shortcomings of the MMSE was that 
there were limited items to evaluate visuospatial and executive 
functions in the MMSE so it could not accurately distinguish the 
patients with fronto-temporal dementia or VD from the healthy older 
adults (Galasko et al., 1994; Tangalos et al., 1996; Romàn et al., 1993; 
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Mungas et al., 2000; Kang et al., 1997). In addition, Nys et al. (2005) 
studied the validity of the MMSE in acute stroke patients. According to 
the result of ROC curve analysis, the AUC of the MMSE was 0.67 (p = 
0.13) which did not discriminate sensitively between the healthy older 
adults and the patients with acute stroke. The reason for this was the 
lack of items to measure the frontal lobe functions such as abstract 
reasoning, executive functioning, and visual perception/construction 
ability among the items in the MMSE. In a study by Dong et al. (2010), 
the Montreal Cognitive Assessment (MoCA) which is one of the 
cognitive screening tests and the MMSE were compared to verify which 
test was more sensitive to discriminate the patients with VCI after 
acute stroke from the healthy older adults. They insisted that the 
MOCA was more sensitive to discriminate the patients with VD from 
the healthy older adults than the MMSE because there were the items 
to evaluate the frontal lobe functions such as executive function, 
attention, and delayed recall in the MoCA.  
As noted in the previous studies, in the MMSE-2 (Folstein et al., 
2010), there are subtests for measuring the frontal lobe function, such 
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as story memory and processing speed tests, so it can be thought that 
the MMSE-2 may be more sensitive to cognitive decline in the patients 
with VCI than the MMSE (Folstein et al., 1975).  
Therefore, in study 4, the purpose of this study is to evaluate the 
validity and reliability of the MMSE-2 for assessing the patients with 
VaMCI and VD in a Korean population. Specifically, we would like to 
focus on the usefulness of the MMSE-2 as a sensitive screening 
measure for detecting early cognitive change of the patients with VCI, 









Materials and Methods 
1. Participants 
1.1. Patients 
Participants who were all over 50 years of old age in this study 
included 66 patients (36 male, 30 female) with VaMCI and 46 patients 
(29 male, 17 female) with VD who were recruited from the Clinical 
Neuroscience Center at the Seoul National University Bundang Hospital 
from November 2015 to March 2017. They were underwent a medical 
examination via an interview, a neurological examination, blood tests, 
brain imaging with CT or MRI, and neuropsychological assessments to 
obtain a diagnosis. The patients with VaMCI were diagnosed as 
„probable VaMCI‟ according to AHA-ASA (American Heart Association-
American Stroke Association) (Gorelick et al., 2011), and the patients 
with VD were diagnosed with the criteria for „probable VD‟ from 
NINCDS-AIREN (National Institute of Neurological Disorders and Stroke 
and the association Internationale pour la Recherche et I‟enseignement 
en Neurosciences) (Romàn et al., 1993). Moreover, based on the Clinical 
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Dementia Rating (CDR) (Morris, 1993) and the Clinical Dementia Rating 
Scale Sum of Boxes (CDR-SOB) (O‟Bryant et al., 2008; O‟Bryant et al., 
2010) scores, patients were classified as having VaMCI (CDR 0.5, CDR-
SOB 0.5-2.5) and VD (CDR 0.5 to CDR 2, CDR-SOB 3.0 to 15.5).  
 
1.2. Control participants 
The normal control group consisted of 75 healthy (29 Male, 46 
female) older adults who were all over 50 years of old age participated 
in this study from November 2015 to March 2017. They were either 
the caregivers for one of the patients undergoing treatment at Seoul 
National University Bundang Hospital, or they were recruited from a 
health care center. They did not have subjective memory complaints, 
any of 29 exclusionary diseases, or a history suggestive of a decrease 
in cognitive function (Christensen et al., 1997).
 
They also had scores 
that were higher than or at most one standard deviation below the 
mean scores of the respective age- and education-matched population 
on the K-MMSE (Kang et al., 1997) and had an average score of 0.42 
or lower on the Korean Instrumental Activities of Daily Living (K-IADL) 
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(Kang et al., 2002). This score has been found to discriminate dementia 
from normal cognitive aging. The K-IADL is an 11-item questionnaire 
that includes IADLs of shopping, mode of transportation, ability to 
handle finances, housekeeping, food preparation, ability to use a 
telephone, taking medication, recent memory, hobbies, watching 
television, and fixing. All participants were determined to be free of 
cognitive deficits, and they all consented to participate in this study. 
Moreover, all participants were free from neurological or psychiatric 
illnesses, underwent the same neuropsychological assessments as the 





The description of the MMSE-2 was the same as that of study 1. 
 
2.2. Other neuropsychological assessments 
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 To measure the correlation of the MMSE-2 with other 
neuropsychological assessments, a variety of cognitive functions, such 
as attention, verbal memory, visuospatial function ability, executive 
function, and language function, were measured. Attention was assessed 
using the Korean-Trail Making Test-Elderly‟s version: Part A (K-TMT-E: 
type A) (Yi et al, 2007). Verbal memory was assessed using the Seoul 
Verbal Learning Test (SVLT) (Kang et al., 2003), and a copy of the 
Rey Complex Figure Test (RCFT) (Meyers et al., 1995) was used to 
assess visuospatial function. Neuropsychological assessments primarily 
associated with executive function, including the Korean-Trail Making 
Test-Elderly‟s version: Part B (K-TMT-E: Part B) (Yi et al., 2007), the 
Semantic Word Fluency Test (SWF)-Animal and the Phonemic Word 
Fluency Test (PWF) (Kang et al., 2000), and the Digit Symbol Coding 
(DSC) (Joy et al., 2004) were used. Naming ability was assessed using 
the Korean version of the Boston Naming Test (K-BNT) (Kim et al., 
1997). Depression was assessed using the Short version of the Geriatric 
Depression Scale (SGDS) (Cho et al., 1999). Global measurements, 
including the K-MMSE (Kang et al., 1997), CDR (Morris, 1993), and 
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In study 1, because the equivalence of the blue and red forms of 
the MMSE-2 was high for all three alternative forms: the MMSE-2:BV 
(r = 0.90, p < 0.01), the MMSE-2:SV (r = 0.97, p < 0.01), and the 
MMSE-2:EV (r = 0.97, p < 0.01), half of the patients who participated 
in this study completed the red form of the MMSE-2, and the other 
half of the patients completed the blue form of the MMSE-2. Moreover, 
the order in which the neuropsychological assessments were 
administered is presented in Table 1.  
 
4. Statistical analysis 
An analysis of variance (ANOVA) was used to compare age and 
education levels, and a chi-square test was used to compare gender 
across all three groups. The results of the neuropsychological tests 
196 
including the K-MMSE, among the three groups were analyzed using an 
analysis of covariance (ANCOVA) after controlling for demographic 
variables (age, education, and gender). Moreover, the MMSE-2 scores of 
all three groups were analyzed with an ANCOVA followed by Tukey’s 
test for post-hoc analysis.  
Reliability was assessed through measurements of internal consistency, 
test-retest reliability, and interrater reliability. The internal consistency 
of the MMSE-2 was measured using Cronbach’s α coefficient. To 
assess test-retest reliability, the MMSE-2 was re-administered one to 
two months (31.35±7.53 days) after the initial test to 11 patients with 
VaMCI, 5 patients with VD, and 4 healthy older adults, and the data 
were analyzed using Pearson’s correlation coefficients. Interrater 
reliability was calculated between two neuropsychologists (n=32) using 
the intraclass correlation coefficient (ICC).  
Finally, the validity of the MMSE-2 was analyzed as follows. To 
assess the concurrent validity of the MMSE-2, Pearson’s correlation 
coefficient was used to compare the MMSE-2 with the K-MMSE, the 
SVLT, the copy test of RCFT, the SWF-animal, the PWF, the K-TMT-E: 
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Part A & B, the DSC, and the K-BNT. To verify the discriminant 
validity based on the severity of dementia, all participants were 
classified into five groups according to CDR and CDR-SOB, and the 
average scores of the MMSE-2 were compared among these five 
groups using an ANCOVA. To evaluate the diagnostic utility of the 
MMSE-2, the sensitivity and specificity of the MMSE-2 was examined 
using a receiver operating characteristics (ROC) curve and area under 
the curve (AUC) measurements. Data were analyzed using IBM SPSS 
22.0. (SPSS Inc., Chicago, IL, USA), and p < 0.05 was considered to be 









1. The participants’ demographic data  
The demographic data are presented in Table 2. A total of 187 
elderly participants (94 men and 93 women) were enrolled in this study. 
The mean age of the patients with VaMCI was 71.97±7.67 years (range: 
54-91 years), and the mean age of the patients with VD was 
72.59±7.35 (range: 54-85 years). The mean age of the healthy older 
adults was 68.59±7.10 years (range: 50-84 years). The mean number of 
years of education was 11.06±3.91 years (range: 6-20 years) in the 
patients with VaMCI, 10.61±3.62 years (range: 6-20 years) in the 
patients with VD, and 12.49±4.03 years (range: 6-20 years) in the 
healthy older adults.  
There was significant difference in the participants’ gender, χ
2 
(1,187) = 7.52, p = 0.02, age, F(2, 184) = 5.57, p < 0.004, and education, 
F(2, 184)=4.07, p < 0.019, among the three groups. According to 
Tukey’s post hoc analysis, the mean age of the patients with VD was 
significantly higher than that of the healthy older adults, and the mean 
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age for the patients with VaMCI was significantly higher than that of 
the healthy older adults. However, there was no significant difference 
in the mean of age for the patients with VaMCI and the patients with 
VD. Moreover, the mean number of years of education for the healthy 
older adults was significantly higher than that of the patients with VD, 
and there was no significant difference in the mean number of years 
of education between the patients with VD and the patients with 
VaMCI or between the patients with VaMCI and the healthy older 
adults. In addition, the rate of gender for the healthy older adults was 
significantly different than that of the patients with VD, but there was 
no significant difference in the rate of gender between healthy older 
adults and the patients with VaMCI or between the patients with VaMCI 
and the patients with AD. 
 
2. The results of participants’ neuropsychological 
assessments  
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The results of the neuropsychological assessments of the three 
groups (VaMCI, VD, and healthy older adults) were compared. With 
respect to each of the cognitive domain scores, the three groups 
differed significantly in each of the domain assessed: attention, verbal 
memory, visuospatial function, language function, and frontal/executive 
function (all p < 0.001). Tukey’s post hoc analysis of the cognitive 
domain revealed that the scores of the healthy older adults were 
significantly higher than the scores of the patients with VaMCI and VD 
and that the scores of the patients with VaMCI were significantly 
higher than the scores of the patients with VD in the K-MMSE, the 
SVLT, the copy of the RCFT, the K-TMT-E: Part B, the SWF-animal, 
the PWF, the K-BNT, and the DSC. However, in the K-TMT-E: Part A, 
although there was no significant difference between the healthy older 
adults and the patients with VaMCI, the scores of the two groups 
(healthy older adults and VaMCI) were significantly higher than those of 
the patients with VD. Moreover, there was no significant difference 
among the three groups in the SGDS. The mean scores of the subtests 
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for each group and the results of Tukey’s post-hoc analysis are 
presented in Table 3.  
 
3. The results of the MMSE-2 in the groups of normal, 
VaMCI, and VD 
3.1. MMSE-2:BV 
The MMSE-2:BV scores of the participants in the three groups are 
presented in Table 4. An ANCOVA that controlled for age, education, 
and gender revealed significant differences among the three groups on 
the MMSE-2:BV. According to Tukey’s post hoc analyses, the total 
score of the MMSE-2:BV was significantly higher for the healthy older 
adults than for the patients with VaMCI and the patients with VD, and 
it was significantly higher for the patients with VaMCI than for the 
patients with VD. Especially, among all items of the MMSE-2:BV, the 
score of recall was significantly higher for the healthy older adults 
than for the patients with VaMCI and the patients with VD, and it was 
significantly higher for the patients with VaMCI than for the patients 
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with VD. However, there were no significant differences in the items 
registration, orientation to time, and orientation to place between the 
healthy older adults and the patients with VaMCI, but the scores of the 
three items in the MMSE-2:BV were significantly higher for the healthy 
older adults and the patients with VaMCI than for the patients with VD.  
 
3.2. MMSE-2:SV 
The MMSE-2:SV scores of the participants in the three groups are 
shown in Table 5. An ANCOVA that controlled for age, education, and 
gender revealed significant differences among the three groups on the 
MMSE-2:SV. Tukey’s post hoc analyses showed that the total score of 
the MMSE-2:SV was significantly higher for the healthy older adults 
than for the patients with VaMCI and the patients with VD, and it was 
also significantly higher for the patients with VaMCI than for the 
patients with VD. Particularly, among all items of the MMSE-2:SV, the 
scores of recall, attention and calculation, and language were 
significantly higher for the healthy older adults than for the patients 
with VaMCI and the patients with VD, and they were also significantly 
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higher for the patients with VaMCI than for the patients with VD. 
However, there were no significant differences in the items registration, 
orientation to time, orientation to place, and drawing between the 
healthy older adults and the patients with VaMCI, but the scores of 
four items on the MMSE-2:SV were significantly higher for the healthy 
older adults and the patients with VaMCI than for the patients with VD.  
 
3.3. MMSE-2:EV 
The MMSE-2:EV scores of the participants in the three groups are 
shown in Table 6. An ANCOVA that controlled for age, education, and 
gender revealed significant differences among the three groups on the 
MMSE-2:EV. Tukey’s post hoc analyses showed that the total score of 
the MMSE-2:EV was significantly higher for the healthy older adults 
than for the patients with VaMCI and the patients with VD, and it was 
also significantly higher for the patients with VaMCI than for the 
patients with VD. Particularly, among the items of the MMSESE-2:EV, 
the scores of recall, attention and calculation, language, story memory, 
and processing speed were significantly higher for the healthy older 
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adults than for the patients with VaMCI and the patients with VD, and 
the scores of five items were also significantly higher for the patients 
with VaMCI than for the patients with VD. However, there were no 
significant differences in the items registration, orientation to time, 
orientation to place, and drawing between the healthy older adults and 
the patients with VaMCI, but the scores of four items on the MMSE-
2:EV were significantly higher for the healthy older adults and the 
patients with VaMCI than for the patients with VD.  
 
4. Reliability analyses 
4.1. Internal Consistency 
The internal reliability (Cronbach’s α) of three versions of the 
MMSE-2 (red and blue forms) among the three groups are presented in 
Table 7. The internal reliability was relatively high because alphas 
ranged from 0.62 to 0.74. 
 
4.2. Test-retest reliability 
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  Eleven patients with VaMCI, 5 patients with VD, and 4 healthy 
older adults were tested twice, at an interval that averaged 31.35±7.53 
days, to examine the test-retest reliability. The mean age of the 
participants was 72.35±7.13 years and the mean number of years of 
education was 11.60±3.62 years. The test-retest reliability of three 
versions of the MMSE-2 was high, ranging from 0.62 to 0.99 (Table 8).  
 
4.3. Interrater reliability 
Two trained neuropsychologists were present during the 
administration of the MMSE-2 to 32 participants. One-way, single-
measure intraclass correlation coefficients (ICCs) were calculated for 
each item of the MMSE-2 (Table 9). The ICCs ranged from 0.95 to 0.99. 
There was 100% agreement for orientation to place, naming, repetition, 
comprehension, reading, writing, and drawing. 
 
5. Validity analyses 
5.1. Concurrent validity 
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The concurrent validity of the MMSE-2 was examined through 
correlation with the values of the K-MMSE, the SVLT, the copy of 
RCFT, the SWF-animal, the PWF, the K-TMT-E: Part A & B, the DSC, 
and the K-BNT. The results showed that the three versions of the 
MMSE-2 were significantly correlated with the cognitive function tests 
(Table 10). Particularly, the correlation coefficients were high between 
the MMSE-2:BV and the MMSE (r = 0.865, p < 0.01), the MMSE-2:SV 
and the MMSE (r = 0.947, p < 0.01), and the MMSE-2:EV and the 
MMSE (r = 0.839, p < 0.01).  
 
5.2. Discriminant validity by CDR stage analysis 
To examine the utility of the MMSE-2 to detect dementia severity, 
the participants were reclassified into five groups according to their 
CDR and CDR-SOB scores. Specifically, the healthy older adults were 
assigned a CDR score of 0 (CDR-SOB 0), the patients with VaMCI were 
assigned a CDR score of 0.5 (CDR-SOB 0.5-2.5), the patients with early 
stage of VD were assigned a CDR score of 0.5 (CDR-SOB 3.0-4.0), the 
patients with mild stage of VD were assigned a CDR score of 1 (CDR-
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SOB 4.5-9.0), and the patients with moderate stage of VD were 
assigned a CDR score of 2 (CDR-SOB 9.5-15.5). The average age, 
educational level, and gender of the participants are shown in Table 11. 
Although there was no significant difference in gender, χ
2
(1,187) = 
8.68, p = 0.70, and education, F(4,182) = 2.041, p = 0.90, among the 
five groups, there were significant differences in age, F(4,182) = 3.426, 
p < 0.01.  
The scores of all three versions of the MMSE-2 for the participants 
in the five groups are presented in Table 12. An ANCOVA that 
controlled for age revealed significant differences among the five 
groups in all three versions of the MMSE-2. According to Tukey’s 
post hoc analyses, the five groups differed significantly with respect to 
the scores of the MMSE-2:BV and the MMSE-2:SV. However, on the 
MMSE-2:EV, the three groups (VaMCI, moderate stage of VD, and 
healthy older adults) differed significantly, but there was no significant 
difference between the patients with early stage of VD and the 
patients with mild stage of VD.  
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6. Diagnostic utility 
To measure the diagnostic utility of the three versions of the MMSE-
2, the ROC curve analysis and the area under the curve (AUC) was 
calculated. The results of each version of the MMSE-2 were as follows.  
 
6.1. MMSE-2:BV 
First, for discriminating the healthy older adults from the patients 
with VaMCI, the AUC of the MMSE-2:BV was 0.79 (95% confidence 
interval, CI, 0.71-0.86, p < 0.001). The sensitivity of the MMSE-2:BV 
was 84% and the specificity was 58% when using a cut-off score of ≤ 
13 of 16 to predict VaMCI. Second, for discriminating the patients with 
VaMCI from the patients with VD, the AUC of the MMSE-2:BV was 
0.89 (95% CI, 0.84-0.95, p < 0.001). The sensitivity of the MMSE-2:BV 
was 85% and the specificity was 72% when using a cut-off score of ≤ 
11 of 16 to predict VD. Finally, for discriminating the healthy older 
adults from the patients with VD, the AUC of the MMSE-2:BV was 0.99 
(95% CI, 0.97-1.00, p < 0.001). The sensitivity of the MMSE-2:BV was 
209 
100% and the specificity was 72% when using a cut-off score of ≤ 11 
of 16 to predict VD (Figure 1). 
 
6.2. MMSE-2:SV 
 First, for discriminating the healthy older adults from the patients 
with VaMCI, the AUC of the MMSE-2:SV was 0.87 (95% CI, 0.81-0.92, p 
< 0.001). The sensitivity of the MMSE-2:SV was 81% and the specificity 
was 80% when using a cut-off score of ≤ 26 of 30 to predict VaMCI. 
Second, for discriminating the patients with VaMCI from the patients 
with VD, the AUC of the MMSE-2:SV was 0.97 (95% CI, 0.94-0.99, p < 
0.001). The sensitivity of the MMSE-2:SV was 82% and the specificity 
was 98% when using a cut-off score of ≤23 of 30 to predict VD. 
Finally, for discriminating the healthy older adults from the patients 
with VD, the AUC of the MMSE-2:SV was 0.99 (95% CI, 0.99-1.00, p < 
0.001). The sensitivity of the MMSE-2:SV was 100% and the specificity 





 First, for discriminating the healthy older adults from the patients 
with VaMCI, the AUC of the MMSE-2:EV was 0.90 (95% CI, 0.85-0.95, p 
< 0.001). The sensitivity of the MMSE-2:EV was 83% and the specificity 
was 82% when using a cut-off score of ≤ 44 of 90 to predict VaMCI. 
Second, for discriminating the patients with VaMCI from the patients 
with VD, the AUC of the MMSE-2:EV was 0.94 (95% CI, 0.89-0.98, p < 
0.001). The sensitivity of the MMSE-2:EV was 85% and the specificity 
was 85% when using a cut-off score of ≤ 33 of 90 to predict VD. 
Finally, for discriminating the healthy older adults from the patients 
with VD, the AUC of the MMSE-2:EV was 0.99 (95% CI, 0.99-1.00, p < 
0.001). The sensitivity of the MMSE-2:EV was 100% and the specificity 








This study verified the newly developed MMSE-2 as a reliable and 
valid cognitive screening measure for the patients with VaMCI and VD 
in a Korean population. The results demonstrated several key points. 
First, the results of the MMSE-2 and other neuropsychological 
assessments among the three groups (healthy older adults, VaMCI, and 
VD) which measure attention, verbal memory, visuospatial function, 
language function, and frontal/executive function were significantly 
differed. 
Second, the MMSE-2 was shown to have good internal consistency, 
high test-retest reliability, and high inter-rater reliability. 
Third, the MMSE-2 was also highly correlated with various 
neuropsychological assessments with verified validity. Particularly, the 
MMSE-2 had a very high correlation with the K-MMSE, and it also 
demonstrated a high correlation with verbal memory, visuospatial 
function, language function, and frontal lobe function tests. This result 
is consistent with the results in study 1. As mentioned before, even 
though there is executive function test in the MMSE such as attention 
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and calculation, the MMSE is insensitive to impairments in executive 
functioning, abstract reasoning, and visual perception/concentration (Nys 
et al., 2005). However, as Folstein et al. (2010) suggested that the 
MMSE-2 has shown its ability to measure executive function in more 
detail, and thus it can measure a greater variety of cognitive functions 
than the MMSE.  
Fourth, as similar with the results in study 1, the scores of the 
MMSE-2 could also discriminate across each of the CDR and CDR-SOB 
stages. Therefore, the scores of the MMSE-2 declined significantly as 
CDR and CDR-SOB scores increased, which confirmed that the MMSE-2 
was able to discriminate across the stages of CDR and CDR-SOB. This 
showed that the MMSE-2 is a useful instrument as a screening measure 
for detecting the progress of cognitive impairment. However, with the 
MMSE-2:EV, there was no significant difference between the patients 
with early stage of VD and the patients with mild stage of VD with 
similar to the results in study 1. There is possible reason for this 
finding is that the difficulty levels of story memory and processing 
speed tests may not enough to sensitive to discriminate between the 
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patients with early stage of VD and the patients with mild stage of VD. 
Thus, the MMSE-2:BV and MMSE-2:SV can be more effective than the 
MMSE-2:EV in assessing cognitive functions of the patients with early 
to mild stages of VD.  
The sensitivity and specificity of the three versions of the MMSE-2 
in discriminating between the healthy older adults and the patients with 
VaMCI were tested: for the MMSE-2:BV, the sensitivity was 84% and 
the specificity was 58% at the cut-off score of 13/14; for the MMSE-
2:SV, the sensitivity was 81% and the specificity was 80% at the cut-
off score of 26/27; and for the MMSE-2:EV, the sensitivity was 83% 
and the specificity was 82% at the cut-off score of 44/45. All three 
versions of the MMSE-2 could similarly discriminate between the two 
groups.  
The sensitivity and specificity of the three versions of the MMSE-2 
in discriminating between the patients with VaMCI and the patients with 
VD were tested: for the MMSE-2:BV, the sensitivity was 85% and the 
specificity was 72% at the cut-off score of 11/12; for the MMSE-2:SV, 
the sensitivity was 82%, and the specificity was 98% at the cut-off 
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score of 23/24; and for the MMSE-2:EV, the sensitivity was 85% and 
the specificity was 85% at the cut-off score of 33/34. All three 
versions of the MMSE-2 could similarly discriminate between the two 
groups. 
Finally, the sensitivity and specificity of three versions of the MMSE-
2 in discriminating between the healthy older adults and the patients 
with VD were tested: for the MMSE-2:BV, the sensitivity was 100% and 
the specificity was 72% at the cut-off score of 11/12; for the MMSE-
2:SV, the sensitivity was 100%, and the specificity was 89% at the cut-
off score of 22/23; and for the MMSE-2:EV, the sensitivity was 100% 
and the specificity was 85% at the cut-off score of 33/34. All three 
versions of the MMSE-2 could similarly discriminate between the two 
groups. 
Overall, as same as the results in study 1, the MMSE-2 is a useful 
screening tool for discriminating between the patients with VaMCI and 
the patients with VD and between healthy older adults and the patients 
with VD. Moreover, it is also more sensitive to discriminate between 
the healthy older adults and the patients with vascular cognitive 
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impairment (VCI) than that of the groups between the healthy older 
adults and the patients with MCI or AD, and it also has more high 
sensitivity to discriminate between the healthy older adults and the 
patients with VaMCI (84%) than to discriminate between the healthy 
older adults and the patients with MCI (60%) although the specificity is 
relatively low (58%). Nevertheless, the MMSE-2 is slightly more 
sensitive in this area than the MMSE, which has sensitivity of 70.3% to 
discriminate the patients with VD from the healthy older adults at the 
cut-off score of 23/24 (Kang et al., 1997). 
In summary, according to these results, as Folstein et al. (2010) 
suggested, the MMSE-2 can be used as a valid and reliable screening 
measure for assessing cognitive impairment of the patients with VCI in 
Korea. In addition, although it has low specificity to discriminate the 
patients with VaMCI from the healthy older adults, its ability to 
distinguish the patients with VaMCI from the healthy older adults may 
be as highly sensitive, and also it has more high sensitivity than that 




Table 1. Order of neuropsychological assessments 
Order List of neuropsychological assessments 
1 MMSE-2 (red form or blue form) 
2 SVLT-immediate recall 
3 RCFT-copy 
4 SGDS 
5 K-TMT-E: Part A 
6 K-TMT-E: Part B 







Abbreviations: MMSE-2, Mini-Mental State Examination-2; SVLT, Seoul Verbal 
Learning Test; RCFT, Rey Complex Figure Test; SGDS, Short version of the 
Geriatric Depression Scale; K-TMT-E: Part A, Korean-Trail Making Test-
Elderly’s version: Part A; K-TMT-E: Part B, Korean-Trail Making Test-
Elderly’s version: Part B; SWF, Semantic Word Fluency; PWF, Phonemic 
Word Fluency; K-BNT, Korean-Boston Naming Test; DSC, Digit Symbol Coding; 













Table 2. Characteristics of participants (M±SD) 
 All participants (n=187) 
Normal (n=75)  VaMCI (n=66) VD (n=46) 
Age (years) 68.59±7.10* 71.97±7.67 72.59±7.35
“
 
Education (years) 12.49±4.03 11.06±3.91 10.61±3.62
”
 
Male/Female 29/46 36/30 29/17
¶
 
Abbreviations: M, Mean; SD, Standard deviation; VaMCI, Vascular Mild Cognitive 
impairment; VD, Vascular dementia. 
Note. 
*p < 0.019 for Normal vs. VaMCI. 
“
p < 0.012 for Normal vs. VD. 
”
p < 0.028 for Normal vs. VD. 
¶












Table 3. The results of neuropsychological assessments in the groups of normal, VaMCI, and VD (M±SD) 
Neuropsychological 
assessments 
N(1) VaMCI(2) VD(3) F df Post-hoc 
MMSE 28.31±1.50 26.02±2.07 20.20±3.22 176.53* 2, 181 1>2>3 
SVLT-immediate recall 21.03±3.93 14.98±3.54 11.22±3.51 78.53* 2, 181 1>2>3 
SVLT-delayed recall 6.92±1.71 2.67±2.00 1.48±1.79 116.87* 2, 181 1>2>3 
SVLT-recognition 21.31±1.63 18.74±2.55 16.61±3.19 38.66* 2, 181 1>2>3 
RCFT-copy 33.69±1.86 28.62±4.05 20.09±9.58 78.17* 2, 179 1>2>3 
K-TMT-E: Part A 18.92±6.34 31.79±13.89 72.30±67.44 32.98* 2, 181 1=2>3 
K-TMT-E: Part B 35.16±23.05 89.70±62.78 207.76±94.14 102.77* 2, 180 1>2>3 
SWF-animal 17.83±4.48 12.00±3.43 6.61±3.40 104.49* 2, 181 1>2>3 
PWF-ㄱ, ㅇ, ㅅ 31.77±12.14 18.29±8.61 7.91±6.28 69.61* 2, 180 1>2>3 
K-BNT 50.03±6.72 41.44±9.80 30.59±11.51 63.16* 2, 181 1>2>3 
DSC 59.88±18.08 38.80±13.70 22.24±12.15 74.30* 2, 180 1>2>3 
SGDS 3.39±3.72 2.95±3.17 4.33±4.07 1.83 2, 181 1=2=3 
Abbreviations: M, Mean; SD, Standard deviation; N, Normal; VaMCI, Vascular Mild Cognitive Impairment; VD, 
Vascular Dementia; MMSE, Korean version of the Mini-Mental State Examination; SVLT, Seoul Verbal Learning 
Test; RCFT, Rey Complex Figure Test; K-TMT-E: Part A, Korean-Trail Making Test-Elderly’s version: Part A; 
K-TMT-E: Part B, Korean-Trail Making Test-Elderly’s version: Part B; SWF, Semantic Word Fluency; PWF, 
Phonemic Word Fluency; K-BNT, Korean version of Boston Naming Test; DSC, Digit Symbol Coding, SGDS, Short 
version of the Geriatric Depression Scale; 1, Normal; 2, Vascular Mild Cognitive Impairment; 3, Vascular 
Dementia. 
Note.  




Table 4. The results of the MMSE-2:BV in the groups of normal, VaMCI, and VD (M±SD) 
MMSE-2:BV N(1) VaMCI(2) VD(3) F df η2 Post-hoc 
Registration 2.96±0.20 2.88±0.37 2.37±0.80 20.42* 2, 181 0.184 1=2>3 
Orientation to time 4.84±0.40 4.67±0.62 3.11±1.46 58.42* 2, 181 0.392 1=2>3 
Orientation to place 4.96±0.20 4.80±0.43 3.89±0.92 55.26* 2, 181 0.379 1=2>3 
Recall 1.85±0.93 0.83±0.90 0.35±0.60 33.58* 2, 181 0.271 1>2>3 
Total score 14.61±1.08 13.14±1.46 9.70±2.46 108.61* 2, 181 0.545 1>2>3 
Abbreviations: M, Mean; SD, Standard deviation; N, Normal; VaMCI, Vascular Mild Cognitive Impairment; VD, 
Vascular Dementia; MMSE-2:BV, Mini-Mental State Examination-2:Brief Version; 1, Normal; 2, Vascular Mild 
Cognitive Impairment; 3, Vascular Dementia. 
Note.  










Table 5. The results of the MMSE-2:SV in the groups of normal, VaMCI, and VD (M±SD) 
MMSE-2:SV N(1) VaMCI(2) VD(3) F df η2 Post-hoc 
Registration 2.96±0.20 2.88±0.37 2.37±0.80 20.42* 2, 181 0.184 1=2>3 
Orientation to time 4.84±0.40 4.67±0.62 3.11±1.46 58.42* 2, 181 0.392 1=2>3 
Orientation to place 4.96±0.20 4.80±0.43 3.89±0.92 55.26* 2, 181 0.379 1=2>3 
Recall 1.85±0.93 0.83±0.90 0.35±0.60 33.58* 2, 181 0.271 1>2>3 
Attention and 
Calculation 
4.41±0.79 3.67±1.16 2.13±1.52 55.71* 2, 181 0.381 1>2>3 
Language 7.87±0.34 7.36±0.82 6.48±1.28 31.75* 2, 181 0.260 1>2>3 
Drawing 0.97±0.16 0.92±0.27 0.61±0.49 19.71* 2, 181 0.179 1=2>3 
Total Score 27.91±1.56 25.11±1.88 18.91±3.55 199.79* 2, 181 0.688 1>2>3 
Abbreviations: M, Mean; SD, Standard deviation; N, Normal; VaMCI, Vascular Mild Cognitive Impairment;  VD, 
Vascular Dementia; MMSE-2:SV, Mini-Mental State Examination-2:Standard Version; 1, Normal; 2, Vascular Mild 
Cognitive Impairment; 3, Vascular Dementia. 
Note. 








Table 6. The results of the MMSE-2:EV in the groups of normal, VaMCI, and VD (M±SD) 
MMSE-2:EV N(1) VaMCI(2) VD(3) F df η2 Post-hoc 
Registration 2.96±0.20 2.88±0.37 2.37±0.80 20.42* 2, 181 0.184 1=2>3 
Orientation to time 4.84±0.40 4.67±0.62 3.11±1.46 58.42* 2, 181 0.392 1=2>3 
Orientation to place 4.96±0.20 4.80±0.43 3.89±0.92 55.26* 2, 181 0.379 1=2>3 
Recall 1.85±0.93 0.83±0.90 0.35±0.60 33.58* 2, 181 0.271 1>2>3 
Attention and 
calculation 
4.41±0.79 3.67±1.16 2.13±1.52 55.71* 2, 181 0.381 1>2>3 
Language 7.87±0.34 7.36±0.82 6.48±1.28 31.75* 2, 181 0.260 1>2>3 
Drawing 0.97±0.16 0.92±0.27 0.61±0.49 19.71* 2, 181 0.179 1=2>3 
Story memory 9.77±3.51 4.71±2.20 2.91±1.95 78.25* 2, 181 0.464 1>2>3 
Processing speed  14.35±4.35 9.94±3.69 5.67±2.86 61.11* 2, 181 0.403 1>2>3 
Total Score 52.00±7.49 39.71±5.65 27.48±6.57 196.98* 2, 181 0.685 1>2>3 
Abbreviations: M, Mean; SD, Standard deviation; N, Normal; VaMCI, Vascular Mild Cognitive Impairment; VD, Vascular 
Dementia; MMSE-2:EV, Mini-Mental State Examination-2:Expanded Version; 1, Normal; 2, Vascular Mild Cognitive 
Impairment; 3, Vascular Dementia. 
Note. 








Table 7. Internal consistency: MMSE-2:BV, MMSE-2:SV, and MMSE-2:EV (red 
and blue forms) 
MMSE-2 
Red form Blue form 
N(r) VaMCI(r) VD(r) N(r) VaMCI(r) VD(r) 
BV 0.656 0.667 0.694 0.625 0.670 0.744 
SV 0.644 0.643 0.622 0.642 0.479 0.697 
EV 0.662 0.657 0.689 0.670 0.624 0.720 
Abbreviations: N, Normal; VaMCI, Vascular Mild Cognitive Impairment; VD, 
Vascular Dementia; MMSE-2, Mini-Mental State Examination-2; BV, Brief 


























r M SD M SD 
BV 0.62* 12.30 2.08 12.70 2.68 
SV 0.93* 24.05 4.02 24.65 9.93 
EV 0.99* 39.30 11.95 39.80 11.48 
Abbreviations: M, Mean; SD, Standard deviation; MMSE-2, Mini-Mental State 
Examination-2; BV, Brief version; SV, Standard version; EV, Expanded version; 
r, Pearson‟s correlation coefficient. 
Note. 



















Table 9. Interrater reliability of the MMSE-2 
MMSE-2 ICC % agreement 
Registration 0.95  
Orientation to time 0.99  
Orientation to place - 100% 
Recall 0.98  
Attention and calculation 0.98  
Naming - 100% 
Repetition - 100% 
Comprehension - 100% 
Reading - 100% 
Writing - 100% 
Drawing - 100% 
Story memory 0.96  
Processing speed 0.99  










Table 10. Correlation between the MMSE-2 and cognitive measures 
 1 2 3 4 5 6 7 8 9 10 11 12 13 
1.MMSE-2:BV 1             
2.MMSE-2:SV 0.896* 1            
3.MMSE-2:EV 0.799* 0.877* 1           
4.MMSE 0.865* 0.947* 0.839* 1          
5.SVLT-IR 0.619* 0.625* 0.739* 0.620* 1         
6.SVLT-DR 0.660* 0.614* 0.727* 0.610* 0.831* 1        
7.SVLT-R 0.639* 0.590* 0.644* 0.574* 0.684* 0.747* 1       
8.RCFT-Copy 0.643* 0.774* 0.740* 0.766* 0.575* 0.512* 0.496* 1      
9.SWF-Animal 0.639* 0.704* 0.783* 0.665* 0.691* 0.656* 0.524* 0.614* 1     
10.PWF-Total 0.570* 0.677* 0.797* 0.661* 0.656* 0.618* 0.490* 0.616* 0.735* 1    
11.DSC 0.644* 0.729* 0.899* 0.720* 0.616* 0.628* 0.539* 0.679* 0.665* 0.754* 1   
12.K-TMT-E:A -0.590* -0.678* -0.617* -0.666* -0.420* -0.378 -0.425* -0.710* -0.500* -0.439* -0.547* 1  
13.K-TMT-E:B -0.680* -0.773* -0.755* -0.793* -0.528* -0.513 -0.460* -0.750* -0.580* -0.580* -0.688* 0.607* 1 
14.K-BNT 0.623* 0.678* 0.700* 0.681* 0.556 0.552 0.492* 0.564* 0.654* 0.584* 0.606* -0.498* -0.610* 
Abbreviations: MMSE-2, Mini-Mental State Examination-2; BV, Brief version; SV, Standard version; EV, Expanded 
version; MMSE, Korean version of Mini-Mental State Examination; SVLT-IR, Seoul Verbal Learning Test-Immediate 
Recall; DR, Delayed Recall; R, Recognition; RCFT, Rey Complex Figure Test; SWF, Semantic Word Fluency; PWF, 
Phonemic Word Fluency; DSC, Digit Symbol Coding; K-TMT-E, Korean-Trail Making Test-Elderly’s version; K-BNT, 




Table 11. Participants‟ average age, education, and gender classified by CDR 
& CDR-SOB stage (M±SD) 
 N(75) 
















CDR 2,  
CDR-SOB  
9.5-15.5 
Age 68.59±7.10 71.97±7.67* 73.19±7.53 73.05±6.56 67.00±9.97 
Education 12.49±4.03 11.06±3.91 10.67±4.16 10.67±3.26 10.00±3.16 
Male/Female 29/46 36/30 15/6 12/9 2/2 
Abbreviations: CDR, Clinical Dementia Rating; CDR-SOB, Clinical Dementia 
Rating-Sum of Boxes; M, Mean; SD, Standard deviation; N, Normal; VaMCI, 
Vascular Mild Cognitive Impairment; EVD, Early stage of Vascular Dementia; 
MiVD, Mild stage of Vascular Dementia; MoVD, Moderate stage of Vascular 
Dementia. 
Note.  















Table 12. The results of the three versions of the MMSE-2 according to CDR & CDR-SOB (M±SD) 
MMSE-2 
N(1) 
















CDR 2,  
CDR-SOB  
9.5-15.5 
F df Post-hoc 
BV 14.61±1.08 13.14±1.46 11.24±1.70 8.90±2.02 5.75±1.50 97.75* 4, 181 1>2>3>4>5 
SV 27.91±1.56 25.11±1.88 20.24±2.76 18.76±3.21 12.75±2.50 139.72* 4. 181 1>2>3>4>5 
EV 52.00±7.49 39.71±5.65 30.14±3.86 27.19±6.49 15.00±2.94 111.56* 4, 181 1>2>3=4>5 
Abbreviations: CDR, Clinical Dementia Rating; CDR-SOB, Clinical Dementia Rating-Sum of Boxes; M, Mean; SD, 
Standard deviation; MMSE-2, Mini-Mental State Examination; BV, Brief Version; SV, Standard Version; EV, Expanded 
Version; N, Normal; VaMCI, Vascular Mild Cognitive Impairment; EVD, Early stage of Vascular Dementia; MiVD, Mild 
stage of Vascular Dementia; MoVD, Moderate stage of Vascular Dementia; 1, Normal; 2, Vascular Mild Cognitive 
Impairment; 3, Early stage of Vascular Dementia; 4, Mild Stage of Vascular Dementia; 5, Moderate stage of Vascular 
Dementia. 
Note.  






Figure 1. Mini-Mental State Examination-2:Brief Version (MMSE-2:BV). Receiver 
operator characteristic (ROC) curve analysis of the MMSE-2:BV in the groups of 
normal, vascular mild cognitive impairment (VaMCI), vascular dementia (VD). (A) 
Normal vs. VaMCI, Area Under the Curve (AUC)=0.79. (B) VaMCI vs. VD, Area 














Figure 2. Mini-Mental State Examination-2:Standard Version (MMSE-2:SV). 
Receiver operator characteristic (ROC) curve analysis of the MMSE-2:SV in the 
groups of normal, vascular mild cognitive impairment (VaMCI), vascular dementia 
(VD). (A) Normal vs. VaMCI, Area Under the Curve (AUC)=0.87. (B) VaMCI vs. 

















Figure 3. Mini-Mental State Examination-2:Expanded Version (MMSE-2:EV). 
Receiver operator characteristic (ROC) curve analysis of the MMSE-2:EV in the 
groups of normal, vascular mild cognitive impairment (VaMCI), and vascular 
dementia (VD). (A) Normal vs. VaMCI, Area Under the Curve (AUC)=0.90. (B) 
VaMCI vs. VD, Area Under the Curve (AUC)=0.94. (C) Normal vs. VD, Area 













Comparison between the Mini-Mental State 
Examination and the Mini-Mental State 
Examination-2 in Korean patients with Vascular 
Mild Cognitive Impairment and Vascular Dementia 
 
Introduction 
In study 4, the validity and reliability of the MMSE-2 in the patients 
with VaMCI and VD were verified, and also it showed that the MMSE-2 
can be used clinically as a cognitive screening test to measure 
cognitive function of the patients with VCI.  
Therefore, in study 5, the purpose of this study is to compare the 
usefulness of the MMSE-2 and the K-MMSE to determine which test is 
more sensitive in discriminating between normal cognitive aging and the 
patients with VaMCI and VD in a Korean population.  
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Materials and Methods 
1. Participants 
The groups of the patients (VaMCI and VD) and control participants 




The description of the MMSE-2 was the same as that of study 1.  
 
2.2. K-MMSE 
The description of the K-MMSE was the same as that of study 2.  
 
2.3. Other Neuropsychological Assessments 
The MMSE-2 and the K-MMSE were performed with a time interval 
of at least 1 hour in order to compensate for the learning effect that 
could be occurred when using the MMSE-2 and the K-MMSE at the 
same time so the detailed neuropsychological assessments were 
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performed in the meantime. In the detailed neuropsychological 
assessments, there were SVLT (Kang et al., 2003) for assessing verbal 
memory, a copy of the RCFT (Meyers et al., 1995) for assessing 
visuospatial function, the SWF-Animal and the PWF (Kang et al., 2000), 
the Digit Symbol Coding (DSC) (Joy et al., 2004), and the Korean-Trail 
Making Test-Elderly‟s version: Part A & B (K-TMT-E) (Yi et al., 2007) 
for assessing executive function of the frontal lobe, the K-BNT (Kim et 
al., 1997) for assessing naming ability, the Short version of the 
Geriatric Depression Scale (SGDS) (Cho et al., 1999) for assessing 
depression. Moreover, global measurements, including CDR (Morris, 1993) 
& CDR-SOB (O‟Bryant et al., 2008, 2010), were also conducted. 
 
3. Procedure 
The procedure of this study was the same as that of study 2.  
 
4. Statistical Analysis 
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First, an ANOVA was used to compare age and educational levels, 
and a chi square test was used to compare gender across the three 
groups (66 patients with VaMCI, 46 patients with VD, and 75 healthy 
older adults). The results of the neuropsychological tests in the three 
groups were analyzed using an ANCOVA after controlling for 
demographic variables (age, education, and gender).  
Second, the results of the MMSE-2 (BV, SV, and EV) in the three 
groups were analyzed using an ANCOVA after controlling for 
demographic variables (age, education, and gender) followed by Tukey‟s 
test for post-hoc analysis. 
Third, the results of the K-MMSE in the three groups were analyzed 
using an ANCOVA after controlling for demographic variables (age, 
education, and gender) followed by Tukey‟s test for post-hoc analysis. 
Fourth, the discrimination analysis was performed to examine the 
classification accuracy and discrimination of the patients with VaMCI 
and VD in the MMSE-2 and the K-MMSE.  
Finally, to evaluate the sensitivity and specificity of the MMSE-2 and 
the K-MMSE for differentiating across the three groups were examined 
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using a receiver operating characteristic (ROC) curve and area under 
the curve (AUC) measurements. 
Data were analyzed using IBM SPSS 22.0 (SPSS Inc., Chicago, IL, USA), 














1. The demographic data of the participants 
The demographic characteristics of the patients with VaMCI, the 
patients with VD, and the healthy older adults were the same as those 
of study 4.  
 
2. The results of participants’ neuropsychological 
assessments  
The results of the neuropsychological assessments in the three groups 
(healthy older adults, VaMCI, and VD) were the same as those of study 
4.  
 
3. The results of the MMSE-2 in the groups of normal, 
VaMCI, and VD 
3.1. MMSE-2:BV, SV, EV 
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The results of the MMSE-2 (BV, SV, and EV) in the three groups 
were the same as those of study 4.  
 
4. The results of the K-MMSE in the groups of normal, 
VaMCI, and VD 
The results of the K-MMSE scores in the three groups are presented 
in Table 1. An ANCOVA that controlled for age, education, and gender 
revealed significant differences across the three groups on the K-MMSE. 
According to Tukey‟s post hoc analyses, the scores of attention and 
calculation, recall, language, and total score of the K-MMSE were 
significantly higher for the healthy older adults than for the patients 
with VaMCI and VD, and they were significantly higher for the patients 
with VaMCI than for the patients with VD. However, there were no 
significant differences in the items such as orientation to time, 
orientation to place, and drawing between the healthy older adults and 
the patients with VaMCI, but the scores of three items in the K-MMSE 
were significantly higher for the two groups (healthy older adults and 
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VaMCI) than for the patients with VD. Moreover, there was no 
significant difference in the item, registration, across the three groups.  
 
5. Comparison of the discriminant analysis between the 
MMSE-2 and the K-MMSE 
5.1. MMSE-2 
5.1.1. The discriminant analysis of the MMSE-2 in the groups of 
normal, VaMCI, and VD 
The discriminant analysis by simultaneous input method was 
performed by using the nine subtests of the MMSE-2 as independent 
variables and the three groups (healthy older adults, VaMCI, and VD) 
as dependent variables. Two significant discriminant functions were 
calculated through analysis, and the results are presented in Table 2. 
The results showed the first function distinguished between the healthy 
older adults and the group of the patients (VaMCI and VD), and the 
second function distinguished between the patients with VaMCI and the 
patients with VD. The first function was statistically significant, 
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explained 88.6% of the total variance in the model (Wilk‟s Lambda = 
0.188, χ
2 
= 301.29, p < 0.001), and the second function was also 
statistically significant, explained 11.4% of the total variance in the 
model (Wilk‟s Lambda = 0.729, χ
2 
= 56.98, p < 0.001).  
According to the results of the standardized canonical discriminant 
function coefficients in the discriminant function, orientation to time 
was the most discriminating subtest in the first function, and story 
memory was the most discriminating subtest in the second function 
(Table 3). Moreover, the structure matrix canonical loadings of the 
predictor variables and the two discriminant functions indicated that the 
first function was strongly correlated with processing speed (canonical 
loading = 0.531), attention and calculation (canonical loading = 0.466), 
orientation to place (canonical loading = 0.455), recall (canonical loading 
= 0.414), and language (canonical loading = 0.389). The second function 
was strongly correlated with story memory (canonical loading = -0.667) 
and orientation to time (canonical loading = 0.479) (Table 4). These 
results indicated that the best discriminative item between the healthy 
older adults and the group of the patients (VaMCI and VD) was 
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processing speed, and the best discriminative item between the patients 
with VaMCI and the patients with VD was story memory.  
The results of classifying the samples by the two functions are 
presented in Table 5. According to the classification results, in the 
MMSE-2:BV, 75.8% of the patients with VaMCI, 67.4% of the patients 
with VD, and 62.7% of the healthy older adults were correctly classified, 
and thus the overall classification accuracy was 68.4%. In the MMSE-
2:SV, 75.8% of the patients with VaMCI, 76.1% of the patients with VD, 
and 72.0% of the healthy older adults were correctly classified, and 
thus the overall classification accuracy was 74.3%. In the MMSE-2:EV, 
81.8% of the patients with VaMCI, 80.4% of the patients with VD, and 
78.7% of the healthy older adults were correctly classified, and thus the 
overall classification accuracy was 80.2%. 
 
5.1.2. The discriminant analysis of the MMSE-2 in the healthy 
older adults vs. the patients with VaMCI 
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The discriminant analysis by simultaneous input method was 
performed by using the nine subtests of the MMSE-2 as independent 
variables and the two groups (healthy older adults and VaMCI) as 
dependent variables. One significant discriminant function was 
calculated through analysis, and the results are presented in Table 6. 
There was significant difference between the two groups over nine 
independent variables (Wilk‟s Lambda = 0.462, χ
2 
= 103.79, p < 0.001).  
According to the results of the standardized canonical discriminant 
function coefficients in the discriminant function, story memory was the 
most discriminating subtest (Table 7). Moreover, the structure matrix 
canonical loadings of the predictor variables and the discriminant 
function indicated that the function was strongly correlated with story 
memory (canonical loading = 0.794), recall (canonical loading = 0.519), 
processing speed (canonical loading = 0.506), language (canonical loading 
= 0.383), and attention and calculation (canonical loading = 0.356), but 
the function was not significantly correlated with orientation to place, 
orientation to time, registration, and drawing (Table 8). These results 
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indicated that the best discriminative item between the healthy older 
adults and the patients with VaMCI was story memory. 
The results of classifying the samples by the function are presented 
Table 9. According to the classification results, in the MMSE-2:BV, 61.3% 
of the healthy older adults and 83.3% of the patients with VaMCI were 
correctly classified, and thus the overall classification accuracy was 
71.6%. In the MMSE-2:SV, 76.0% of the healthy older adults and 80.3% 
of the patients with VaMCI were correctly classified, and thus the 
overall classification accuracy was 78.0%. In the MMSE-2:EV, 82.7% of 
the healthy older adults and 83.3% of the patients with VaMCI were 
correctly classified, and thus the overall classification accuracy was 
83.0%. 
 
5.1.3. The discriminant analysis of the MMSE-2 in the patients 
with VaMCI vs. the patients with VD 
The discriminant analysis by simultaneous input method was 
performed by using the nine subtests of the MMSE-2 as independent 
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variables and the two groups (VaMCI and VD) as dependent variables. 
One significant discriminant function was calculated through analysis, 
and the results are presented in Table 10. There was significant 
difference between the two groups over nine independent variables 
(Wilk‟s Lambda = 0.410, χ
2 
= 94.16, p < 0.001).  
According to the results of the standardized canonical discriminant 
function coefficients in the discriminant function, orientation to time 
was the most discriminating subtest (Table 11). Moreover, the structure 
matrix canonical loadings of the predictor variables and the discriminant 
function indicated that the function was strongly correlated with 
orientation to time (canonical loading = 0.614), orientation to place 
(canonical loading = 0.554), processing speed (canonical loading = 0.522), 
attention and calculation (canonical loading = 0.484), registration 
(canonical loading = 0.359), language (canonical loading = 0.355), story 
memory (canonical loading = 0.354), and drawing (canonical loading =  
0.347), but the function was not significantly correlated with recall 
(Table 12). These results indicated that the best discriminative item 
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between the patients with VaMCI and the patients with VD was 
orientation to time.  
The results of classifying the samples by the function are presented 
Table 13. According to the classification results, in the MMSE-2:BV, 
95.5% of the patients with VaMCI and 76.1% of the patients with VD 
were correctly classified, and thus the overall classification accuracy 
was 87.5%. In the MMSE-2:SV, 97.0% of the patients with VaMCI and 
78.3% of the patients with VD were correctly classified, and thus the 
overall classification accuracy was 89.3%. In the MMSE-2:EV, 95.5% of 
the patients with VaMCI and 78.3% of the patients with VD were 
correctly classified, and thus the overall classification accuracy was 
88.4%. 
 
5.1.4. The discriminant analysis of the MMSE-2 in the healthy 
older adults vs. the patients with VD 
The discriminant analysis by simultaneous input method was 
performed by using the nine subtests of the MMSE-2 as independent 
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variables and the two groups (healthy older adults and VD) as 
dependent variables. One significant discriminant function was 
calculated through analysis, and the results are presented in Table 14. 
There was significant difference between the two groups over nine 
independent variables (Wilk‟s Lambda = 0.888, χ
2 
= 178.18, p < 0.001).  
According to the results of the standardized canonical discriminant 
function coefficients in the discriminant function, orientation to time 
was the most discriminating subtest (Table 15). Moreover, the structure 
matrix canonical loadings of the predictor variables and the discriminant 
function indicated that the function was strongly correlated with story 
memory (canonical loading = 0.576), processing speed (canonical loading 
= 0.569), attention and calculation (canonical loading = 0.516), recall 
(canonical loading = 0.465), orientation to place (canonical loading = 
0.459), orientation to time (canonical loading = 0.459), and language 
(canonical loading = 0.423), but the function was not significantly 
correlated with registration and drawing (Table 16). These results 
indicated that the best discriminative item between the healthy older 
adults and the patients with VD was story memory.   
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The results of classifying the samples by the function are presented 
Table 17. According to the classification results, in the MMSE-2:BV, 
96.0% of the healthy older adults and 87.0% of the patients with VD 
were correctly classified, and thus the overall classification accuracy 
was 92.6%. In the MMSE-2:SV, 100.0% of the healthy older adults and 
91.3% of the patients with VD were correctly classified, and thus the 
overall classification accuracy was 96.7%. In the MMSE-2:EV, 100.0% of 
the healthy older adults and 97.8% of the patients with VD were 




5.2.1. The discriminant analysis of the K-MMSE in the groups of 
normal, VaMCI, and VD 
The discriminant analysis by simultaneous input method was 
performed by using the seven subtests of the K-MMSE as independent 
variables and the three groups (healthy older adults, VaMCI, and VD) 
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as dependent variables. Two significant discriminant functions were 
calculated through analysis, and the results are presented in Table 18. 
The results showed that the first function distinguished between the 
healthy older adults and the group of the patients (VaMCI and VD), and 
the second function distinguished between the patients with VaMCI and 
the patients with VD. The first function was statistically significant, 
explained 95.5% of the total variance in the model (Wilk‟s Lambda = 
0.295, χ
2 
= 220.85, p < 0.001), and the second function was also 
statistically significant, explained 4.5% of the total variance in the 
model (Wilk‟s Lambda = 0.910, χ
2 
= 17.07, p < 0.05).  
According to the results of the standardized canonical discriminant 
function coefficients in the discriminant function, attention and 
calculation was the most discriminating subtest in the first function, and 
recall was the most discriminating subtest in the second function (Table 
19). Moreover, the structure matrix canonical loadings of the predictor 
variables and the two discriminant functions indicated that the first 
function was strongly correlated with orientation to time (canonical 
loading = 0.577), orientation to place (canonical loading = 0.555), 
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attention and calculation (canonical loading = 0.546), language (canonical 
loading = 0.412), and drawing (canonical loading = 0.314). The second 
function was strongly correlated with recall (canonical loading = 0.538) 
and registration (canonical loading = 0.100) (Table 20). These results 
indicated that the best discriminative item between the healthy older 
adults and the group of the patients (VaMCI and VD) was orientation to 
time, and the best discriminative item between the patients with VaMCI 
and the patients with VD was recall. 
The results of classifying the samples by the two functions are 
presented in Table 21. According to the classification results, 63.6% of 
the patients with VaMCI, 80.4% of the patients with VD, 72.0% of the 
healthy older adults were correctly classified, and thus the overall 
classification accuracy was 71.1%.  
 
5.2.2. The discriminant analysis of the K-MMSE in the healthy 
older adults vs. the patients with VaMCI 
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The discriminant analysis by simultaneous input method was 
performed by using the seven subtests of the K-MMSE as independent 
variables and the two groups (healthy older adults and VaMCI) as 
dependent variables. One significant discriminant function was 
calculated through analysis, and the results are presented in Table 22. 
There was significant difference between the two groups over seven 
independent variables (Wilk‟s Lambda = 0.688, χ
2 
= 50.65, p < 0.05).  
According to the results of the standardized canonical discriminant 
function coefficients in the discriminant function, language was the 
most discriminating subtest (Table 23). Moreover, the structure matrix 
canonical loadings of the predictor variables and the discriminant 
function indicated that the function was strongly correlated with 
attention and calculation (canonical loading = 0.571), language (canonical 
loading = 0.566), recall (canonical loading = 0.561), and orientation to 
place (canonical loading = 0.353), but the function was not significantly 
correlated with orientation to time, registration, and drawing (Table 24). 
These results indicated that the best discriminative item between the 
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healthy older adults and the patients with VaMCI was attention and 
calculation.  
The results of classifying the samples by the function are presented 
in Table 25. According to the classification results, 84.0% of the healthy 
older adults and 84.0% of the patients with VaMCI was correctly 
classified, and thus the overall classification accuracy was 73.8%. 
 
5.2.3. The discriminant analysis of the K-MMSE in the patients 
with VaMCI vs. the patients with VD 
The discriminant analysis by simultaneous input method was 
performed by using the seven subtests of the K-MMSE as independent 
variables and the two groups (VaMCI and VD) as dependent variables. 
One significant discriminant function was calculated through analysis, 
and the results are presented in Table 26. There was significant 
difference between the two groups over seven independent variables 
(Wilk‟s Lambda = 0.447, χ
2 
= 85.71, p < 0.001).  
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According to the results of the standardized canonical discriminant 
function coefficients in the discriminant function, orientation to time 
was the most discriminating subtest (Table 27). Moreover, the structure 
matrix canonical loadings of the predictor variables and the discriminant 
function indicated that the function was strongly correlated with 
orientation to time (canonical loading = 0.670), orientation to place 
(canonical loading = 0.598), attention and calculation (canonical loading 
= 0.519), drawing (canonical loading = 0.374), language (canonical 
loading = 0.340), and recall (canonical loading = 0.318), but the function 
was not significantly correlated with registration (Table 28). These 
results indicated that the best discriminative item between the patients 
with VaMCI and the patients with VD was orientation to time.  
The results of classifying the samples by the function are presented 
in Table 29. According to the classification results, 89.4% of the 
patients with VaMCI and 80.4% of the patients with VD was correctly 
classified, and thus the overall classification accuracy was 85.7%. 
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5.2.4. The discriminant analysis of the healthy older adults vs. the 
patients with VD 
The discriminant analysis by simultaneous input method was 
performed by using the seven subtests of the K-MMSE as independent 
variables and the two groups (healthy older adults and VD) as 
dependent variables. One significant discriminant function was 
calculated through analysis, and the results are presented in Table 30. 
There was significant difference between the two groups over seven 
independent variables (Wilk‟s Lambda = 0.247, χ
2 
= 161.51, p < 0.001).  
According to the results of the standardized canonical discriminant 
function coefficients in the discriminant function, attention and 
calculation was the most discriminating subtest (Table 31). Moreover, 
the structure matrix canonical loadings of the predictor variables and 
the discriminant function indicated that the function was strongly 
correlated with attention and calculation (canonical loading = 0.564), 
orientation to place (canonical loading = 0.508), orientation to time 
(canonical loading = 0.508), language (canonical loading = 0.429), and 
recall (canonical loading = 0.426), but the function was not significantly 
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correlated with drawing and registration (Table 32). These results 
indicated that the best discriminative item between the healthy older 
adults and the patients with VD was attention and calculation. 
The results of classifying the samples by the function are presented 
in Table 33. According to the classification results, 98.7% of the healthy 
older adults and 93.5% of the patients with VD was correctly classified, 
and thus the overall classification accuracy was 96.7%. 
 
6. Diagnostic utility of the MMSE-2 and the K-MMSE 
6.1. MMSE-2 
The results of each version of the MMSE-2 (BV, SV, and EV) were 
the same as in the study 4.  
 
6.2. K-MMSE 
The ROC curve analysis and the area under the curve (AUC) was 
performed to verify the diagnostic utility of the K-MMSE in the 
patients with VaMCI, the patients with VD, and the healthy older adults. 
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First, for discriminating the healthy older adults from the patients 
with VaMCI, the AUC of the K-MMSE was 0.81, (95% CI, 0.74-0.88, p < 
0.001). The sensitivity of the K-MMSE was 72% and the specificity was 
76% when using a cut-off score ≤ 27 of 30 to predict VaMCI. Second, 
for discriminating the patients with VaMCI from the patients with VD, 
the AUC of the K-MMSE was 0.95, (95% CI, 0.91-0.99, p < 0.001). The 
sensitivity of the K-MMSE was 89% and the specificity was 85% when 
using a cut-off score ≤ 23 of 30 to predict VD. Finally, for 
discriminating the healthy older adults from the patients with VD, the 
AUC of the K-MMSE was 1.00 (95% CI, 0.99-1.00), p < 0.001). The 
sensitivity of the K-MMSE was 100% and the specificity was 85% when 
using a cut-off score ≤ 23 of 30 to predict VD (Figure 1). 
 
7. Comparison between the MMSE-2 and the K-MMSE 
7.1. Comparison between the healthy older adults and the 
patients with VaMCI 
7.1.1. The MMSE-2:BV vs. the K-MMSE 
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The MMSE-2:BV and the K-MMSE were compared with the ROC 
curve analysis to determine which test was more sensitive in 
discriminating between the healthy older adults and the patients with 
VaMCI. The AUC of the MMSE-2:BV was 0.786, and the AUC of the K-
MMSE was 0.809, but there was no significant difference between the 
two tests (Table 34). 
 
7.1.2. The MMSE-2:SV vs. the K-MMSE 
The MMSE-2:SV and the K-MMSE were compared with the ROC 
curve analysis to determine which test was more sensitive in 
discriminating between the healthy older adults and the patients with 
VaMCI. The AUC of the MMSE-2:SV was 0.865, and the AUC of the K-
MMSE was 0.809, and the AUC of the MMSE-2:SV was significantly 
higher than that of the K-MMSE (Table 34). 
 
7.1.3. The MMSE-2:EV vs. the K-MMSE 
    The MMSE-2:EV and the K-MMSE were compared with the ROC 
curve analysis to determine which test was more sensitive in 
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discriminating between the healthy older adults and the patients with 
VaMCI. The AUC of the MMSE-2:EV was 0.902, and the AUC of the K-
MMSE was 0.809, and the AUC of the MMSE-2:EV was significantly 
higher than that of the K-MMSE (Table 34). 
 
7.2. Comparison between the patients with VaMCI and the 
patients with VD 
7.2.1. The MMSE-2:BV vs. the K-MMSE 
The MMSE-2:BV and the K-MMSE were compared with the ROC 
curve analysis to determine which test was more sensitive in 
discriminating between the patients with VaMCI and the patients with 
VD. The AUC of the MMSE-2:BV was 0.893, and the AUC of the K-
MMSE was 0.949, and the AUC of the K-MMSE was significantly higher 
than that of the MMSE-2:BV (Table 35). 
 
7.2.2. The MMSE-2:SV vs. K-MMSE 
The MMSE-2:SV and the K-MMSE were compared with the ROC 
curve analysis to determine which test was more sensitive in 
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discriminating between the patients with VaMCI and the patients with 
VD. The AUC of the MMSE-2:SV was 0.968, and the AUC of the K-
MMSE was 0.949, but there was no significant difference between the 
two tests (Table 35). 
 
7.2.3. The MMSE-2:EV vs. the K-MMSE 
The MMSE-2:EV and the K-MMSE were compared with the ROC 
curve analysis to determine which test was more sensitive in 
discriminating between the patients with VaMCI and the patients with 
VD. The AUC of the MMSE-2:EV was 0.921, and the AUC of the K-
MMSE was 0.949, but there was no significant difference between the 
two tests (Table 35). 
 
7.3. Comparison between the healthy older adults and the 
patients with VD 
7.3.1. The MMSE-2:BV vs. the K-MMSE 
The MMSE-2:BV and the K-MMSE were compared with the ROC 
curve analysis to determine which test was more sensitive in 
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discriminating between the healthy older adults and the patients with 
VD. The AUC of the MMSE-2:BV was 0.986, and the AUC of the K-
MMSE was 0.997, but there was no significant difference between the 
two tests (Table 36). 
 
7.3.2. The MMSE-2:SV vs. the K-MMSE 
The MMSE-2:SV and the K-MMSE were compared with the ROC 
curve analysis to determine which test was more sensitive in 
discriminating between the healthy older adults and the patients with 
VD. The AUC of the MMSE-2:SV was 0.999, and the AUC of the K-
MMSE was 0.997, but there was no significant difference between the 
two tests (Table 36).  
 
7.3.3. The MMSE-2:EV vs. the K-MMSE 
The MMSE-2:EV and the K-MMSE were compared with the ROC 
curve analysis to determine which test was more sensitive in 
discriminating between the healthy older adults and the patients with 
VD. The AUC of the MMSE-2:EV was 0.999, and the AUC of the K-
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MMSE was 0.997, but there was no significant difference between the 

















In study 5, the MMSE-2 and the K-MMSE were compared to 
determine which test is more sensitive in discriminating across the 
three groups (healthy older adults, VaMCI, and VD).  
The main results of study 5 were as follows. First, the results of the 
MMSE-2 (BV, SV, and EV) and the K-MMSE were significantly differed 
across the three groups (heathy older adults, VaMCI, and VD). In all 
three versions of the MMSE-2 (BV, SV, and EV), the subtests in the 
MMSE-2 such as recall (η
 2





= 0.26), story memory (η
2
= 0.46), and processing speed 
(η
 2
= 0.40) of the healthy older adults were significantly higher than 
those of the patients with VaMCI and VD, and also the items of the 
MMSE-2 of the patients with VaMCI were significantly higher than 
those of the patients with VD. In the patients with VaMCI and VD, 
deficits of executive function as well as verbal memory are most 
distinct from those of the patients with MCI and AD. 
In addition, among the subtests of the K-MMSE, the subtests in the 
K-MMSE such as attention and calculation (η
 2




0.18), and language (η
 2
= 0.22) of the healthy older adults were 
significantly higher than those of the patients with VaMCI and VD, and 
also the items of the K-MMSE of the patients with VaMCI were 
significantly higher than those of the patients with VD. 
When comparing the magnitude of the recall test in the MMSE-2 (η
2
 
= 0.27) and the K-MMSE (η
2
 = 0.18), the recall test of the MMSE-2 
could be seen to discriminate each group slightly more sensitively than 
the K-MMSE. Moreover, when comparing the magnitude of the story 
memory test in the MMSE-2 (η
2
 = 0.46) with the recall tests in the 
MMSE-2 (η
2
 = 0.27) and the K-MMSE (η
2
 = 0.18), among the verbal 
memory tests, the story memory test could discriminate each group 
more sensitively than the recall. Therefore, the verbal memory tests 
(story memory and recall) in the MMSE-2 might be more sensitive to 
discriminate across the three groups (healthy older adults, VaMCI, and 
VD) than those of the K-MMSE.  
Second, in the MMSE-2, the magnitude of the subtests related with 
executive function, processing speed (η
2
 = 0.40) and attention and 
calculation (η
2
 = 0.38), were higher than those of the recall test 
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related with verbal memory (η
2
 = 0.27) in the MMSE-2. Moreover, in 
the K-MMSE, the magnitude of the subtest related with executive 
function, attention and calculation (η
2
 = 0.38), was higher than those 
of the recall test (η
2
 = 0.18) related with verbal memory in the K-
MMSE. According to these results, the executive function test is more 
sensitive than the verbal memory test to distinguish the patients with 
VaMCI and VD from the healthy older adults.  
Third, the results of the discriminant analysis of the MMSE-2 were 
as follows. In the MMSE-2, the subtests which discriminated significantly 
between the healthy older adults and the group of patients (VaMCI and 
VD) were processing speed, attention and calculation, orientation to 
place, recall, language, registration, and drawing. Moreover, the subtests 
which discriminated significantly between the patients with VaMCI and 
the patients with VD were story memory and orientation to time. The 
processing speed and attention and calculation are the tests which 
measure psychomotor ability and working memory of the frontal lobe 
functions, and orientation to time, orientation to place, recall, and story 
memory are the tests that measure episodic memory. As shown in 
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many previous studies, these results suggested that tests related with 
the frontal lobe function are important variables in group discrimination 
because the frontal lobe function is one of the first deteriorating 
functions of the patients with VaMCI or the patients with VD (O‟Brien 
et al., 2003; Erkinjuntti et al., 2000; Bombois et al., 2007). Moreover, 
when discriminating between the patients with VaMCI and the patients 
with VD, it was shown that the story memory and recall tests related 
with episodic memory are more sensitive than the tests related with 
the frontal lobe function so it is important to measure episodic memory 
as dementia progresses.  
Fourth, in the MMSE-2, the subtests that discriminated significantly 
between the healthy older adults and the patients with VaMCI were 
story memory, recall, processing speed, language, and attention and 
calculation. Thus, these results also showed that measuring the frontal 
lobe and language functions rather than episodic memory are more 
sensitive to discriminate between the two groups (healthy older adults 
and VaMCI). This is the result of supporting the previous studies (Han 
et al., 2006; Xu et al., 2014; Dong et al., 2010). Moreover, as shown in 
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study 3, the story memory test can be considered as the most sensitive 
test because it measures not only the verbal memory but also the 
general brain function, especially the frontal lobe function.  
Fifth, in the MMSE-2, the subtests that discriminated significantly 
between the patients with VaMCI and the patients with VD were 
orientation to time, orientation to place, processing speed, attention and 
calculation, recall, language, story memory, and drawing. These results 
showed that as the dementia progressed, orientation tests, one of the 
tests for measuring episodic memory, discriminated the two groups 
(VaMCI and VD) more sensitively than the tests related with the frontal 
lobe function, and the story memory test, which was a relatively 
difficult test, was not sensitive to discriminate between the two groups. 
This is the same result as in study 2.  
Sixth, the results of the discriminant analysis of the K-MMSE were as 
follows. In the K-MMSE, the subtests that discriminated significantly 
between the healthy older adults and the group of patients (VaMCI and 
VD) were orientation to time, orientation to place, attention and 
calculation, language, and drawing. Moreover, the subtests that 
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discriminated significantly between the patients with VaMCI and the 
patients with VD were orientation to time, orientation to place, 
attention and calculation, drawing, language, and recall. Therefore, as 
the dementia progressed, orientation tests, one of the tests for 
measuring episodic memory, were the most sensitive to discriminate the 
two groups (VaMCI and VD). Therefore, in the K-MMSE, as in the 
MMSE-2, the tests related with the frontal lobe function were more 
sensitive to distinguish between the healthy older adults and the 
patients with VCI than those of measuring episodic memory, and also it 
showed that as the dementia progressed, the tests related with episodic 
memory were more sensitive than the tests related with the frontal 
lobe function.  
Seventh, in the K-MMSE, the subtests that discriminated significantly 
between the healthy older adults and the patients with VD were 
attention and calculation, language, recall, and orientation to place. 
These results also showed that the tests related with the frontal lobe 
and language functions were the most sensitive to discriminate between 
the two groups (healthy older adults and VD). In conclusion, it is 
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important to evaluate the frontal lobe function when evaluating early 
stage of VCI in both MMSE-2 and the K-MMSE, and it has been shown 
that the test related with episodic memory is the most sensitive for 
group discrimination as the dementia progresses.  
Comparing the results of the discriminant analysis of the MMSE-2 
and the K-MMSE comprehensively, the classification accuracy of the 
MMSE-2 in the three groups was 80.2%, and the classification accuracy 
of the K-MMSE in the three groups was 71.1%, suggesting that the 
MMSE-2 was more accurate than the K-MMSE. In more detail, the 
accuracy rate of classifying the healthy older adults and the patients 
with VaMCI was 83.0% for the MMSE-2 and 73.8% for the K-MMSE, 
suggesting that the MMSE-2 was more sensitive and accurate than the 
K-MMSE. Moreover, the accuracy of classification of the patients with 
VaMCI and the patients with VD was 88.4% for the MMSE-2 and 85.7% 
for the K-MMSE, suggesting that the MMSE-2 was slightly more 
sensitive than K-MMSE to discriminate between the two groups. Finally, 
the accuracy of classification of the healthy older adults and the 
patients with VD was 99.2% for the MMSE-2 and 96.7% for the K-
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MMSE, suggesting that the MMSE-2 was slightly more sensitive than K-
MMSE to discriminate between the two groups. In summary, the MMSE-
2 was a more sensitive test than the K-MMSE when discriminating 
across the three groups. Especially, the MMSE-2 was about 10% more 
accurate than the K-MMSE when discriminating between the healthy 
older adults and the patients with VaMCI. This result is similar to study 
2. Moreover, even though there was no significant difference in 
discriminating between the patients with VaMCI and the patients with 
VD or between the healthy older adults and the patients with VD, the 
MMSE-2 was slightly more sensitive than the K-MMSE.  
Finally, when the AUC of the MMSE-2 and the K-MMSE was 
compared, the MMSE-2:SV and MMSE-2:EV were more sensitive than 
the K-MMSE when discriminating between the healthy older adults and 
the patients with VaMCI, but even though there was no significant 
difference in the MMSE-2:BV and the K-MMSE when discriminating 
between the two groups (healthy older adults and VaMCI), the K-MMSE 
might seem to discriminate slightly more than the MMSE-2:BV. In other 
words, the reason for this result is that in the MMSE-2:BV, there is no 
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test for measuring the frontal lobe function than the K-MMSE. 
However, as in study 2, the MMSE-2:BV and the K-MMSE might seem 
to discriminate slightly more than the MMSE-2:SV and the MMSE-2:EV 
when discriminating the patients with VD from the healthy older adults 
or the patients with VaMCI. In other words, when discriminating the 
healthy older adults and the patients with VaMCI, the more difficult 
test and the tests related with the frontal lobe function are more 
sensitive to distinguish the groups, and when discriminating the patients 
with VD from the healthy older adults or the patients with VaMCI, it is 
found that a test with low difficulty is more sensitive for discrimination. 
As in the study 2, the overall results showed that when 
discriminating between the healthy older adults and the group of the 
patients with VCI (VaMCI and VD), the MMSE-2:SV and the MMSE-2:EV 
are more sensitive and accurate to detect early cognitive decline than 
the K-MMSE or the MMSE-2:BV, but as the dementia progresses, the 
K-MMSE or the MMSE-2:BV may be more useful than the MMSE-2:SV 
and the MMSE-2:EV. Therefore, the MMSE-2 can be useful as a 
cognitive screening test for measuring cognitive function of patients in 
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clinical settings not only for the patients with AD but also for the 





































Table 1. The results of the K-MMSE in the groups of normal, VaMCI, and VD 
(M±SD) 





4.84±0.40 4.68±0.61 3.11±1.46 59.30* 2, 181 0.40 1=2>3 
Orientation to 
place 
4.96±0.20 4.80±0.44 3.89±0.92 55.92* 2, 181 0.38 1=2>3 
Registration 3.00±0.00 2.97±0.25 2.93±0.25 1.12 2, 181 0.01 1=2=3 
Attention and 
Calculation 
4.40±0.81 3.65±1.14 2.13±1.51 55.11* 2, 181 0.38 1>2>3 
Recall 2.28±0.92 1.56±0.99 0.87±0.93 19.77* 2, 181 0.18 1>2>3 
Language 7.87±0.34 7.41±0.80 6.65±1.22 25.75* 2, 181 0.22 1>2>3 
Drawing 0.96±0.20 0.92±0.27 0.61±0.49 17.95* 2, 181 0.17 1=2>3 
Total 28.31±1.50 26.02±2.07 20.20±3.22 176.53* 2, 181 0.66 1>2>3 
Abbreviations: M, Mean; SD, Standard deviation; N, Normal; VaMCI, Vascular 
Mild Cognitive Impairment; VD, Vascular Dementia; K-MMSE, Korean version of 
the Mini-Mental State Examination; 1, Normal; 2, Vascular Mild Cognitive 
Impairment; 3, Vascular Dementia. 
Note. 













Table 2. The results by the discriminant analysis in the groups of normal, 













1 2.886 88.6 88.6 0.862 0.188 301.292 18 0.000 
2 0.372 11.4 100.0 0.521 0.729 56.978 8 0.000 
Abbreviations: MMSE-2, Mini-Mental State Examination-2; VaMCI, Vascular Mild 
Cognitive Impairment; VD, Vascular Dementia; 1, Normal vs. VaMCI & VD; 2, 







Table 3. The standardized canonical discriminant function coefficients in the 




Registration 0.055 0.234 
Orientation to time 0.445 0.489 
Orientation to place 0.163 0.278 
Recall 0.239 -0.274 
Attention and calculation 0.279 0.081 
Language 0.426 0.092 
Drawing 0.096 0.136 
Story memory 0.377 -0.634 
Processing speed 0.116 -0.095 
Abbreviations: MMSE-2, Mini-Mental State Examination-2; VaMCI, Vascular Mild 
Cognitive Impairment; VD, Vascular Dementia; 1, Normal vs. VaMCI & VD; 2, 







Table 4. The results of the structure matrix in the groups of normal, VaMCI, 
and VD (MMSE-2)  
Discriminatory factors 
Correlation with the discriminant functions 
Function 1 Function 2 
Processing speed 0.531* -0.197 
Attention and calculation 0.466* 0.114 
Orientation to place 0.455* 0.393 
Recall 0.414* -0.390 
Language 0.389* 0.048 
Registration 0.289* 0.259 
Drawing 0.272* 0.246 
Story memory 0.583 -0.667* 
Orientation to time 0.468 0.479* 
Abbreviations: MMSE-2, Mini-Mental State Examination-2; VaMCI, Vascular Mild 
Cognitive Impairment; VD, Vascular Dementia; 1, Normal vs. VaMCI & VD; 2, 
























Table 5. Classification rates (%) by discriminant analysis in the groups of 
normal, VaMCI, and VD (MMSE-2) 
MMSE-2 
  Predictive groups 
 Groups Normal VaMCI VD Total 
BV 
Frequency 
Normal 47 28 0 75 
VaMCI 14 50 2 66 
VD 0 15 31 46 
% 
Normal 62.7 37.3 0.0 100.0 
VaMCI 21.2 75.8 3.0 100.0 
VD 0.0 32.6 67.4 100.0 
MMSE-2:BV Classification accuracy  68.4% 
SV 
  Predictive groups 
 Groups Normal VaMCI VD Total 
Frequency 
Normal 54 21 0 75 
VaMCI 12 50 4 66 
VD 1 10 35 46 
% 
Normal 72.0 28.0 0.0 100.0 
VaMCI 18.2 75.8 6.1 100.0 
VD 2.2 21.7 76.1 100.0 
MMSE-2:SV Classification accuracy  74.3% 
EV 
  Predictive groups 
 Groups Normal VaMCI VD Total 
Frequency 
Normal 59 16 0 75 
VaMCI 8 54 4 66 
VD 0 9 37 46 
% 
Normal 78.7 21.3 0.0 100.0 
VaMCI 12.1 81.8 6.1 100.0 
VD 0.0 19.6 80.4 100.0 
MMSE-2:EV Classification accuracy  80.2% 
Abbreviations: MMSE-2, Mini-Mental State Examination-2; BV, Brief Version; SV, 
Standard Version; EV, Expanded Version; VaMCI, Vascular Mild Cognitive 







Table 6. The result by the discriminant analysis in the healthy older adults and 













1 1.163 100.0 100.0 0.733 0.462 103.793 9 0.000 
Abbreviations: MMSE-2, Mini-Mental State Examination-2; VaMCI, Vascular Mild 








Table 7. The standardized canonical discriminant function coefficients in the 





Orientation to time 0.186 
Orientation to place 0.036 
Recall 0.384 
Attention and calculation 0.214 
Language 0.472 
Drawing 0.039 
Story memory 0.595 
Processing speed 0.064 
Abbreviations: MMSE-2, Mini-Mental State Examination-2; VaMCI, Vascular Mild 









Table 8. The results of the structure matrix in the healthy older adults and 
the patients with VaMCI (MMSE-2)  
Discriminatory factors 
Correlation with the discriminant functions 
Function 1 
Story memory 0.794 
Recall 0.519 
Processing speed 0.506 
Language 0.383 
Attention and calculation 0.356 
Orientation to place 0.220 
Orientation to time 0.157 
Registration 0.129 
Drawing 0.105 
Abbreviations: MMSE-2, Mini-Mental State Examination-2; VaMCI, Vascular Mild 
























Table 9. Classification rates (%) by discriminant analysis in the healthy older 
adults and the patients with VaMCI (MMSE-2) 
MMSE-2 
  Predictive groups 
 Groups Normal VaMCI Total 
BV 
Frequency 
Normal 46 29 75 
VaMCI 11 55 66 
% 
Normal 61.3 38.7 100.0 
VaMCI 16.7 83.3 100.0 
MMSE-2:BV Classification accuracy 71.6% 
SV 
  Predictive groups 
 Groups Normal VaMCI Total 
Frequency 
Normal 57 18 75 
VaMCI 13 53 66 
% 
Normal 76.0 24.0 100.0 
VaMCI 19.7 80.3 100.0 
MMSE-2:SV Classification accuracy 78.0% 
EV 
  Predictive groups 
 Groups Normal VaMCI Total 
Frequency 
Normal 62 13 75 
VaMCI 11 55 66 
% 
Normal 82.7 17.3 100.0 
VaMCI 16.7 83.3 100.0 
MMSE-2:EV Classification accuracy 83.0% 
Abbreviations: MMSE-2, Mini-Mental State Examination-2; BV, Brief Version; SV, 













Table 10. The result by the discriminant analysis in the patients with VaMCI 













1 1.441 100.0 100.0 0.768 0.410 94.155 9 0.000 
Abbreviations: MMSE-2, Mini-Mental State Examination-2; VaMCI, Vascular Mild 








Table 11. The standardized canonical discriminant function coefficients in the 





Orientation to time 0.563 
Orientation to place 0.212 
Recall 0.179 
Attention and calculation 0.284 
Language 0.420 
Drawing 0.107 
Story memory 0.132 
Processing speed 0.155 
Abbreviations: MMSE-2, Mini-Mental State Examination-2; VaMCI, Vascular Mild 










Table 12. The results of the structure matrix in the patients with VaMCI and 
the patients with VD (MMSE-2)  
Discriminatory factors 
Correlation with the discriminant functions 
Function 1 
Orientation to time 0.614 
Orientation to place 0.554 
Processing speed 0.522 
Attention and calculation 0.484 
Registration 0.359 
Language 0.355 
Story memory 0.354 
Drawing 0.347 
Recall 0.252 
Abbreviations: MMSE-2, Mini-Mental State Examination-2; VaMCI, Vascular Mild 

























Table 13. Classification rates (%) by discriminant analysis in the patients with 
VaMCI and the patients with VD (MMSE-2) 
MMSE-2 
  Predictive groups 
 Groups VaMCI VD Total 
BV 
Frequency 
VaMCI 63 3 66 
VD 11 35 46 
% 
VaMCI 95.5 4.5 100.0 
VD 23.9 76.1 100.0 
MMSE-2:BV Classification accuracy 87.5% 
SV 
  Predictive groups 
 Groups VaMCI VD Total 
Frequency 
VaMCI 64 2 66 
VD 10 36 46 
% 
VaMCI 97.0 3.0 100.0 
VD 21.7 78.3 100.0 
MMSE-2:SV Classification accuracy 89.3% 
EV 
  Predictive groups 
 Groups VaMCI VD Total 
Frequency 
VaMCI 63 3 66 
VD 10 36 46 
% 
VaMCI 95.5 4.5 100.0 
VD 21.7 78.3 100.0 
MMSE-2:EV Classification accuracy 88.4% 
Abbreviations: MMSE-2, Mini-Mental State Examination-2; BV, Brief Version; SV, 
Standard Version; EV, Expanded Version; VaMCI, Vascular Mild Cognitive 













Table 14. The result by the discriminant analysis in the healthy older adults 













1 3.741 100.0 100.0 0.888 0.211 178.178 9 0.000 
Abbreviations: MMSE-2, Mini-Mental State Examination-2; VD, Vascular 









Table 15. The standardized canonical discriminant function coefficients in the 





Orientation to time 0.444 
Orientation to place 0.152 
Recall 0.206 
Attention and calculation 0.320 
Language 0.393 
Drawing 0.048 
Story memory 0.374 
Processing speed 0.105 
Abbreviations: MMSE-2, Mini-Mental State Examination-2; VD, Vascular 










Table 16. The results of the structure matrix in the healthy older adults and 
the patients with VD (MMSE-2)  
Discriminatory factors 
Correlation with the discriminant functions 
Function 1 
Story memory 0.576 
Processing speed 0.569 
Attention and calculation 0.516 
Recall 0.465 
Orientation to place 0.459 




Abbreviations: MMSE-2, Mini-Mental State Examination-2; VD, Vascular 

























Table 17. Classification rates (%) by discriminant analysis in the healthy older 
adults and the patients with VD (MMSE-2) 
MMSE-2 
  Predictive groups 
 Groups Normal VD Total 
BV 
Frequency 
Normal 72 3 75 
VD 6 40 46 
% 
Normal 96.0 4.0 100.0 
VD 13.0 87.0 100.0 
MMSE-2:BV Classification accuracy 92.6% 
SV 
  Predictive groups 
 Groups Normal VD Total 
Frequency 
Normal 75 0 75 
VD 4 42 46 
% 
Normal 100.0 0.0 100.0 
VD 8.7 91.3 100.0 
MMSE-2:SV Classification accuracy 96.7% 
EV 
  Predictive groups 
 Groups Normal VD Total 
Frequency 
Normal 75 0 75 
VD 1 45 46 
% 
Normal 100.0 0.0 100.0 
VD 2.2 97.8 100.0 
MMSE-2:EV Classification accuracy 99.2% 
Abbreviations: MMSE-2, Mini-Mental State Examination-2; BV, Brief Version; SV, 













Table 18. The result by the discriminant analysis in the groups of normal, 













1 2.083 95.5 95.5 0.822 0.295 220.845 14 0.000 
2 0.099 4.5 100.0 0.300 0.910 17.073 6 0.009 
Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 
VaMCI; Vascular Mild Cognitive Impairment; VD, Vascular Dementia; 1, Normal 









Table 19. The standardized canonical discriminant function coefficients in the 




Orientation to time 0.148 -0.498 
Orientation to place 0.282 -0.396 
Registration 0.013 0.184 
Attention and calculation 0.448 0.235 
Recall 0.387 0.710 
Language 0.378 0.337 
Drawing 0.155 -0.178 
Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 
VaMCI; Vascular Mild Cognitive Impairment; VD, Vascular Dementia; 1, Normal 










Table 20. The results of the structure matrix in the groups of normal, VaMCI, 
and VD (K-MMSE)  
Discriminatory factors 
Correlation with the discriminant functions 
Function 1 Function 2 
Orientation to time 0.577* -0.556 
Orientation to place 0.555* -0.373 
Attention and calculation 0.546* 0.179 
Language 0.412* 0.244 
Drawing 0.314* -0.285 
Recall 0.392 0.538* 
Registration 0.091 0.100* 
Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 
VaMCI; Vascular Mild Cognitive Impairment; VD, Vascular Dementia; 1, Normal 






Table 21. Classification rates (%) by discriminant analysis in the groups of 
normal, VaMCI, and VD (K-MMSE) 
  Predictive groups 
 Groups Normal VaMCI VD Total 
Frequency 
Normal 54 21 0 75 
VaMCI 18 42 6 66 
VD 0 9 37 46 
% 
Normal 72.0 28.0 0.0 100.0 
VaMCI 27.3 63.6 9.1 100.0 
VD 0.0 19.6 80.4 100.0 
Classification accuracy  71.1% 
Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 






Table 22. The result by the discriminant analysis in the healthy older adults 













1 0.453 100.0 100.0 0.558 0.688 50.646 7 0.000 
Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 
VaMCI, Vascular Mild Cognitive Impairment; 1, Normal vs. VaMCI. 
 
 
Table 23. The standardized canonical discriminant function coefficients in the 




Orientation to time 0.205 
Orientation to place 0.133 
Registration 0.133 




Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 
VaMCI, Vascular Mild Cognitive Impairment; 1, Normal vs. VaMCI. 
 
 
Table 24. The results of the structure matrix in the healthy older adults and 
the patients with VaMCI (K-MMSE)  
Discriminatory factors 
Correlation with the discriminant functions 
Function 1 
Attention and calculation 0.571 
Language 0.566 
Recall 0.561 
Orientation to place 0.353 
Orientation to time 0.231 
Registration 0.134 
Drawing 0.115 
Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 
VaMCI, Vascular Mild Cognitive Impairment; 1, Normal vs. VaMCI. 
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Table 25. Classification rates (%) by discriminant analysis in the healthy older 
adults and the patients with VaMCI (K-MMSE) 
  Predictive groups 
 Groups Normal VaMCI Total 
Frequency 
Normal 63 12 75 
VaMCI 25 41 66 
% 
Normal 84.0 16.0 100.0 
VaMCI 37.9 62.1 100.0 
Classification accuracy 73.8% 
Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 





























Table 26. The result by the discriminant analysis in the patients with VaMCI 













1 1.236 100.0 100.0 0.744 0.447 85.708 7 0.000 
Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 
VaMCI, Vascular Mild Cognitive Impairment; VD, Vascular Dementia; 1, VaMCI 
vs. VD. 
 
Table 27. The standardized canonical discriminant function coefficients in the 




Orientation to time 0.490 
Orientation to place 0.307 
Registration 0.003 




Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 
VaMCI, Vascular Mild Cognitive Impairment; VD, Vascular Dementia; 1, VaMCI 
vs. VD. 
 
Table 28. The results of the structure matrix in the patients with VaMCI and 
the patients with VD (K-MMSE) 
Discriminatory factors 
Correlation with the discriminant functions 
Function 1 
Orientation to time 0.670 
Orientation to place 0.598 





Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 
VaMCI, Vascular Mild Cognitive Impairment; VD, Vascular Dementia; 1, VaMCI 
vs. VD. 
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Table 29. Classification rates (%) by discriminant analysis in the patients with 
VaMCI and the patients with VD (K-MMSE) 
  Predictive groups 
 Groups VaMCI VD Total 
Frequency 
VaMCI 59 7 66 
VD 9 37 46 
% 
VaMCI 89.4 10.6 100.0 
VD 19.6 80.4 100.0 
Classification accuracy 85.7% 
Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 





























Table 30. The result by the discriminant analysis in the healthy older adults 













1 3.049 100.0 100.0 0.868 0.247 161.514 7 0.000 
Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 
VD, Vascular Dementia; 1, Normal vs. VD. 
 
 
Table 31. The standardized canonical discriminant function coefficients in the 




Orientation to time 0.341 
Orientation to place 0.234 
Registration -0.051 




Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 
VD, Vascular Dementia; 1, Normal vs. VD. 
 
 
Table 32. The results of the structure matrix in the healthy older adults and 
the patients with VD (K-MMSE) 
Discriminatory factors 
Correlation with the discriminant functions 
Function 1 
Attention and calculation 0.564 
Orientation to place 0.508 





Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 
VD, Vascular Dementia; 1, Normal vs. VD. 
 
290 
Table 33. Classification rates (%) by discriminant analysis in the healthy older 
adults and the patients with VD (K-MMSE) 
  Predictive groups 
 Groups Normal VD Total 
Frequency 
Normal 74 1 75 
VD 3 43 46 
% 
Normal 98.7 1.3 100.0 
VD 6.5 93.5 100.0 
Classification accuracy 96.7% 
Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; 
























Table 34. The AUC of the MMSE-2:BV, the MMSE-2:SV, the MMSE-2:EV, and 
the K-MMSE for the healthy older adults compared with the patients with 
VaMCI 




















 72%  76% 
Abbreviations: AUC, Area Under the Curve; MMSE-2:BV, Mini-Mental State 
Examinaion-2:Brief Version; MMSE-2:SV, MMSE-2:Standard Version; MMSE-2:EV, 
MMSE-2:Expanded Version; K-MMSE, Korean version of the Mini-Mental State 
Examination; VaMCI, Vascular Mild Cognitive Impairment. 
Note. 
*p = 0.539 for MMSE-2:BV vs. K-MMSE. 
“
p = 0.018 for MMSE-2:SV vs. K-MMSE. 
”


















Table 35. The AUC of the MMSE-2:BV, the MMSE-2:SV, the MMSE-2:EV, and 
the K-MMSE for the patients with VaMCI compared with the patients with VD 




















 89%  85% 
Abbreviations: AUC, Area Under the Curve; MMSE-2:BV, Mini-Mental State 
Examinaion-2:Brief Version; MMSE-2:SV, MMSE-2:Standard Version; MMSE-2:EV, 
MMSE-2:Expanded Version; K-MMSE, Korean version of the Mini-Mental State 
Examination; VaMCI, Vascular Mild Cognitive Impairment; VD, Vascular 
Dementia. 
Note. 
*p = 0.029 for MMSE-2:BV vs. K-MMSE. 
“
p = 0.186 for MMSE-2:SV vs. K-MMSE. 
”


















Table 36. The AUC of the MMSE-2:BV, the MMSE-2:SV, the MMSE-2:EV, and 
the K-MMSE for the healthy older adults compared with the patients with VD 




















100%  85% 
Abbreviations: AUC, Area Under the Curve; MMSE-2:BV, Mini-Mental State 
Examinaion-2:Brief Version; MMSE-2:SV, MMSE-2:Standard Version; MMSE-2:EV, 
MMSE-2:Expanded Version; K-MMSE, Korean version of the Mini-Mental State 
Examination; VD, Vascular Dementia. 
Note. 
*p = 0.071 for MMSE-2:BV vs. K-MMSE. 
“
p = 0.293 for MMSE-2:SV vs. K-MMSE. 
”


















Figure 1. Korean version of the Mini-Mental State Examination (K-MMSE). 
Receiver operator characteristic (ROC) curve analysis of the K-MMSE in the 
groups of normal, vascular mild cognitive impairment (VaMCI), and vascular 
dementia (VD). (A) Normal vs. VaMCI, Area Under the Curve (AUC)=0.81. (B) 
VaMCI vs. VD, Area Under the Curve (AUC)=0.95. (C) Normal vs. VD, Area 














In this study, the newly developed cognitive screening test, the 
MMSE-2 (Folstein et al., 2010), was translated into Korean to measure 
the reliability and validity of the MMSE-2, and then it was investigated 
whether the MMSE-2 can be used clinically as a diagnostic test for the 
patients with dementia in Korea. In the MMSE-2, the disadvantages of 
the MMSE (Folstein et al., 1975), which has been widely used as a 
cognitive screening test, was revised, and the story memory test which 
can assess verbal memory in detail and the processing speed test 
related with executive function of the frontal lobe were included. 
Therefore, it was investigated whether the MMSE-2 is reliable in 
distinguishing between the healthy older adults and the patients with 
dementia.   
In this study, the five studies can be summarized into three major 
perspectives. First, according to the results in study 1 & 4, the validity 
and reliability of the MMSE-2 was examined for assessing patients with 
MCI, AD, VaMCI, and VD in a Korean population. The results are 
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summarized in Table 1. The MMSE-2 is useful for discriminating 
between the patients with MCI and the patients with AD, but its ability 
to discriminate between the healthy older adults and the patients with 
MCI is less than satisfactory. Moreover, in study 4, the MMSE-2 also 
can be used as a valid and reliable screening measure for assessing 
cognitive impairment to discriminate between the healthy older adults 
and the patients with VCI (VaMCI and VD). Although it had low 
specificity to discriminate the patients with MCI from the healthy older 
adults, its ability to distinguish the patients with VaMCI from the 
healthy older adults might be as highly sensitive, and also it had more 
high sensitivity than that of the groups (MCI and healthy older adults). 
Second, in study 2 & 5, the usefulness of the MMSE-2 and the K-
MMSE were compared to determine which test is more sensitive in 
discriminating between normal cognitive aging vs. the patients with MCI 
and AD and between normal cognitive aging vs. the patients with 
VaMCI and VD in a Korean population. Overall, the results showed that 
the MMSE-2:SV and the MMSE-2:EV were more sensitive and accurate 
to detect early cognitive decline of the patients with MCI or VaMCI 
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than that of the K-MMSE and the MMSE-2:BV. As the dementia (AD 
and VD) progressed, the K-MMSE and the MMSE-2:BV might be more 
useful than that of the MMSE-2:SV and the MMSE-2:EV. Therefore, the 
MMSE-2 is found to be more useful in the clinical setting as a 
cognitive screening test depending on the group of patients (Figure 1). 
Finally, in study 3, the correlations between the total scores of the 
MMSE-2 and the K-MMSE with global volume changes in cortical gray 
matter measured by structural magnetic resonance imaging (MRI) using 
voxel-based morphometry (VBM) were examined, and also it was 
measured how they changed with progression of dementia. The results 
showed that the MMSE-2 was found to be more correlated with the 
atrophy of overall brain area than the K-MMSE. Especially, in the 
MMSE-2:EV, it had the highest correlation with the general brain area, 
and also the frontal lobe function could be measured which could not 
be measured by the K-MMSE (Figure 2). 
Based on the above results, the findings and implications of this 
study are as follows.  
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First, in this study, it is significant that the MMSE-2 developed in 
2010 is converted into Korean for the first time and the discrimination 
power of this test is evaluated in a Korean population. In addition, the 
reliability and validity of the MMSE-2 are measured in the various 
group of patients (MCI, AD, VaMCI, and VD), and it is confirmed that 
there is a difference in the discrimination power of the MMSE-2 
according to the groups of patients. According to the results of the 
previous studies, unlike the MMSE, the MMSE-2 has a high reliability 
and validity in distinguishing between the patients with AD or the 
patients with VD from the healthy older adults. In particular, although 
not as high as expected, the MMSE-2 is somewhat sensitive to 
distinguish the patients with MCI or the patients with VaMCI from 
normal cognitive aging and proved to be more useful than the MMSE 
in clinical settings. 
Second, it is also meaningful to compare the K-MMSE, which has 
been widely used in Korea as a cognitive screening test, and the newly 
developed MMSE-2 to evaluate which test is more useful in clinical 
settings. Considering the results of this study, as for the development 
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purpose of the MMSE-2, the MMSE-2:SV and the MMSE-2:EV are more 
sensitive and accurate to detect early cognitive decline of patients than 
the K-MMSE, and as the dementia progresses, the K-MMSE or the 
MMSE-2:BV may be more useful in clinical settings than the MMSE-
2:SV or the MMSE-2:EV. Therefore, we found that the MMSE-2 can be 
more useful than the K-MMSE depending on the condition of various 
types of patients.  
 Third, as mentioned above, one of the purposes of developing the 
MMSE-2 is to use the same test across the world unlike the MMSE. 
Therefore, in this study, it is meaningful that the MMSE-2 is translated 
into Korean without modification and applied to the patients in Korean. 
According to the study of Folstein et al. (2010), when discriminating 
between the healthy older adults and the patients with dementia, the 
AUC was 0.84 in both the MMSE-2:SV and the MMSE-2:EV. In this 
study, when discriminating between the healthy older adults and the 
patients with AD, the AUC was 0.97 for the MMSE-2:BV, 0.95 for the 
MMSE-2:SV, and 0.94 for the MMSE-2:EV. Moreover, when 
discriminating between the healthy older adults and the patients with 
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VD, the AUC was 0.99 in the MMSE-2 (BV, SV, and EV). These results 
of this study showed that even though the MMSE-2 is not modified 
according to Korean culture, there is no difference in discriminating the 
healthy older adults and the patients with dementia using the MMSE-2 
to Korean culture.  
Limitations of this study and suggestions for future research are as 
follows.  
First, the age and education level of the groups of the patients and 
the healthy older adults were not controlled. Although when statistical 
analysis was conducted, the differences of age and education level 
were controlled, but there was a disadvantage in that the range of age 
and education level was too wide when the participants in this study 
were included.  
Second, in this study, we compared and analyzed the discriminant 
power of the MMSE-2 only in the groups (healthy older adults, MCI, 
VaMCI, AD, and VD). However, the MMSE-2 should be applied to a 
variety of different groups of dementia (PD, FTD, Huntington's disease, 
etc.). Therefore, it should be analyzed the differences in the 
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performance of the MMSE-2 in each group of patients to see how the 
MMSE-2 can be used clinically, and we also need to look at how the 
characteristics of the MMSE-2 change according to the group of 
patients.  
Third, because this study is a cross-sectional study, this study focuses 
on evaluating the cognitive function of patients in the present. 
However, the continuous follow-up studies should be conducted to 
confirm the prognosis of patients. We should investigate whether the 
changes in the MMSE-2 score are sensitive to the progression of the 
disease of patients, and how the sensitivity of the MMSE-2 is different 
from other cognitive screening tests to determine whether the MMSE-2 
can be used to evaluate the diagnosis and prognosis of the disease. 
Moreover, as with the MMSE, it should be examined whether the 
MMSE-2 can be continuously evaluated over time, and also in the 
future, it should be necessary to evaluate whether the MMSE-2 can be 
widely used in communities including public health centers as well as 
university hospitals.  
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Finally, in the previous studies, the Montreal Cognitive Assessment 
(MOCA) (Nasreddin et al., 2005), which includes a measure of the 
frontal lobe function among the various cognitive screening tests, was 
more sensitive than the MMSE in discriminating the patients with VCI 
from the healthy older adults (Xu et al., 2014; Dong et al., 2010; Bocti 
et al., 2013). In the MMSE-2, because the newly added tests such as 
the story memory and processing speed tests which can measure the 
frontal lobe function, it is necessary to compare the differences 
between the MOCA and the MMSE-2 to find out which test is more 
sensitive to detect cognitive decline of patients with VCI.  
The prevalence of dementia has been gradually increasing as the 
elderly population increases in Korea. In the neuropsychological 
assessments which measure the cognitive function of patients with 
dementia, although there is a comprehensive battery that evaluates the 
various cognitive domains of patients in detail, it has been used in 
limited clinical scenes due to problems in temporal or cost. Therefore, 
the utility of screening tests, which can be used in various fields such 
as a public health center or a welfare institution for the elderly as 
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well as a hospital, has been increasing. Through this present study, we 
showed that the newly developed MMSE-2 (Folstein et al., 2010) as a 
cognitive screening test can be useful in clinical settings so we expect 

























Table 1. The AUC of the MMSE-2:BV, the MMSE-2:SV, and the MMSE-2:EV 
for the healthy older adults and the patients with MCI, VaMCI, AD, and VD 
  N vs. MCI MCI vs. AD N vs. AD 
MMSE-2 
BV 0.71 0.93 0.97 
SV 0.72 0.93 0.95 
EV 0.73 0.92 0.94 
 N vs. VaMCI VaMCI vs. VD N vs. VD 
BV 0.79 0.89 0.99 
SV 0.87 0.97 0.99 
EV 0.90 0.94 0.99 
Abbreviations: AUC, Area Under the Curve; MMSE-2, Mini-Mental State 
Examination-2; BV, Brief Version; SV, Standard Version; EV, Expanded Version; 
N, Normal; MCI, Mild Cognitive Impairment; AD, Alzheimer‟s Disease; VaMCI, 










Figure 1. Comparison of classification rates (%) by discriminant analysis between the K-MMSE vs.  
the MMSE-2 (BV, SV, & EV) 
 
Abbreviations: K-MMSE, Korean version of the Mini-Mental State Examination; MMSE-2, Mini-Mental  
State Examination-2; BV, Brief Version; SV, Standard Version; EV, Expanded Version; N, Normal; MCI, 
Mild Cognitive Impairment; AD, Alzheimer‟s Disease; VaMCI, Vascular Mild Cognitive Impairment; VD,  
Vascular Dementia. 
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Figure 2. Comparison of the GM volume reduction correlated with the K-MMSE 
and the MMSE-2 (BV, SV, & EV) 
 
Abbreviations: GM, Gray Matter; K-MMSE, Korean version of the Mini-Mental 
State Examination; MMSE-2, Mini-Mental State Examinaion-2; BV, Brief Version; 
SV, Standard Version; EV, Expanded Version. 
Note. 
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인지기능을 측정하는 선별검사 중 세계적으로 가장 널리 사용되고 
있는 검사는 Mini-Mental State Examination (MMSE) (Folstein 등, 
1975)이다. 최근에 MMSE 의 단점을 보안하여 Mini-Mental State 
Examination, 2
nd
 edition (MMSE-2) (Folstein 등, 2010)가 개발되었다. 
MMSE-2 는 기존 MMSE 의 형태를 유지하면서 언어적 기억력을 보다 
자세하게 측정하는 이야기기억검사(story memory test)와 전두엽 기능 중 
집행기능을 측정하는 스피드검사(processing speed test)가 포함되어 
경도인지장애 환자나 초기 치매 환자들을 변별하는데 MMSE 보다 더 
예민하다고 기대되고 있다. 따라서, 본 연구에서는 5 개의 연구를 통하여 
한국어판 MMSE-2 를 제작하고, 신뢰도와 타당도를 측정하여, 한국판 
MMSE-2 가 우리나라에서 임상적으로 유용하게 쓰일 수 있는지를 
알아보고자 하였다.  
연구 1 에서는 Folstein 등(2010)이 개발한 MMSE-2 를 한국어로 
변환하였고, 이 검사가 정상노인집단, 경도인지장애 환자집단, 
알츠하이머병치매 환자집단을 변별하는지에 대한 신뢰도와 타당도를 
살펴본 결과, MMSE-2 의 타당도가 우수하고 신뢰도가 높아 한국에서도 
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인지기능 선별검사로서 유용하게 쓰일 수 있는 것으로 확인되었지만, 
경도인지장애 환자들의 인지기능 저하를 탐지하는 능력은 기대만큼 
예민하지 못한 것으로 확인되었다. 
연구 2 에서는 연구 1 의 결과를 바탕으로 정상노인집단, 경도인지장애 
환자집단, 알츠하이머병치매 환자집단을 대상으로 MMSE-2 와 K-MMSE 
(Korean version of the Mini-Mental State Examination) (강연욱 등, 
1997)중에서 어떤 검사 도구가 보다 정확하게 변별하는지 알아보고자 
하였다. 그 결과, MMSE-2 검사 중 MMSE-2:SV (MMSE-2:Standard 
version)와 MMSE-2:EV (MMSE-2:Expanded version)가 K-MMSE 보다 초기 
인지기능 저하를 더 민감하게 변별하였고, 치매가 진행이 될수록 K-
MMSE 나 MMSE-2:BV (MMSE-2:Brief version)가 임상적으로 더 유용하게 
쓰일 수 있는 것으로 나타나, MMSE-2 가 임상현장에서 인지기능 
선별검사로서 K-MMSE 보다 더 유용하게 쓰일 수 있는 것으로 
확인되었다. 
연구 3 에서는 뇌 자기공명영상(Magnetic resonance imaging: MRI)을 
이용하여 정상노인집단, 경도인지장애 환자집단, 알츠하이머병치매 
환자집단의 K-MMSE 와 MMSE-2 의 결과와 두뇌 위축 정도의 
상관관계를 살펴보았다. 그 결과, MMSE-2 가 K-MMSE 보다 전반적인 뇌 
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영역의 위축 정도와 관련도가 높았다. 특히 MMSE-2:EV 가 전반적인 뇌 
영역과 상관이 가장 높았고, K-MMSE 에서 측정하지 못하는 전두엽 
기능도 측정할 수 있어서 MMSE-2 가 임상현장에서 인지기능 
선별검사로서 K-MMSE 보다 더 유용하게  쓰일 수 있는 것으로 
확인되었다. 
연구 4 에서는 MMSE-2 소검사 중 집행기능을 측정하는 스피드검사와 
언어적 기억력을 자세히 측정하는 이야기기억검사가 추가 되었기 때문에 
MMSE 에서 변별하기 힘들었던 초기 혈관치매 환자들을 보다 더 
민감하게 변별할 수 있을 것이라 예상되었다. 따라서, 정상노인집단, 
혈관경도인지장애 환자집단, 혈관치매 환자집단을 신뢰롭게 변별하는지 
신뢰도와 타당도를 살펴본 결과, 연구 1 에서처럼 MMSE-2 가 혈관 
인지장애 환자들을 정상노인집단과 변별하는데 타당도와 신뢰도가 높게 
나와 임상적으로 유용하게 쓰일 수 있는 것으로 확인되었다.  
마지막으로, 연구 5 에서는 연구 4 의 결과를 바탕으로 정상노인집단, 
혈관경도인지장애 환자집단, 혈관치매 환자집단을 대상으로 MMSE 와 
MMSE-2 를 실시하여, 어떤 검사 도구가 보다 정확하게 변별하는지 
알아보고자 하였다. 그 결과, 연구 2 에서처럼, 정상노인들과 혈관성 
인지장애 환자들을 변별할 때도 MMSE-2:SV 와 MMSE-2:EV 가 K-
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MMSE 보다 초기 인지기능 저하를 더 민감하게 변별하는 것으로 
나타났고, 치매가 진행이 될수록 K-MMSE 나 MMSE-2:BV 가 더 유용하게 
쓰일 수 있는 것으로 확인되었다. 따라서, MMSE-2 가 알츠하이머병 치매 
환자들뿐만 아니라, 혈관성 인지장애 환자들을 대상으로도 임상 
장면에서 인지기능 선별검사로서 K-MMSE 보다 더 유용하게 쓰일 수 
있는 것으로 확인되었다. 
본 연구를 통하여 새롭게 개발된 MMSE-2 (Flostein 등, 2010)가 현재 
널리 사용되고 있는 MMSE 보다 경도인지장애 환자나 초기 치매 
환자들을 변별하는데 더 민감하고, 임상적으로 유용하게 쓰일 수 있음을 
보여주었다. 따라서, 앞으로 일차병원, 보건소, 노인복지관 등에서 일차 
인지기능 선별검사로서 널리 사용된다면, 조기 치매 발견에 도움을 줄 
수 있을 것이라 기대된다.   
 
주요어: MMSE, MMSE-2, K-MMSE, 경도인지장애, 알츠하이머병치매, 
혈관경도인지장애, 혈관치매 
학  번: 2015-30006 
